US20180346923A1 - Methods and Compositions for Plant Pest Control - Google Patents

Methods and Compositions for Plant Pest Control Download PDF

Info

Publication number
US20180346923A1
US20180346923A1 US16/011,218 US201816011218A US2018346923A1 US 20180346923 A1 US20180346923 A1 US 20180346923A1 US 201816011218 A US201816011218 A US 201816011218A US 2018346923 A1 US2018346923 A1 US 2018346923A1
Authority
US
United States
Prior art keywords
gene
plant
seq
transcript
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/011,218
Inventor
Michael J. Crawford
Xiangqian Li
Mahak Kapoor
Deryck Jeremy Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Technology LLC
Original Assignee
Monsanto Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology LLC filed Critical Monsanto Technology LLC
Priority to US16/011,218 priority Critical patent/US20180346923A1/en
Assigned to MONSANTO TECHNOLOGY LLC reassignment MONSANTO TECHNOLOGY LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LI, XIANGQIAN, KAPOOR, Mahak, WILLIAMS, DERYCK JEREMY, CRAWFORD, MICHAEL J.
Publication of US20180346923A1 publication Critical patent/US20180346923A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8285—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for nematode resistance
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
    • A01H1/12—Processes for modifying agronomic input traits, e.g. crop yield
    • A01H1/122—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • A01H1/1245—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance
    • A01H1/1255—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance for fungal resistance
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8206—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A01N63/04—
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/351—

Definitions

  • Powdery mildews are fungal diseases that affect a wide range of plants including cereals, grasses, vegetables, ornamentals, weeds, shrubs, fruit trees, broad-leaved shade and forest trees, that is caused by different species of fungi in the order Erysiphales.
  • the disease is characterized by spots or patches of white to grayish, talcum-powder-like growth that produce tiny, pinhead-sized, spherical fruiting structures (the cleistothecia or overwintering bodies of the fungus), that are first white, later yellow-brown and finally black.
  • the fungi that cause powdery mildews are host specific and cannot survive without the proper host plant.
  • mycelium fungal threads
  • haustoria or root-like structures
  • the fungi overwinter on plant debris as cleistothecia or mycelia.
  • the cleistothecia produce spores that are moved to susceptible hosts by rain, wind or insects.
  • Powdery mildew disease is particularly prevalent in temperate and humid climates, where they frequently cause significant yield losses and quality reductions in various agricultural settings including greenhouse and field farming. This affects key cereals (e.g. barley and wheat), horticultural crops (e.g. grapevine, pea and tomato) and economically important ornamentals (e.g. roses). Limited access to natural sources of resistance to powdery mildews, rapid changes in pathogen virulence and the time consuming introgression of suitable resistance genes into elite varieties has led to the widespread use of fungicides to control the disease. This has not surprisingly led to the evolution and spread of fungicide resistance, which is especially dramatic amongst the most economically important powdery mildews.
  • Downy mildew diseases are caused by oomycete microbes from the family Peronosporaceae that are parasites of plants. Peronosporaceae are obligate biotrophic plant pathogens and parasitize their host plants as an intercellular mycelium using haustoria to penetrate the host cells.
  • the downy mildews reproduce asexually by forming sporangia on distinctive white sporangiophores usually formed on the lower surface of infected leaves. These constitute the “downy mildew” and the initial symptoms appear on leaves as light green to yellow spots.
  • the sporangia are wind-dispersed to the surface of other leaves.
  • the sporangia may germinate by forming zoospores or by germ-tube. In the latter case, the sporangia behave like fungal conidia and are often referred to as such. Sexual reproduction is via oospores.
  • Peronosporaceae are pathogens of herbaceous dicots. Some downy mildew genera have relatively restricted host ranges, e.g. Basidiophora, Paraperonospora, Protobremia and Bremia on Asteraceae; Perofascia and Hyaloperonospora almost exclusively on Brassicaceae; Viennotia, Graminivora, Poakatesthia, Sclerospora and Peronosclerospora on Poaceae, Plasmoverna on Ranunculaceae. However, the largest genera, Peronospora and Plasmopara , have very wide host ranges.
  • Rusts Pucciniales , formerly Uredinales
  • Rusts are obligate biotrophic parasites of vascular plants. Rusts affect a variety of plants; leaves, stems, fruits and seeds and is most commonly seen as coloured powder, composed of tiny aeciospores which land on vegetation producing pustules, or uredia, that form on the lower surfaces.
  • yellow orange or brown, hairlike or ligulate structures called telia grow on the leaves or emerge from bark of woody hosts. These telia produce teliospores which will germinate into aerial basidiospores, spreading and causing further infection.
  • compositions comprising polynucleotide molecules and methods for treating a plant to alter or regulate gene or gene transcript expression in the plant, for example, by providing RNA or DNA for inhibition of expression.
  • Various aspects provide compositions comprising polynucleotide molecules and related methods for topically applying such compositions to plants to regulate endogenous BAX inhibitor 1 (BI-1) genes in a plant cell.
  • the polynucleotides, compositions, and methods disclosed herein are useful in decreasing levels of BI-1 transcript and improving fungal disease resistance of a plant.
  • compositions and methods that increase plant resistance to powdery mildew, downy mildew, rust infection or other fungal pathogens by suppression of plant BAX inhibitor 1 (BI-1) genes.
  • polynucleotide molecules are provided in compositions that can permeate or be absorbed into living plant tissue to initiate localized, partially systemic, or systemic gene inhibition or regulation.
  • the polynucleotide molecules ultimately provide to a plant, or allow the in planta production of, RNA that is capable of hybridizing under physiological conditions in a plant cell to RNA transcribed from a target endogenous gene or target transgene in the plant cell, thereby effecting regulation of the endogenous BI-1 target gene.
  • regulation of the BI-1 target genes such as by silencing or suppression of the target gene, leads to the upregulation of another gene that is itself affected or regulated by decreasing the BI-1 target gene's expression.
  • the topical application of a composition comprising an exogenous polynucleotide and a transfer agent to a plant or plant part according to the methods described herein does not necessarily result in nor require the exogenous polynucleotide's integration into a chromosome of the plant.
  • the topical application of a composition comprising an exogenous polynucleotide and a transfer agent to a plant or plant part according to the methods described herein does not necessarily result in nor require transcription of the exogenous polynucleotide from DNA integrated into a chromosome of the plant.
  • topical application of a composition comprising an exogenous polynucleotide and a transfer agent to a plant according to the methods described herein also does not necessarily require that the exogenous polynucleotide be physically bound to a particle, such as in biolistic mediated introduction of polynucleotides associated with a gold or tungsten particles into internal portions of a plant, plant part, or plant cell.
  • An exogenous polynucleotide used in certain methods and compositions provided herein can optionally be associated with an operably linked promoter sequence in certain embodiments of the methods provided herein.
  • an exogenous polynucleotide used in certain methods and compositions provided herein is not associated with an operably linked promoter sequence. Also, in certain embodiments, an exogenous polynucleotide used in certain methods and compositions provided herein is not operably linked to a viral vector.
  • methods for improving fungal disease resistance in a plant comprising topically applying compositions comprising a polynucleotide and a transfer agent that suppress the target BI-1 gene are provided.
  • methods for selectively suppressing the target BI-1 gene by topically applying the polynucleotide composition to a plant surface at one or more selected seed, vegetative, or reproductive stage(s) of plant growth are provided. Such methods can provide for gene suppression in a plant or plant part on an as needed or as desired basis.
  • methods for selectively suppressing the target BI-1 gene by topically applying the polynucleotide composition to a plant surface at one or more pre-determined seed, vegetative, or reproductive stage(s) of plant growth are provided. Such methods can provide for BI-1 gene suppression in a plant or plant part that obviates any undesired or unnecessary effects of suppressing the genes expression at certain seed, vegetative, or reproductive stage(s) of plant development.
  • methods for selectively improving fungal disease resistance in a plant by topically applying the polynucleotide composition to the plant surface at one or more selected seed, vegetative, or reproductive stage(s) are provided. Such methods can provide for improved fungal disease resistance in a plant or plant part on an as needed or as desired basis. In certain embodiments, methods for selectively improving fungal disease resistance in a plant by topically applying the polynucleotide composition to the plant surface at one or more predetermined seed, vegetative, or reproductive stage(s) are provided. Such methods can provide for improving fungal disease resistance in a plant or plant part that obviates any undesired or unnecessary effects of suppressing BI-1 gene expression at certain seed, vegetative, or reproductive stage(s) of plant development.
  • compositions that provide for the topical application of certain polynucleotides in the presence of transfer agents can be used to suppress BAX inhibitor 1 (BI-1) gene expression in an optimal manner.
  • Topically induced BI-1 gene suppression methods and compositions provided herein can control the timing and degree of BI-1 knockdown to achieve fungal control while minimizing deleterious pleotropic effects in the host plant.
  • the compositions provided herein can be applied on an “as needed” basis upon scouting for the occurrence of fungal disease.
  • the compositions can be applied in a manner that obviates any deleterious effects on yield or other characteristics that can be associated with suppression of BI-1 gene expression in a crop plant.
  • the applied polynucleotides are complementary to the BI-1 target host gene in plants and their topical application leads to suppression of the BI-1 gene.
  • Plant fungal diseases that can be controlled with the methods and compositions provided herein include, but are not limited to, obligate biotrophic powdery mildew, downy mildew, and rust fungal infestations in plants.
  • Plant fungal diseases that can be controlled with the methods and compositions provided herein also include, but are not limited to, fungal pathogens such as those causing anthracnose stalk rot, Diplodia Stalk or Ear Rot, Gibberella Stalk or Ear Rot, and Fusarium Stalk Rot in corn, or causing Take-all in wheat, Fusarium head blight in barley and wheat, or causing rice blast.
  • methods and compositions for reducing expression of one or more host plant BI-1 polynucleotide and/or protein molecules in one or more cells or tissues of the plant such that the plant is rendered less susceptible to fungal infections from the order Erysiphales, the family Peronosporaceae or the order Pucciniales are provided.
  • nucleotide and amino acid sequences of plant BAX inhibitor 1 (BI-1) genes which can be downregulated by methods and compositions provided herein to increase plant resistance to powdery mildew, downy mildew, rust infection, or fungal pathogens such as those causing anthracnose stalk rot, Diplodia Stalk or Ear Rot, Gibberella Stalk or Ear Rot, and Fusarium Stalk Rot in corn, or causing Take-all in wheat, Fusarium head blight in barley and wheat, or causing rice blast are disclosed.
  • powdery mildew fungi of the order Erysiphales which are controlled by the compositions and methods provided herein include, but are not limited to, Blumeria graminis f.
  • Examples of downy mildew of the family Peronosporaceae include Pseudoperonospora humuli, Pseudoperonospora cubensis, Plasmopara viticola, Peronospora tabacina, Bremia lactucae , and Plasmopara halstedii .
  • Examples of rusts of the order Pucciniales which are controlled by the compositions and methods provided herein include, but are not limited to, Phakopsora meibomiae, Phakopsora pachyrhizi, Puccinia graminis, Puccinia recondita, Uromyces phaseoli and Uromyces appendeculatus .
  • fungal pathogens which are controlled by the compositions and methods provided herein include, but are not limited to, Colletotrichum graminicola, Stenocarpella (or Diplodia ) maydis, Gibberella zeae, Fusarium moniliforme, Gaeumannomyces graminis, Fusarium graminearum, Magnaporthe grisea (also known as Pyricularia grisea or Pyricularia oryzae ), Septoria nodorum , and Septoria tritici.
  • Colletotrichum graminicola Stenocarpella (or Diplodia ) maydis
  • Gibberella zeae Fusarium moniliforme
  • Gaeumannomyces graminis Fusarium graminearum
  • Magnaporthe grisea also known as Pyricularia grisea or Pyricularia oryzae
  • Septoria nodorum Septoria tritici.
  • plants protected by the compositions and methods provided herein include, but are not limited to, barley, rye, wheat, rice, oats, corn, sorghum, switchgrass, and sugar cane.
  • Polynucleotides that can be used to suppress a BI-1 include, but are not limited to, any of: i) polynucleotides comprising at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BI-1 gene or to a transcript of the gene of SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32 or Example 5; or ii) polynucleotides comprising at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a polynucleotide of SEQ ID NO:33-106, 109-140, or 142-146 as provided herein.
  • the polynucleotide molecule comprises sense ssDNA, sense ssRNA, dsRNA, dsDNA, a double stranded DNA/RNA hybrid, anti-sense ssDNA, or anti-sense ssRNA.
  • the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
  • the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
  • the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucle
  • the composition comprises any combination of two or more polynucleotide molecules.
  • the polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length.
  • the composition further comprises a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, a polynucleotide that suppresses an herbicide target gene, an insecticide, a fungicide, a nematocide, or a combination thereof.
  • the composition further comprises a non-polynucleotide herbicidal molecule and the plant is resistant to the herbicidal molecule.
  • the transfer agent comprises an organosilicone preparation.
  • the polynucleotide is not operably linked to a viral vector. In certain embodiments of the methods, the polynucleotide is not integrated into the plant chromosome.
  • Further embodiments are directed to: a plant made according to the above-described methods; progeny of the plant that exhibit fungal disease resistance; seed of the plant, wherein seed from the plant exhibits fungal disease resistance; and a processed product of the plant, the progeny plant, or the seed, wherein the processed product exhibits fungal disease resistance.
  • the processed product exhibits an improved attribute relative to a processed product of an untreated control plant and the improved attribute results from the improved fungal disease resistance.
  • An improved attribute of a processed product can include, but is not limited to, decreased mycotoxin content, improved nutritional content, improved storage characteristics, improved flavor, improved consistency, and the like when compared to a processed product obtained from an untreated plant or plant part.
  • compositions comprising a polynucleotide molecule that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of the gene, wherein the polynucleotide is not operably linked to a promoter; and, b) a transfer agent.
  • a polynucleotide molecule that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of the gene, wherein the polynucleotide is not operably linked to a promoter; and, b) a transfer agent.
  • BI-1 BAX inhibitor 1
  • the polynucleotide is selected from the group consisting of wherein the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
  • the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
  • the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of
  • the polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length.
  • the composition further comprises a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, a polynucleotide that suppresses an herbicide target gene, an insecticide, a fungicide, a nematocide, or a combination thereof.
  • the transfer agent is an organosilicone preparation.
  • the polynucleotide is not physically bound to a biolistic particle.
  • compositions comprising the step of combining at least: a) a polynucleotide molecule comprising at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of a plant, wherein the polynucleotide is not operably linked to a promoter or a viral vector; and, b) a transfer agent.
  • the polynucleotide is obtained by in vivo biosynthesis, in vitro enzymatic synthesis, or chemical synthesis.
  • the methods further comprises combining with the polynucleotide and the transfer agent at least one of a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, an insecticide, a fungicide, and/or a nematocide.
  • the transfer agent is an organosilicone preparation.
  • the polynucleotide is selected from the group consisting of wherein the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
  • the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
  • the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucle
  • a further embodiment is directed to a plant comprising an exogenous polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of the gene, wherein the exogenous polynucleotide is not operably linked to a promoter or to a viral vector, is not integrated into the chromosomal DNA of the plant, and is not found in a non-transgenic plant; and, wherein the plant exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene.
  • the plant further comprises an organosilicone compound or a component thereof.
  • the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
  • the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
  • the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene
  • An additional embodiment is directed to a plant part comprising an exogenous polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of the gene, wherein the exogenous polynucleotide is not operably linked to a promoter or to a viral vector and is not found in a non-transgenic plant; and, wherein the plant part exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene.
  • the plant part further comprises an organosilicone compound or a component thereof.
  • the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • the plant part is a barley plant part
  • the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript
  • the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24
  • the plant part is a rice plant part
  • the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript
  • the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26
  • the plant part is a wheat plant part
  • the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript
  • the plant part is a flower, meristem, ovule, stem, tuber, fruit, anther, pollen, leaf, root, or seed.
  • the plant part is a seed.
  • processed plant products obtained from the plant parts that exhibit an improved attribute relative to a processed plant product of an untreated control plant and wherein the improved attribute results from the improved disease tolerance.
  • the processed product is a meal, a pulp, a feed, or a food product.
  • Another embodiment is directed to a plant that exhibits an improvement in fungal disease resistance, wherein the plant was topically treated with a composition that comprises: a. at least one polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or to a transcript of the gene; and, b. a transfer agent; and, wherein the plant exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene.
  • the transfer agent is an organosilicone preparation.
  • Certain embodiments are directed to a method for providing a seed that produces a plant exhibiting an improvement in fungal disease resistance comprising: a) soaking the seed in a liquid composition that comprises at least one polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or to a transcript of the gene, wherein the seed produces a plant exhibiting an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene.
  • the liquid composition further comprises a transfer agent.
  • the polynucleotide comprises sense ssDNA, sense ssRNA, dsRNA, dsDNA, a double stranded DNA/RNA hybrid, anti-sense ssDNA, or anti-sense ssRNA.
  • the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • the seed is a barley seed
  • the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript
  • the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24
  • the seed is a rice seed
  • the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript
  • the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26
  • the seed is a wheat seed, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript
  • the liquid composition comprises any combination of two or more polynucleotide molecules.
  • the polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length.
  • the composition further comprises an insecticide, a fungicide, a nematocide, or a combination thereof.
  • the transfer agent comprises an organosilicone preparation.
  • the polynucleotide is not operably linked to a viral vector. In certain embodiments, the polynucleotide is not integrated into the plant chromosome.
  • Further embodiments are directed to: a plant grown from a seed treated according to the above-described methods; progeny of the plant that exhibit fungal disease resistance; seed of the plant, wherein seed from the plant exhibits fungal disease resistance; and a processed product of the plant, the progeny plant, or the seed, wherein the processed product exhibits fungal disease resistance.
  • the processed product exhibits an improved attribute relative to a processed product of an untreated control plant and the improved attribute results from the improved fungal disease resistance.
  • An improved attribute of a processed product can include, but is not limited to, decreased mycotoxin content, improved nutritional content, improved storage characteristics, improved flavor, improved consistency, and the like when compared to a processed product obtained from an untreated plant or plant part.
  • transgenes can be integrated into the genome of the transgenic plant or provided in recombinant viral genomes that can be propagated in the plant.
  • the transgene confers an improvement in fungal disease resistance and/or nematode resistance to the transgenic plants or plant parts that contain the transgene.
  • the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a polynucleotide selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146 or comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BI-1 gene or to a transcript of the gene of SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
  • the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
  • the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene
  • the transgenic plant part is a flower, meristem, ovule, stem, tuber, fruit, anther, pollen, leaf, root, or seed.
  • Processed plant products containing the transgene include, but are not limited to, a meal a pulp, a feed, or a food product obtainable from the transgenic plant parts.
  • the processed plant products exhibit an improved attribute relative to a processed plant product of an untreated control plant and wherein the improved attribute results from the improved fungal disease resistance and/or nematode resistance conferred by the transgene.
  • the processed product is a meal, a pulp, a feed, or a food product.
  • Also provided herein are methods for obtaining transgenic plants exhibiting an improvement in fungal disease resistance and/or nematode resistance comprising the steps of introducing any of the aforementioned transgenes into the genome of a plant and selecting for a transgenic plant wherein expression of an endogenous BAX inhibitor 1 (BI-1) gene is suppressed, thereby obtaining a plant exhibiting an improvement in fungal disease resistance and/or nematode resistance.
  • BI-1 BAX inhibitor 1
  • Also provided herein are methods for improving fungal disease resistance and/or nematode resistance in plants that comprise growing transgenic plants comprising any of the aforementioned transgenes wherein expression of an endogenous BI-1 gene is suppressed in the presence of fungi and/or nematodes, wherein fungal disease resistance and/or nematode resistance of the transgenic plants is improved in comparison to a control plant that lack a transgene that suppresses an endogenous BI-1 gene in the control plant.
  • FIG. 1A , B Panel A. shows a graph of cyst counts for Soy Cyst Nematode (SCN) disease measurement at twenty eight days after treatment and inoculation with SCN. Panel B. shows a graph of gall weights.
  • SCN Soy Cyst Nematode
  • FIG. 2 presents the gall rating results for Root Knot Nematode (RKN) disease measured as % root mass galled for dsRNA treatments (or controls) followed by inoculation with vermiform eggs.
  • RKN Root Knot Nematode
  • DNA refers to a single-stranded DNA or double-stranded DNA molecule of genomic or synthetic origin, such as, a polymer of deoxyribonucleotide bases or a DNA polynucleotide molecule.
  • DNA sequence As used herein, the terms “DNA sequence,” “DNA nucleotide sequence,” and “DNA polynucleotide sequence” refer to the nucleotide sequence of a DNA molecule.
  • the term “gene” refers to any portion of a nucleic acid that provides for expression of a transcript or encodes a transcript.
  • a “gene” thus includes, but is not limited to, a promoter region, 5′ untranslated regions, transcript encoding regions that can include intronic regions, and 3′ untranslated regions.
  • RNA refers to a single-stranded RNA or double-stranded RNA molecule of genomic or synthetic origin, such as, a polymer of ribonucleotide bases that comprise single or double stranded regions.
  • nucleotide sequences in the text of this specification are given, when read from left to right, in the 5′ to 3′ direction.
  • the nomenclature used herein is that required by Title 37 of the United States Code of Federal Regulations ⁇ 1.822 and set forth in the tables in WIPO Standard ST.25 (1998), Appendix 2, Tables 1 and 3.
  • a “plant surface” refers to any exterior portion of a plant. Plant surfaces thus include, but are not limited to, the surfaces of flowers, stems, tubers, fruit, anthers, pollen, leaves, roots, or seeds. A plant surface can be on a portion of a plant that is attached to other portions of a plant or on a portion of a plant that is detached from the plant.
  • polynucleotide is not operably linked to a promoter refers to a polynucleotide that is not covalently linked to a polynucleotide promoter sequence that is specifically recognized by either a DNA dependent RNA polymerase II protein or by a viral RNA dependent RNA polymerase in such a manner that the polynucleotide will be transcribed by the DNA dependent RNA polymerase II protein or viral RNA dependent RNA polymerase.
  • a polynucleotide that is not operably linked to a promoter can be transcribed by a plant RNA dependent RNA polymerase.
  • SEQ ID NO: though displayed in the Sequence Listing in the form of ssDNA or ssRNA, encompass dsDNA equivalents, dsRNA equivalents, ssRNA as shown or equivalents, ssRNA complements, ssDNA as shown or equivalents, and ssDNA complements.
  • a first nucleic-acid sequence is “operably” connected or “linked” with a second nucleic acid sequence when the first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence.
  • a promoter is operably linked to an RNA and/or protein-coding sequence if the promoter provides for transcription or expression of the RNA or coding sequence.
  • operably linked DNA sequences are contiguous and, where necessary to join two protein-coding regions, are in the same reading frame.
  • organosilicone preparation refers to a liquid comprising one or more organosilicone compounds, wherein the liquid or components contained therein, when combined with a polynucleotide in a composition that is topically applied to a target plant surface, enable the polynucleotide to enter a plant cell.
  • organosilicone preparations include, but are not limited to, preparations marketed under the trade names “Silwet®” or “BREAK-THRU®” and preparations provided in Table 1.
  • an organosilicone preparation can enable a polynucleotide to enter a plant cell in a manner permitting a polynucleotide suppression of target gene expression in the plant cell.
  • an improvement in fungal disease resistance refers to any measurable increase in a plants resistance to fungal damage.
  • an improvement in fungal disease resistance in a plant or plant part can be determined in a comparison to a control plant or plant part that has not been treated with a composition comprising a polynucleotide and a transfer agent.
  • a control plant is a plant that has not undergone treatment with polynucleotide and a transfer agent. Such control plants would include, but are not limited to, untreated plants or mock treated plants.
  • a reduction of the level of a transcript in a plant or plant part can be determined in a comparison to a control plant or plant part that has not been treated with a composition comprising a polynucleotide and a transfer agent.
  • a control plant or plant part is a plant or plant part that has not undergone treatment with polynucleotide and a transfer agent.
  • Such control plants or plant parts would include, but are not limited to, untreated or mock treated plants and plant parts.
  • the phrase “wherein said plant does not comprise a transgene” refers to a plant that lacks either a DNA molecule comprising a promoter that is operably linked to a polynucleotide or a recombinant viral vector.
  • expression of a gene can be suppressed when there is a reduction in levels of a transcript from the gene, a reduction in levels of a protein encoded by the gene, a reduction in the activity of the transcript from the gene, a reduction in the activity of a protein encoded by the gene, any one of the preceding conditions, or any combination of the preceding conditions.
  • the activity of a transcript includes, but is not limited to, its ability to be translated into a protein and/or to exert any RNA-mediated biologic or biochemical effect.
  • the activity of a protein includes, but is not limited to, its ability to exert any protein-mediated biologic or biochemical effect.
  • a suppression of gene expression in a plant or plant part can be determined in a comparison of gene product levels or activities in a treated plant to a control plant or plant part that has not been treated with a composition comprising a polynucleotide and a transfer agent.
  • a control plant or plant part is a plant or plant part that has not undergone treatment with polynucleotide and a transfer agent.
  • Such control plants or plant parts would include, but are not limited to, untreated or mock treated plants and plant parts.
  • transcript corresponds to any RNA that is produced from a gene by the process of transcription.
  • a transcript of a gene can thus comprise a primary transcription product which can contain introns or can comprise a mature RNA that lacks introns.
  • liquid refers to both homogeneous mixtures such as solutions and non-homogeneous mixtures such as suspensions, colloids, micelles, and emulsions.
  • the hypersensitive reaction (HR) in plants is a form of programmed cell death involved in many developmental processes and stress responses including disease resistance to pathogens.
  • the protein BAX inhibitor 1 (BI-1), localized at the endoplasmic reticulum and the nuclear envelope in both plants and animals, is a negative regulator of programmed cell death.
  • the silencing of BAX inhibitor 1 increases the resistance of barley to powdery mildew infection.
  • compositions that can be applied to living plant cells/tissues to suppress expression of target genes and that provide improved fungal disease resistance to a crop plant.
  • plants and plant parts exhibiting fungal disease resistance as well as processed products of such plants or plant parts.
  • the compositions may be topically applied to the surface of a plant, such as to the surface of a leaf, and include a transfer agent.
  • aspects of the method can be applied to various crops, for example, including but not limited to: i) row crop plants including, but are not limited to, corn, barley, sorghum, soybean, cotton, canola, sugar beet, alfalfa, sugarcane, rice, and wheat; ii) vegetable plants including, but not limited to, tomato, potato, sweet pepper, hot pepper, melon, watermelon, cucumber, eggplant, cauliflower, broccoli, lettuce, spinach, onion, peas, carrots, sweet corn, Chinese cabbage, leek, fennel, pumpkin, squash or gourd, radish, Brussels sprouts, tomatillo, garden beans, dry beans, or okra; iii) culinary plants including, but not limited to, basil, parsley, coffee, or tea; iv) fruit plants including but not limited to apple, pear, cherry, peach, plum, apricot, banana, plantain, table grape, wine grape, citrus, avocado, mango, or berry; v) a tree grown
  • an ornamental flowering plant or shrub or turf grass g., an ornamental flowering plant or shrub or turf grass.
  • the methods and compositions provided herein can also be applied to plants produced by a cutting, cloning, or grafting process (i. e., a plant not grown from a seed) that include fruit trees and plants.
  • Fruit trees produced by such processes include, but are not limited to, citrus and apple trees.
  • Plants produced by such processes include, but are not limited to, avocados, tomatoes, eggplant, cucumber, melons, watermelons, and grapes as well as various ornamental plants.
  • compositions and methods of the present embodiments are believed to operate through one or more of the several natural cellular pathways involved in RNA-mediated gene suppression as generally described in Brodersen and Voinnet (2006), Trends Genetics, 22:268-280; Tomari and Zamore (2005) Genes & Dev., 19:517-529; Vaucheret (2006) Genes Dev., 20:759-771; Meins et al. (2005) Annu. Rev. Cell Dev. Biol., 21:297-318; and Jones-Rhoades et al. (2006) Annu. Rev. Plant Biol., 57:19-53.
  • RNA-mediated gene suppression generally involves a double-stranded RNA (dsRNA) intermediate that is formed intra-molecularly within a single RNA molecule or inter-molecularly between two RNA molecules.
  • This longer dsRNA intermediate is processed by a ribonuclease of the RNAase III family (Dicer or Dicer-like ribonuclease) to one or more shorter double-stranded RNAs, one strand of which is incorporated into the RNA-induced silencing complex (“RISC”).
  • RISC RNA-induced silencing complex
  • siRNA pathway involves the cleavage of a longer double-stranded RNA intermediate to small interfering RNAs (“siRNAs”).
  • siRNAs The size of siRNAs is believed to range from about 19 to about 25 base pairs, but the most common classes of siRNAs in plants include those containing 21 to 24 base pairs (See, Hamilton et al. (2002) EMBO J., 21:4671-4679).
  • polynucleotide refers to a DNA or RNA molecule containing multiple nucleotides and generally refers both to “oligonucleotides” (a polynucleotide molecule of 18-25 nucleotides in length) and longer polynucleotides of 26 or more nucleotides.
  • Embodiments include compositions including oligonucleotides having a length of 18-25 nucleotides (18-mers, 19-mers, 20-mers, 21-mers, 22-mers, 23-mers, 24-mers, or 25-mers), or medium-length polynucleotides having a length of 26 or more nucleotides (polynucleotides of 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, about 65, about 70, about 75, about 80, about 85, about 90, about 95, about 100, about 110, about 120, about 130, about 140, about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, about 250, about 260, about 270, about 280, about 290, or about
  • a polynucleotide is double-stranded, its length can be similarly described in terms of base pairs.
  • Polynucleotide compositions used in the various embodiments include compositions including oligonucleotides, polynucleotides, or a mixture of both, including: RNA or DNA or RNA/DNA hybrids or chemically modified oligonucleotides or polynucleotides or a mixture thereof.
  • the polynucleotide may be a combination of ribonucleotides and deoxyribonucleotides, for example, synthetic polynucleotides consisting mainly of ribonucleotides but with one or more terminal deoxyribonucleotides or synthetic polynucleotides consisting mainly of deoxyribonucleotides but with one or more terminal dideoxyribonucleotides.
  • the polynucleotide includes non-canonical nucleotides such as inosine, thiouridine, or pseudouridine.
  • the polynucleotide includes chemically modified nucleotides.
  • Examples of chemically modified oligonucleotides or polynucleotides are well known in the art; see, for example, U.S. Patent Publication 2011/0171287, U.S. Patent Publication 2011/0171176, U.S. Patent Publication 2011/0152353, U.S. Patent Publication 2011/0152346, and U.S. Patent Publication 2011/0160082, which are herein incorporated by reference.
  • Illustrative examples include, but are not limited to, the naturally occurring phosphodiester backbone of an oligonucleotide or polynucleotide which can be partially or completely modified with phosphorothioate, phosphorodithioate, or methylphosphonate internucleotide linkage modifications, modified nucleoside bases or modified sugars can be used in oligonucleotide or polynucleotide synthesis, and oligonucleotides or polynucleotides can be labeled with a fluorescent moiety (e. g., fluorescein or rhodamine) or other label (e. g., biotin).
  • a fluorescent moiety e. g., fluorescein or rhodamine
  • biotin e.g., biotin
  • Polynucleotides can be single- or double-stranded RNA, single- or double-stranded DNA, double-stranded DNA/RNA hybrids, and modified analogues thereof.
  • the polynucleotides that provide single-stranded RNA in the plant cell may be: (a) a single-stranded RNA molecule (ssRNA), (b) a single-stranded RNA molecule that self-hybridizes to form a double-stranded RNA molecule, (c) a double-stranded RNA molecule (dsRNA), (d) a single-stranded DNA molecule (ssDNA), (e) a single-stranded DNA molecule that self-hybridizes to form a double-stranded DNA molecule, (f) a single-stranded DNA molecule including a modified Pol III gene that is transcribed to an RNA molecule, (g) a double-stranded DNA molecule (dss
  • these polynucleotides can comprise both ribonucleic acid residues and deoxyribonucleic acid residues. In certain embodiments, these polynucleotides include chemically modified nucleotides or non-canonical nucleotides. In certain embodiments of the methods, the polynucleotides include double-stranded DNA formed by intramolecular hybridization, double-stranded DNA formed by intermolecular hybridization, double-stranded RNA formed by intramolecular hybridization, or double-stranded RNA formed by intermolecular hybridization.
  • the anti-sense strand will comprise at least 18 nucleotides that are essentially complementary to the target gene.
  • the polynucleotides include single-stranded DNA or single-stranded RNA that self-hybridizes to form a hairpin structure having an at least partially double-stranded structure including at least one segment that will hybridize to RNA transcribed from the gene targeted for suppression. Not intending to be bound by any mechanism, it is believed that such polynucleotides are or will produce single-stranded RNA with at least one segment that will hybridize to RNA transcribed from the gene targeted for suppression.
  • the polynucleotides can be operably linked to a promoter—generally a promoter functional in a plant, for example, a pol II promoter, a pol III promoter, a pol IV promoter, or a pol V promoter.
  • a promoter generally a promoter functional in a plant, for example, a pol II promoter, a pol III promoter, a pol IV promoter, or a pol V promoter.
  • the polynucleotide molecules of the present embodiments are designed to modulate expression by inducing regulation or suppression of an endogenous gene in a plant and are designed to have a nucleotide sequence essentially identical or essentially complementary to the nucleotide sequence of an endogenous gene of a plant or to the sequence of RNA transcribed from an endogenous gene of a plant, which can be coding sequence or non-coding sequence.
  • a trigger or triggers
  • the trigger polynucleotides or at least one strand of a double-stranded polynucleotide have sufficient identity or complementarity to the endogenous gene or to the RNA transcribed from the endogenous gene (e.g. the transcript) to suppress expression of the endogenous gene (e.g. to effect a reduction in levels or activity of the gene transcript and/or encoded protein).
  • Polynucleotides of the methods and compositions provided herein need not have 100 percent identity to a complementarity to the endogenous gene or to the RNA transcribed from the endogenous gene (i.e. the transcript) to suppress expression of the endogenous gene (i.e.
  • the polynucleotide or a portion thereof is designed to be essentially identical to, or essentially complementary to, a sequence of at least 18 or 19 contiguous nucleotides in either the target gene or messenger RNA transcribed from the target gene (e.g. the transcript).
  • an “essentially identical” polynucleotide has 100 percent sequence identity or at least about 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99 percent sequence identity when compared to the sequence of 18 or more contiguous nucleotides in either the endogenous target gene or to an RNA transcribed from the target gene (e.g. the transcript).
  • an “essentially complementary” polynucleotide has 100 percent sequence complementarity or at least about 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99 percent sequence complementarity when compared to the sequence of 18 or more contiguous nucleotides in either the target gene or RNA transcribed from the target gene.
  • polynucleotides used in the methods and compositions provided herein can be essentially identical or essentially complementary to any of: i) conserved regions of BAX inhibitor 1 (BI-1) genes of both monocot and dicot plants; ii) conserved regions of BAX inhibitor 1 (BI-1) genes of monocot plants; or iii) conserved regions of BAX inhibitor 1 (BI-1) genes of dicot plants.
  • Such polynucleotides that are essentially identical or essentially complementary to such conserved regions can be used to improve fungal disease resistance by suppressing expression of BAX inhibitor 1 (BI-1) genes in any of: i) both dicot and monocot plants, including, but not limited to, corn, barley, wheat, sorghum, rice, cucumber, pea, Medicago sp., soybean, pepper, tomato, and grape; ii) monocot plants, including, but not limited to, corn, barley, wheat, sorghum, switchgrass, and rice, and; or iii) dicot plants, including, but not limited to, cucumber, pea, Medicago sp., soybean, pepper, tomato, and grape.
  • conserveed regions of dicot and monocot plant BAX inhibitor 1 (BI-1) genes of SEQ ID NO: 2, 4, 6, 7, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, and 32 can be targeted by essentially identical or essentially complementary polynucleotides.
  • a polynucleotide can comprise at least 19 contiguous nucleotides that are essentially identical or essentially complementary to said gene or said transcript or comprises at least 19 contiguous nucleotides that are essentially identical or essentially complementary to the target gene or target gene transcript.
  • a polynucleotide of 19 continuous nucleotides that is essentially identical or essentially complementary to the endogenous target gene or to an RNA transcribed from the target gene can have 1 or 2 mismatches to the target gene or transcript.
  • a polynucleotide of 20 or more nucleotides that contains a contiguous 19 nucleotide span of identity or complementarity to the endogenous target gene or to an RNA transcribed from the target gene can have 1 or 2 mismatches to the target gene or transcript.
  • a polynucleotide of 21 continuous nucleotides that is essentially identical or essentially complementary to the endogenous target gene or to an RNA transcribed from the target gene e.g. the transcript
  • a polynucleotide of 22 or more nucleotides that contains a contiguous 21 nucleotide span of identity or complementarity to the endogenous target gene or to an RNA transcribed from the target gene can have 1, 2, or 3 mismatches to the target gene or transcript.
  • mismatches of certain types and at certain positions that are more likely to be tolerated can be used.
  • mismatches formed between adenine and cytosine or guanosine and uracil residues are used as described by Du et al. Nucleic Acids Research, 2005, Vol.
  • mismatches in 19 base pair overlap regions can be at the low tolerance positions 5, 7, 8 or 11 (from the 5′ end of a 19 nucleotide target) with well tolerated nucleotide mismatch residues, at medium tolerance positions 3, 4, and 12-17, and/or at the high tolerance nucleotide positions at either end of the region of complementarity (i.e. positions 1, 2, 18, and 19) as described by Du et al. Nucleic Acids Research, 2005, Vol. 33, No. 5 1671-1677.
  • tolerated mismatches can be empirically determined in assays where the polynucleotide is applied to the plants via the methods provided herein and the treated plants assayed for suppression of BAX inhibitor 1 (BI-1) expression or appearance of fungal disease resistance.
  • polynucleotide molecules are designed to have 100 percent sequence identity with or complementarity to one allele or one family member of a given target gene coding or non-coding sequence of a BI-1 target gene. In other embodiments, the polynucleotide molecules are designed to have 100 percent sequence identity with or complementarity to multiple alleles or family members of a given BAX inhibitor 1 (BI-1) target gene.
  • the polynucleotide can thus comprise at least 18 contiguous nucleotides that are identical or complementary to SEQ ID NO: 33-106, 108-140, or 142-146. In certain embodiments, the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • polynucleotide compositions and methods provided herein typically effect regulation or modulation (e. g., suppression) of gene expression during a period during the life of the treated plant of at least 1 week or longer and typically in systemic fashion. For instance, within days of treating a plant leaf with a polynucleotide composition as described herein, primary and transitive siRNAs can be detected in other leaves lateral to and above the treated leaf and in apical tissue.
  • methods of systemically suppressing expression of a gene in a plant comprising treating said plant with a composition comprising at least one polynucleotide and a transfer agent, wherein said polynucleotide comprises at least 18 or at least 19 contiguous nucleotides that are essentially identical or essentially complementary to a gene or a transcript encoding a BAX inhibitor 1 (BI-1) gene of the plant are provided, whereby expression of the gene in said plant or progeny thereof is systemically suppressed in comparison to a control plant that has not been treated with the composition.
  • a composition comprising at least one polynucleotide and a transfer agent, wherein said polynucleotide comprises at least 18 or at least 19 contiguous nucleotides that are essentially identical or essentially complementary to a gene or a transcript encoding a BAX inhibitor 1 (BI-1) gene of the plant are provided, whereby expression of the gene in said plant or progeny thereof is systemically suppressed in comparison to a control plant
  • compositions used to suppress a target gene can comprise one or more polynucleotides that are essentially identical or essentially complementary to multiple genes, or to multiple segments of one or more genes.
  • compositions used to suppress a target gene can comprise one or more polynucleotides that are essentially identical or essentially complementary to multiple consecutive segments of a target gene, multiple non-consecutive segments of a target gene, multiple alleles of a target gene, or multiple target genes from one or more species.
  • the polynucleotide includes two or more copies of a nucleotide sequence (of 18 or more nucleotides) where the copies are arranged in tandem fashion.
  • the polynucleotide includes two or more copies of a nucleotide sequence (of 18 or more nucleotides) where the copies are arranged in inverted repeat fashion (forming an at least partially self-complementary strand).
  • the polynucleotide can include both tandem and inverted-repeat copies. Whether arranged in tandem or inverted repeat fashion, each copy can be directly contiguous to the next, or pairs of copies can be separated by an optional spacer of one or more nucleotides.
  • the optional spacer can be unrelated sequence (i.
  • the polynucleotide includes two copies of a nucleotide sequence of between about 20 to about 30 nucleotides, where the two copies are separated by a spacer no longer than the length of the nucleotide sequence.
  • Polynucleotide trigger molecules can be identified by “tiling” gene targets in random length fragments, e.g. 200-300 polynucleotides in length, with partially overlapping regions, e.g. 25 or so nucleotide overlapping regions along the length of the target gene. Multiple gene target sequences can be aligned and polynucleotide sequence regions with homology in common are identified as potential trigger molecules for multiple targets. Multiple target sequences can be aligned and sequence regions with poor homology are identified as potential trigger molecules for selectively distinguishing targets. To selectively suppress a single gene, trigger sequences may be chosen from regions that are unique to the target gene either from the transcribed region or the non-coding regions, e.g., promoter regions, 3′ untranslated regions, introns and the like.
  • Polynucleotides fragments are designed along the length of the full length coding and untranslated regions of a BI-1 gene or family member as contiguous overlapping fragments of 200-300 polynucleotides in length or fragment lengths representing a percentage of the target gene. These fragments are applied topically (as sense or anti-sense ssDNA or ssRNA, dsRNA, or dsDNA) to determine the relative effectiveness in providing the fungal disease resistance phenotype. Fragments providing the desired activity may be further subdivided into 50-60 polynucleotide fragments which are evaluated for providing the fungal disease resistance phenotype.
  • the 50-60 base fragments with the desired activity may then be further subdivided into 19-30 base fragments which are evaluated for providing the fungal disease resistance phenotype. Once relative effectiveness is determined, the fragments are utilized singly, or in combination in one or more pools to determine effective trigger composition or mixture of trigger polynucleotides for providing the fungal disease resistance phenotype.
  • Coding and/or non-coding sequences of gene families in the crop of interest are aligned and 200-300 polynucleotide fragments from the least homologous regions amongst the aligned sequences are evaluated using topically applied polynucleotides (as sense or anti-sense ssDNA or ssRNA, dsRNA, or dsDNA) to determine their relative effectiveness in providing the fungal disease resistance phenotype.
  • the effective segments are further subdivided into 50-60 polynucleotide fragments, prioritized by least homology, and reevaluated using topically applied polynucleotides.
  • the effective 50-60 polynucleotide fragments are subdivided into 19-30 polynucleotide fragments, prioritized by least homology, and again evaluated for induction of the fungal disease resistance phenotype. Once relative effectiveness is determined, the fragments are utilized singly, or again evaluated in combination with one or more other fragments to determine the trigger composition or mixture of trigger polynucleotides for providing the fungal disease resistance phenotype.
  • Coding and/or non-coding sequences of gene families in the crop of interest are aligned and 200-300 polynucleotide fragments from the most homologous regions amongst the aligned sequences are evaluated using topically applied polynucleotides (as sense or anti-sense ssDNA or ssRNA, dsRNA, or dsDNA) to determine their relative effectiveness in inducing the fungal disease resistance phenotype.
  • the effective segments are subdivided into 50-60 polynucleotide fragments, prioritized by most homology, and reevaluated using topically applied polynucleotides.
  • the effective 50-60 polynucleotide fragments are subdivided into 19-30 polynucleotide fragments, prioritized by most homology, and again evaluated for induction of the yield/quality phenotype. Once relative effectiveness is determined, the fragments may be utilized singly, or in combination with one or more other fragments to determine the trigger composition or mixture of trigger polynucleotides for providing the fungal disease resistance phenotype.
  • a preferred polynucleotide for improving fungal disease in a plant are provided herein.
  • Populations of candidate polynucleotides that are essentially identical or essentially complementary to a BI-1 gene or transcript of the gene can be generated by a variety of approaches, including but not limited to, any of the tiling, least homology, or most homology approaches provided herein.
  • populations of polynucleotides can also be generated or obtained from any of the polynucleotides or genes provided herewith in SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 33-106, 108-140, or 142-146.
  • Such populations of polynucleotides can also be generated or obtained from any genes that are orthologous to the genes or proteins provided herewith as SEQ ID NO: 1-32.
  • Such polynucleotides can be topically applied to a surface of plants in a composition comprising at least one polynucleotide from said population and a transfer agent to obtain treated plants.
  • Treated plants that exhibit suppression of the BI-1 gene and/or exhibit an improvement in fungal disease resistance are identified, thus identifying a preferred polynucleotide that improves fungal disease in a plant. Suppression of the gene can be determined by any assay for the levels and/or activity of a gene product (i.e. transcript or protein).
  • Suitable assays for transcripts include, but are not limited to, semi-quantitative or quantitative reverse transcriptase PCR® (qRT-PCR) assays.
  • Suitable assays for proteins include, but are not limited to, semi-quantitative or quantitative immunoassays, biochemical activity assays, or biological activity assays.
  • the polynucleotides can be applied alone. In other embodiments, the polynucleotides can be applied in pools of multiple polynucleotides.
  • the pool can be de-replicated and retested as necessary or desired to identify one or more preferred polynucleotide(s) that improves fungal disease resistance in a plant.
  • RNA molecules can be made by either in vivo or in vitro synthesis from DNA templates where a suitable promoter is operably linked to the polynucleotide and a suitable DNA-dependent RNA polymerase is provided.
  • DNA-dependent RNA polymerases include, but are not limited to, E. coli or other bacterial RNA polymerases as well as the bacteriophage RNA polymerases such as the T7, T3, and SP6 RNA polymerases.
  • oligonucleotides often provides two deoxyribonucleotides on the 3′ end of the sense strand.
  • Long polynucleotide molecules can be synthesized from commercially available kits, for example, kits from Applied Biosystems/Ambion (Austin, Tex.) have DNA ligated on the 5′ end that encodes a bacteriophage T7 polymerase promoter that makes RNA strands that can be assembled into a dsRNA.
  • dsRNA molecules can be produced from expression cassettes in bacterial cells that have regulated or deficient RNase III enzyme activity.
  • Long polynucleotide molecules can also be assembled from multiple RNA or DNA fragments.
  • design parameters such as Reynolds score (Reynolds et al. Nature Biotechnology 22, 326-330 (2004) and Tuschl rules (Pei and Tuschl, Nature Methods 3(9): 670-676, 2006) are known in the art and are used in selecting polynucleotide sequences effective in gene silencing.
  • random design or empirical selection of polynucleotide sequences is used in selecting polynucleotide sequences effective in gene silencing.
  • the sequence of a polynucleotide is screened against the genomic DNA of the intended plant to minimize unintentional silencing of other genes.
  • concentrations and dosages of polynucleotide molecules While there is no upper limit on the concentrations and dosages of polynucleotide molecules that can be useful in the methods and compositions provided herein, lower effective concentrations and dosages will generally be sought for efficiency.
  • concentrations can be adjusted in consideration of the volume of spray or treatment applied to plant leaves or other plant part surfaces, such as flower petals, stems, tubers, fruit, anthers, pollen, leaves, roots, or seeds.
  • a useful treatment for herbaceous plants using 25-mer polynucleotide molecules is about 1 nanomole (nmol) of polynucleotide molecules per plant, for example, from about 0.05 to 1 nmol polynucleotides per plant.
  • herbaceous plants include useful ranges of about 0.05 to about 100 nmol, or about 0.1 to about 20 nmol, or about 1 nmol to about 10 nmol of polynucleotides per plant. In certain embodiments, about 40 to about 50 nmol of a ssDNA polynucleotide are applied. In certain embodiments, about 0.5 nmol to about 2 nmol of a dsRNA is applied. In certain embodiments, a composition containing about 0.5 to about 2.0 mg/mL, or about 0.14 mg/mL of dsRNA or ssDNA (21-mer) is applied.
  • a composition of about 0.5 to about 1.5 mg/mL of a long dsRNA polynucleotide i.e. about 50 to about 200 or more nucleotides
  • about 1 nmol to about 5 nmol of a dsRNA is applied to a plant.
  • the polynucleotide composition as topically applied to the plant contains the at least one polynucleotide at a concentration of about 0.01 to about 10 milligrams per milliliter, or about 0.05 to about 2 milligrams per milliliter, or about 0.1 to about 2 milligrams per milliliter.
  • the factor 1 ⁇ when applied to oligonucleotide molecules is arbitrarily used to denote a treatment of 0.8 nmol of polynucleotide molecule per plant; 10 ⁇ , 8 nmol of polynucleotide molecule per plant; and 100 ⁇ , 80 nmol of polynucleotide molecule per plant.
  • compositions of certain embodiments are useful in compositions, such as liquids that comprise polynucleotide molecules, alone or in combination with other components either in the same liquid or in separately applied liquids that provide a transfer agent.
  • a transfer agent is an agent that, when combined with a polynucleotide in a composition that is topically applied to a target plant surface, enables the polynucleotide to enter a plant cell.
  • a transfer agent is an agent that conditions the surface of plant tissue, e. g., seeds, leaves, stems, roots, flowers, or fruits, to permeation by the polynucleotide molecules into plant cells.
  • the transfer of polynucleotides into plant cells can be facilitated by the prior or contemporaneous application of a polynucleotide-transferring agent to the plant tissue.
  • the transferring agent is applied subsequent to the application of the polynucleotide composition.
  • the polynucleotide transfer agent enables a pathway for polynucleotides through cuticle wax barriers, stomata and/or cell wall or membrane barriers into plant cells.
  • Suitable transfer agents to facilitate transfer of the polynucleotide into a plant cell include agents that increase permeability of the exterior of the plant or that increase permeability of plant cells to oligonucleotides or polynucleotides.
  • Such agents to facilitate transfer of the composition into a plant cell include a chemical agent, or a physical agent, or combinations thereof.
  • Chemical agents for conditioning or transfer include (a) surfactants, (b) an organic solvent or an aqueous solution or aqueous mixtures of organic solvents, (c) oxidizing agents, (d) acids, (e) bases, (f) oils, (g) enzymes, or combinations thereof.
  • Embodiments of the method can optionally include an incubation step, a neutralization step (e.g., to neutralize an acid, base, or oxidizing agent, or to inactivate an enzyme), a rinsing step, or combinations thereof.
  • Embodiments of agents or treatments for conditioning of a plant to permeation by polynucleotides include emulsions, reverse emulsions, liposomes, and other micellar-like compositions.
  • Embodiments of agents or treatments for conditioning of a plant to permeation by polynucleotides include counter-ions or other molecules that are known to associate with nucleic acid molecules, e. g., inorganic ammonium ions, alkyl ammonium ions, lithium ions, polyamines such as spermine, spermidine, or putrescine, and other cations.
  • Organic solvents useful in conditioning a plant to permeation by polynucleotides include DMSO, DMF, pyridine, N-pyrrolidine, hexamethylphosphoramide, acetonitrile, dioxane, polypropylene glycol, other solvents miscible with water or that will dissolve phosphonucleotides in non-aqueous systems (such as is used in synthetic reactions).
  • Naturally derived or synthetic oils with or without surfactants or emulsifiers can be used, e. g., plant-sourced oils, crop oils (such as those listed in the 9 th Compendium of Herbicide Adjuvants, publicly available on the worldwide web (internet) at herbicide.adjuvants.com can be used, e.
  • Transfer agents include, but are not limited to, organosilicone preparations.
  • an organosilicone preparation that is commercially available as Silwet® L-77 surfactant having CAS Number 27306-78-1 and EPA Number: CAL.REG.NO. 5905-50073-AA, and currently available from Momentive Performance Materials, Albany, N.Y. can be used to prepare a polynucleotide composition.
  • Silwet® L-77 organosilicone preparation is used as a pre-spray treatment of plant leaves or other plant surfaces, freshly made concentrations in the range of about 0.015 to about 2 percent by weight (wt percent) (e.
  • composition that comprises a polynucleotide molecule and an organosilicone preparation comprising Silwet L-77 in the range of about 0.015 to about 2 percent by weight (wt percent) (e.
  • compositions that comprises a polynucleotide molecule and an organosilicone preparation comprising Silwet L-77 in the range of about 0.3 to about 1 percent by weight (wt percent) or about 0.5 to about 1% by weight (wt percent) is used or provided.
  • any of the commercially available organosilicone preparations provided in the following Table 1 can be used as transfer agents in a polynucleotide composition.
  • an organosilicone preparation of Table 1 is used as a pre-spray treatment of plant leaves or other surfaces, freshly made concentrations in the range of about 0.015 to about 2 percent by weight (wt percent) (e.
  • composition that comprises a polynucleotide molecule and an organosilicone preparation of the following Table 1 in the range of about 0.015 to about 2 percent by weight (wt percent) (e.
  • Organosilicone preparations used in the methods and compositions provided herein can comprise one or more effective organosilicone compounds.
  • the phrase “effective organosilicone compound” is used to describe any organosilicone compound that is found in an organosilicone preparation that enables a polynucleotide to enter a plant cell.
  • an effective organosilicone compound can enable a polynucleotide to enter a plant cell in a manner permitting a polynucleotide mediated suppression of a target gene expression in the plant cell.
  • effective organosilicone compounds include, but are not limited to, compounds that can comprise: i) a trisiloxane head group that is covalently linked to, ii) an alkyl linker including, but not limited to, an n-propyl linker, that is covalently linked to, iii) a poly glycol chain, that is covalently linked to, iv) a terminal group.
  • Trisiloxane head groups of such effective organosilicone compounds include, but are not limited to, heptamethyltrisiloxane.
  • Alkyl linkers can include, but are not limited to, an n-propyl linker.
  • Poly glycol chains include, but are not limited to, polyethylene glycol or polypropylene glycol.
  • Poly glycol chains can comprise a mixture that provides an average chain length “n” of about “7.5”. In certain embodiments, the average chain length “n” can vary from about 5 to about 14.
  • Terminal groups can include, but are not limited to, alkyl groups such as a methyl group.
  • Effective organosilicone compounds are believed to include, but are not limited to, trisiloxane ethoxylate surfactants or polyalkylene oxide modified heptamethyl trisiloxane.
  • an organosilicone preparation that comprises an organosilicone compound comprising a trisiloxane head group is used in the methods and compositions provided herein. In certain embodiments, an organosilicone preparation that comprises an organosilicone compound comprising a heptamethyltrisiloxane head group is used in the methods and compositions provided herein. In certain embodiments, an organosilicone composition that comprises Compound I is used in the methods and compositions provided herein. In certain embodiments, an organosilicone composition that comprises Compound I is used in the methods and compositions provided herein.
  • a composition that comprises a polynucleotide molecule and one or more effective organosilicone compound in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent) is used or provided.
  • wt percent percent by weight
  • the polynucleotide compositions that comprise an organosilicone preparation can comprise a salt such as ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate.
  • a salt such as ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate.
  • Ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate can be provided in the polynucleotide composition at a concentration of about 0.5% to about 5% (w/v).
  • an ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate concentration of about 1% to about 3%, or about 2% (w/v) can also be used in the polynucleotide compositions that comprise an organosilicone preparation.
  • the polynucleotide compositions can comprise an ammonium salt at a concentration greater or equal to 300 millimolar.
  • the polynucleotide compositions that comprise an organosilicone preparation can comprise ammonium sulfate at concentrations from about 80 to about 1200 mM or about 150 mM to about 600 mM.
  • the polynucleotide compositions can also comprise a phosphate salt.
  • Phosphate salts used in the compositions include, but are not limited to, calcium, magnesium, potassium, or sodium phosphate salts.
  • the polynucleotide compositions can comprise a phosphate salt at a concentration of at least about 5 millimolar, at least about 10 millimolar, or at least about 20 millimolar.
  • the polynucleotide compositions will comprise a phosphate salt in a range of about 1 mM to about 25 mM or in a range of about 5 mM to about 25 mM.
  • the polynucleotide compositions can comprise sodium phosphate at a concentration of at least about 5 millimolar, at least about 10 millimolar, or at least about 20 millimolar. In certain embodiments, the polynucleotide compositions can comprise sodium phosphate at a concentration of about 5 millimolar, about 10 millimolar, or about 20 millimolar. In certain embodiments, the polynucleotide compositions will comprise a sodium phosphate salt in a range of about 1 mM to about 25 mM or in a range of about 5 mM to about 25 mM. In certain embodiments, the polynucleotide compositions can comprise a sodium phosphate buffer at a pH of about 6.8.
  • other useful transfer agents or adjuvants to transfer agents that can be used in polynucleotide compositions provided herein include surfactants and/or effective molecules contained therein.
  • Surfactants and/or effective molecules contained therein include, but are not limited to, sodium or lithium salts of fatty acids (such as tallow or tallowamines or phospholipids) and organosilicone surfactants.
  • the polynucleotide compositions that comprise a transfer agent are formulated with counter-ions or other molecules that are known to associate with nucleic acid molecules.
  • Illustrative examples include, tetraalkyl ammonium ions, trialkyl ammonium ions, sulfonium ions, lithium ions, and polyamines such as spermine, spermidine, or putrescine.
  • the polynucleotide compositions are formulated with a non-polynucleotide herbicide.
  • Non-polynucleotide herbicidal molecules include, but are not limited to, glyphosate, auxin-like benzoic acid herbicides including dicamba, chloramben and TBA, glufosinate, auxin-like herbicides including phenoxy carboxylic acid herbicide, pyridine carboxylic acid herbicide, quinoline carboxylic acid herbicide, pyrimidine carboxylic acid herbicide, and benazolin-ethyl herbicide, sulfonylureas, imidazolinones, bromoxynil, delapon, cyclohezanedione, protoporphyrionogen oxidase inhibitors, and 4-hydroxyphenyl-pyruvate-dioxygenase inhibiting herbicides.
  • the polynucleotides used in the compositions that are essentially identical or essentially complementary to the BI-1 target gene or transcript will comprise the predominant nucleic acid in the composition.
  • the polynucleotides that are essentially identical or essentially complementary to the target gene or transcript will comprise at least about 50%, 75%, 95%, 98%, or 100% of the nucleic acids provided in the composition by either mass or molar concentration.
  • the polynucleotides that are essentially identical or essentially complementary to the target gene or transcript can comprise at least about 1% to about 50%, about 10% to about 50%, about 20% to about 50%, or about 30% to about 50% of the nucleic acids provided in the composition by either mass or molar concentration.
  • compositions where the polynucleotides that are essentially identical or essentially complementary to the target gene or transcript can comprise at least about 1% to 100%, about 10% to 100%, about 20% to about 100%, about 30% to about 50%, or about 50% to a 100% of the nucleic acids provided in the composition by either mass or molar concentration.
  • Polynucleotides comprising ssDNA, dsDNA, ssRNA, dsRNA, or RNA/DNA hybrids that are essentially identical or complementary to certain plant target genes or transcripts and that can be used in compositions containing transfer agents that include, but are not limited to, organosilicone preparations, to suppress those target genes when topically applied to plants are disclosed in co-assigned U.S. patent application Ser. No. 13/042,856.
  • compositions comprising those polynucleotide herbicidal molecules and transfer agents that include, but are not limited to, organosilicone preparations, and methods whereby herbicidal effects are obtained by the topical application of such compositions to plants are also disclosed in co-assigned U.S. patent application Ser. No. 13/042,856 (U.S. Patent Application Publication No. 20110296556), and those polynucleotide herbicidal molecules, compositions, and methods are incorporated herein by reference in their entireties.
  • Genes encoding proteins that can provide tolerance to an herbicide and/or that are targets of a herbicide are collectively referred to herein as “herbicide target genes”.
  • Herbicide target genes include, but are not limited to, a 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), a glyphosate oxidoreductase (GOX), a glyphosate decarboxylase, a glyphosate-N-acetyl transferase (GAT), a dicamba monooxygenase, a phosphinothricin acetyltransferase, a 2,2-dichloropropionic acid dehalogenase, an acetohydroxyacid synthase, an acetolactate synthase, a haloarylnitrilase, an acetyl-coenzyme A carboxylase (ACCase), a dihydropteroate synthase, a phytoene desaturase (PDS), a protoporphyrin IX oxygenase (PPO), a hydroxyphenylpyruv
  • compositions comprising polynucleotides that are essentially identical or complementary to certain herbicide target genes and transfer agents on plants containing the herbicide target genes was shown to be potentiated or enhanced by subsequent application of an herbicide that targets the same gene as the polynucleotide in co-assigned U.S. patent application Ser. No. 13/042,856.
  • compositions comprising polynucleotides targeting the EPSPS herbicide target gene were potentiated by glyphosate in experiments disclosed in co-assigned U.S. patent application Ser. No. 13/042,856.
  • the composition comprising a polynucleotide and a transfer agent can thus further comprise a second polynucleotide comprising at least 19 contiguous nucleotides that are essentially identical or essentially complementary to a transcript to a protein that confers resistance to a herbicide.
  • the second polynucleotide does not comprise a polynucleotide that is essentially identical or essentially complementary to a transcript encoding a protein of a target plant that confers resistance to said herbicidal molecule.
  • the second polynucleotide could be essentially identical or essentially complementary to a transcript encoding a protein that confers resistance to a herbicide in a weed (such as an EPSPS encoding transcript) but would not be essentially identical or essentially complementary to a transcript encoding a protein that confers resistance to that same herbicide in a crop plant.
  • the polynucleotide compositions that comprise a transfer agent can comprise glycerin.
  • Glycerin can be provided in the composition at a concentration of about 0.1% to about 1% (w/v or v/v).
  • a glycerin concentration of about 0.4% to about 0.6%, or about 0.5% (w/v or v/v) can also be used in the polynucleotide compositions that comprise a transfer agent.
  • the polynucleotide compositions that comprise a transfer agent can further comprise organic solvents.
  • organic solvents include, but are not limited to, DMSO, DMF, pyridine, N-pyrrolidine, hexamethylphosphoramide, acetonitrile, dioxane, polypropylene glycol, other solvents miscible with water or that will dissolve phosphonucleotides in non-aqueous systems (such as is used in synthetic reactions).
  • the polynucleotide compositions that comprise a transfer agent can further comprise naturally derived or synthetic oils with or without surfactants or emulsifiers.
  • oils include, but are not limited to, plant-sourced oils, crop oils (such as those listed in the 9th Compendium of Herbicide Adjuvants, publicly available on line at www.herbicide.adjuvants.com), paraffinic oils, polyol fatty acid esters, or oils with short-chain molecules modified with amides or polyamines such as polyethyleneimine or N-pyrrolidine.
  • methods include one or more applications of the composition comprising a polynucleotide and a transfer agent or one or more effective components contained therein.
  • one or more applications of a transfer agent or one or more effective components contained therein can precede one or more applications of the composition comprising a polynucleotide and a transfer agent.
  • RNA oligonucleotides are double-stranded RNA oligonucleotides, single-stranded RNA oligonucleotides, double-stranded RNA polynucleotides, single-stranded RNA polynucleotides, double-stranded DNA oligonucleotides, single-stranded DNA oligonucleotides, double-stranded DNA polynucleotides, chemically modified RNA or DNA oligonucleotides or polynucleotides or mixtures thereof.
  • compositions and methods described herein are useful for modulating or suppressing the expression of an endogenous BAX inhibitor 1 (BI-1) target gene or transgenic BAX inhibitor 1 (BI-1) target gene in a plant cell or plant.
  • expression of BI-1 target genes can be suppressed completely, partially and/or transiently to result in an improvement in fungal disease resistance.
  • a BAX inhibitor 1 (BI-1) target gene includes coding (protein-coding or translatable) sequence, non-coding (non-translatable) sequence, or both coding and non-coding sequence.
  • Compositions can include polynucleotides and oligonucleotides designed to target multiple BAX inhibitor 1 (BI-1) genes, or multiple segments of one or more BAX inhibitor 1 (BI-1) genes.
  • the target gene can include multiple consecutive segments of a target BAX inhibitor 1 (BI-1) gene, multiple non-consecutive segments of a BAX inhibitor 1 (BI-1) target gene, multiple alleles of a target gene, or multiple BAX inhibitor 1 (BI-1) target genes from one or more species.
  • BAX inhibitor 1 (BI-1) target genes include, but are not limited to, the endogenous BAX inhibitor 1 (BI-1) plant genes of SEQ ID NO: or.
  • BAX inhibitor 1 (BI-1) target genes include, but are not limited to, BAX inhibitor 1 (BI-1) plant genes that encode proteins that are orthologous to the proteins encoded by SEQ ID NO:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, or 31.
  • BAX inhibitor 1 (BI-1) target genes include, but are not limited to, BAX inhibitor 1 (BI-1) plant genes that encode the proteins of SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, or 31.
  • Target genes and plants containing those target genes can be obtained from: i) row crop plants including, but are not limited to, corn, soybean, cotton, canola, sugar beet, alfalfa, sugarcane, rice, and wheat; ii) vegetable plants including, but not limited to, tomato, potato, sweet pepper, hot pepper, melon, watermelon, cucumber, eggplant, cauliflower, broccoli, lettuce, spinach, onion, peas, carrots, sweet corn, Chinese cabbage, leek, fennel, pumpkin, squash or gourd, radish, Brussels sprouts, tomatillo, garden beans, dry beans, or okra; iii) culinary plants including, but not limited to, basil, parsley, coffee, or tea; iv) fruit plants including but not limited to apple, pear, cherry, peach, plum, apricot, banana, plantain, table grape, wine grape, citrus, avocado, mango, or berry; v) a tree grown for ornamental or commercial use, including, but not limited to,
  • an ornamental flowering plant or shrub or turf grass g., an ornamental flowering plant or shrub or turf grass.
  • the methods and compositions provided herein can also be applied to plants produced by a cutting, cloning, or grafting process (i. e., a plant not grown from a seed) include fruit trees and plants that include, but are not limited to, citrus, apples, avocados, tomatoes, eggplant, cucumber, melons, watermelons, and grapes as well as various ornamental plants.
  • Such row crop, vegetable, culinary, fruit, tree, or ornamental plants improvements in fungal disease resistance that result from suppressing BAX inhibitor 1 (BI-1) gene expression are provided herein.
  • Such row crop, vegetable, culinary, fruit, tree, or ornamental plant parts or processed plant products exhibiting improvements in fungal disease resistance that result from suppressing BAX inhibitor 1 (BI-1) gene expression are also provided herein.
  • Such plant parts can include, but are not limited to, flowers, stems, tubers, fruit, anthers, meristems, ovules, pollen, leaves, or seeds.
  • Such processed plant products obtained from the plant parts can include, but are not limited to, a meal, a pulp, a feed, or a food product.
  • a method for modulating or suppressing expression of an BAX inhibitor 1 (BI-1) gene in a plant including (a) conditioning of a plant to permeation by polynucleotides and (b) treatment of the plant with the polynucleotide molecules, wherein the polynucleotide molecules include at least one segment of 18 or more contiguous nucleotides cloned from or otherwise identified from the BAX inhibitor 1 (BI-1) target gene in either anti-sense or sense orientation, whereby the polynucleotide molecules permeate the interior of the plant and induce modulation of the target gene is provided.
  • the conditioning and polynucleotide application can be performed separately or in a single step.
  • the conditioning can precede or can follow the polynucleotide application within minutes, hours, or days. In some embodiments more than one conditioning step or more than one polynucleotide molecule application can be performed on the same plant.
  • the segment can be cloned or identified from (a) coding (protein-encoding), (b) non-coding (promoter and other gene related molecules), or (c) both coding and non-coding parts of the BAX inhibitor 1 (BI-1) target gene.
  • Non-coding parts include DNA, such as promoter regions or the RNA transcribed by the DNA that provide RNA regulatory molecules, including but not limited to: introns, 5′ or 3′ untranslated regions, and microRNAs (miRNA), trans-acting siRNAs, natural anti-sense siRNAs, and other small RNAs with regulatory function or RNAs having structural or enzymatic function including but not limited to: ribozymes, ribosomal RNAs, t-RNAs, aptamers, and riboswitches.
  • DNA such as promoter regions or the RNA transcribed by the DNA that provide RNA regulatory molecules, including but not limited to: introns, 5′ or 3′ untranslated regions, and microRNAs (miRNA), trans-acting siRNAs, natural anti-sense siRNAs, and other small RNAs with regulatory function or RNAs having structural or enzymatic function including but not limited to: ribozymes, ribosomal RNAs, t-RNAs
  • the polynucleotide used in the composition comprises a promoter sequence essentially identical to, or essentially complementary to at least 18 contiguous nucleotides of the promoter of the endogenous target gene
  • the promoter sequence of the polynucleotide is not operably linked to another sequence that is transcribed from the promoter sequence.
  • compositions comprising a polynucleotide and a transfer agent provided herein can be topically applied to a plant or plant part by any convenient method, e.g., spraying or coating with a powder, or with a liquid composition comprising any of an emulsion, suspension, or solution.
  • topically applied sprays or coatings can be of either all or of any a portion of the surface of the plant or plant part.
  • compositions that comprise a transfer agent or other pre-treatment can in certain embodiments be applied to the plant or plant part by any convenient method, e. g., spraying or wiping a solution, emulsion, or suspension.
  • compositions comprising a polynucleotide and a transfer agent provided herein can be topically applied to plant parts that include, but are not limited to, flowers, stems, tubers, meristems, ovules, fruit, anthers, pollen, leaves, or seeds.
  • compositions comprising a polynucleotide and a transfer agent to seeds is specifically provided herein. Seeds can be contacted with such compositions by spraying, misting, immersion, and the like.
  • compositions comprising a polynucleotide and a transfer agent to plants, plant parts, or seeds in particular can provide for an improvement in fungal disease resistance in progeny plants, plant parts, or seeds derived from those treated plants, plant parts, or seeds.
  • progeny plants, plant parts, or seeds derived from those treated plants, plant parts, or seeds will exhibit an improvement in an improvement in fungal disease resistance that results from suppressing expression of an BI-1 gene.
  • the methods and compositions provided herein can provide for an improvement in an improvement in fungal disease resistance in progeny plants or seeds as a result of epigenetically inherited suppression of BI-1 expression.
  • progeny plants exhibit an improvement in an improvement in fungal disease resistance from epigenetically inherited suppression of BI-1 gene expression that is not caused by a transgene where the polynucleotide is operably linked to a promoter, a viral vector, or a copy of the polynucleotide that is integrated into a non-native location in the chromosomal DNA of the plant.
  • progeny plants or seeds derived from those treated plants, plant parts, or seeds can exhibit an improvement in an improvement in fungal disease resistance through an epigenetic mechanism that provides for propagation of an epigenetic condition where suppression of BI-1 gene expression occurs in the progeny plants, plant parts, or plant seeds.
  • progeny plants or seeds exhibiting an improvement in an improvement in fungal disease resistance as a result of epigenetically inherited suppression of BI-1 gene expression can also exhibit increased methylation, and in particular, increased methylation of cytosine residues, in the endogenous BI-1 gene of the plant.
  • Plant parts, including seeds, of the progeny plants that exhibit an improvement in an improvement in fungal disease resistance as a result of epigenetically inherited suppression of BI-1 gene expression can also in certain embodiments exhibit increased methylation, and in particular, increased methylation of cytosine residues, in the endogenous BI-1 gene.
  • DNA methylation levels in DNA encoding the endogenous BI-1 gene can be compared in plants that exhibit the an improvement in fungal disease resistance and control plants that do not exhibit an improvement in fungal disease resistance to correlate the presence of the an improvement in fungal disease resistance to epigenetically inherited suppression of BI-1 gene expression and to identify plants that comprise the epigenetically inherited improvement in fungal disease resistance.
  • compositions on plants or plant parts can be used to topically apply to a plant surface a composition comprising a polynucleotide that comprises a transfer agent.
  • a composition can be applied with a boom that extends over the crops and delivers the composition to the surface of the plants or with a boomless sprayer that distributes a composition across a wide area.
  • Agricultural sprayers adapted for directional, broadcast, or banded spraying can also be used in certain embodiments.
  • Sprayers adapted for spraying particular parts of plants including, but not limited to, leaves, the undersides of leaves, flowers, stems, male reproductive organs such as tassels, meristems, pollen, ovules, and the like can also be used.
  • Compositions can also be delivered aerially, such as by a crop dusting airplane.
  • the spray can be delivered with a pressurized backpack sprayer calibrated to deliver the appropriate rate of the composition.
  • a backpack sprayer is a carbon dioxide pressurized sprayer with a 11015 flat fan or equivalent spray nozzle with a customized single nozzle assembly (to minimize waste) at a spray pressure of about 0.25 MPa and/or any single nozzle sprayer providing an effective spray swath of 60 cm above the canopy of 3 to 12 inch tall growing plants can be used.
  • Plants in a greenhouse or growth chamber can be treated using a track sprayer or laboratory sprayer with a 11001XR or equivalent spray nozzle to deliver the sample solution at a determined rate.
  • a non-limiting rate is about 140 L/ha at about 0.25 MPa pressure.
  • a plant part can be sprayed with the composition comprising a polynucleotide that comprises a transfer agent.
  • Such plant parts can be sprayed either pre- or post-harvest to provide for an improvement in fungal disease resistance in the plant part that results from suppression of BI-1 gene expression.
  • Compositions can be topically applied to plant parts attached to a plant by a spray as previously described.
  • Compositions can be topically applied to plant parts that are detached from a plant by a spray as previously described or by an alternative method.
  • Alternative methods for applying compositions to detached parts include, but are not limited to, passing the plant parts through a spray by a conveyor belt or trough, or immersing the plant parts in the composition.
  • compositions comprising polynucleotides and transfer agents can be applied to plants or plant parts at one or more developmental stages as desired and/or as needed.
  • Application of compositions to pre-germination seeds and/or to post-germination seedlings is provided in certain embodiments.
  • Seeds can be treated with polynucleotide compositions provided herein by methods including, but not limited to, spraying, immersion, or any process that provides for coating, imbibition, and/or uptake of the polynucleotide composition by the seed. Seeds can be treated with polynucleotide compositions using seed batch treatment systems or continuous flow treatment systems. Seed coating systems are at least described in U.S. Pat. Nos.
  • Seed treatment can also be effected in laboratory or commercial scale treatment equipment such as a tumbler, a mixer, or a pan granulator.
  • a polynucleotide composition used to treat seeds can contain one or more other desirable components including, but not limited to liquid diluents, binders to serve as a matrix for the polynucleotide, fillers for protecting the seeds during stress conditions, and plasticizers to improve flexibility, adhesion and/or spreadability of the coating.
  • drying agents such as calcium carbonate, kaolin or bentonite clay, perlite, diatomaceous earth or any other adsorbent material can be added.
  • drying agents such as calcium carbonate, kaolin or bentonite clay, perlite, diatomaceous earth or any other adsorbent material.
  • Use of such components in seed treatments is described in U.S. Pat. No. 5,876,739. Additional ingredients can be incorporated into the polynucleotide compositions used in seed treatments.
  • Such ingredients include but are not limited to: conventional sticking agents, dispersing agents such as methylcellulose (Methocel A15LV or Methocel A15C, for example, serve as combined dispersant/sticking agents for use in seed treatments), polyvinyl alcohol (e.g., Elvanol 51-05), lecithin (e.g., Yelkinol P), polymeric dispersants (e.g., polyvinylpyrrolidone/vinyl acetate PVPNA S-630), thickeners (e.g., clay thickeners such as Van Gel B to improve viscosity and reduce settling of particle suspensions), emulsion stabilizers, surfactants, antifreeze compounds (e.g., urea), dyes, colorants, and the like that can be combined with compositions comprising a polynucleotide and a transfer agent.
  • dispersing agents such as methylcellulose (Methocel A15LV or Methocel A15C, for example, serve as combined
  • compositions that can be applied to seeds can be found in McCutcheon's, vol. 1, “Emulsifiers and Detergents,” MC Publishing Company, Glen Rock, N.J., U.S.A., 1996 and in McCutcheon's, vol. 2, “Functional Materials,” MC Publishing Company, Glen Rock, N.J., U.S.A., 1996.
  • Methods of applying compositions to seeds and pesticidal compositions that can be used to treat seeds are described in US patent application publication 20080092256, which is incorporated herein by reference in its entirety.
  • compositions in early, mid-, and late vegetative stages of plant development is provided in certain embodiments.
  • Application of the compositions in early, mid-, and late reproductive stages is also provided in certain embodiments.
  • Application of the compositions to plant parts at different stages of maturation is also provided.
  • Target BI-1 genes at least occur in the genome of plants provided in Table 2.
  • the BI-1 genes and provided in Table 2 or their corresponding transcripts can be used as targets of polynucleotide compositions comprising a polynucleotide that of at least 18 contiguous nucleotides that are essentially identical or essentially complementary to those genes or transcripts.
  • the genes and proteins provided in Table 2, or sequences contained within those genes provided herewith in Example 5 can also be used to obtain orthologous BI-1 genes from plants not listed in Table 2.
  • Such orthologous genes and their transcripts can then serve as targets of polynucleotides provided herein or as a source of polynucleotides that are specifically designed to target the orthologous genes or transcripts.
  • Table 2 contains the target BI-1 DNA sequences from the indicated plant species.
  • polynucleotides such as single stranded or double stranded DNA or RNA fragments in sense and/or antisense orientation will be mixed with an organosilicone preparation.
  • These compositions will be topically applied to plants to effect expression of the target genes in the specified plant to obtain the plants that exhibit disease resistance.
  • plants that are resistant to powdery mildew, downy mildew, rust and/or other fungal infections will be obtained through the application of such compositions.
  • sequences disclosed in SEQ ID NO: 1 through 32 can be used to efficiently identify and clone BI-1 homologs useful for the control on pathogens causing powdery mildews, downy mildews or rusts, from other plant species not explicitly described here.
  • Example 3 Polynucleotides that can be Used to Reduce BI-1 Expression in Various Plants
  • polynucleotides that can be used to reduce expression of BI-1 genes in various plants is provided herewith as SEQ ID NOS: 33-106, 109-140, and 142-146.
  • Other regions of BI-1 genes can also be targeted to modify expression including the use of antisense DNA oligonucleotides against coding regions and/or targeting promoter regions using sense/antisense dsRNA, sense or antisense ssDNA as well as sense/antisense double stranded DNA.
  • a polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32 can be used to downregulate expression of those BI-1 genes.
  • Barley seeds are planted in 2 inch pots in the greenhouse. Five days later, barley seedlings are sprayed with polynucleotides such as ssDNA and/or dsRNA oligos directed to the promoter and/or targeting the coding region of a target gene of interest.
  • the nucleotide solution applied consists of 6-20 nm of each ssDNA oligonucleotide or 0.5-4 nm dsRNA, 0.1 to 0.3% L77 silwet, 50 mM NaPO 4 in a final volume of 40 microliters of water.
  • seedlings Two to 4 days post spraying, seedlings will be infected with dry spores of barley powdery mildew ( Blumeria graminis f. sp. hordei ) and 7 days post infection, disease development is scored for the percentage of leaf area covered with powdery mildew.
  • Cucumber seeds are planted in a 3-inch square pot and thinned to one plant per pot after emergence.
  • a polynucleotide solution such as ssDNA and/or dsRNA oligos directed to the promoter and/or targeting the coding region of a target gene of interest is applied to the first true leaf or the cotyledons.
  • the nucleotide solution applied consists of 6-20 nm of each ssDNA oligonucleotide or 0.5-4 nm dsRNA, 0.1 to 0.3% L77 Silwet, 50 mM NaPO 4 in a final volume of 40 microliters of water.
  • Tomato seeds are planted in a 3-inch square pot and thinned to one plant per pot after emergence. Two weeks old tomato seedlings are treated with 6-20 nm of each ssDNA oligonucleotide or 0.5-4 nm dsRNA, 0.2-0.5% L77 silwet, 50 mM NaPO 4 , 1% ammonium sulfate in a final volume of 30 microliters of water. Two to 4 days post spraying plants are innoculated with dry spores of tomato powdery mildew ( Oidium neolycopersici ) and 13 days post infection, disease development is scored for the percentage of leaf area covered with powdery mildew.
  • tomato powdery mildew Oidium neolycopersici
  • Barley plants were treated with control and oligonucleotide containing solutions essentially as indicated in Example 4. More specifically, Barley seeds (Perry variety) are planted about 1 ⁇ 4′′ into soil in 2 inch pots in the growth chamber and grown at 25° C. with a 16 hr light cycle in 50% humidity. Before polynucleotide application the plants are randomized. Application of polynucleotides (either ssDNA oligos and/or dsRNA) is performed by pipet application where 5 ⁇ L of solution containing nucleotides is applied to both sides of the first leaf.
  • Polynucleotides either ssDNA oligos and/or dsRNA
  • the nucleotide solution applied consists of ⁇ 3-15 nm of each ssDNA oligonucleotide or ⁇ 0.5-1 nm dsRNA, 0.1-0.3% Silwet L-77, 5 mM NaPO4, and 1% AMS in Gibco ultra pure water.
  • Two days post treatment seedlings are infected with barley powdery mildew ( Blumeria graminis f. sp. hordei ).
  • the growth chamber settings for the infection are as follows: 23° C., with a 12 hr light cycle in 70% humidity. At seven days post infection disease severity is scored for the percentage of leaf area covered with powdery mildew.
  • Table 4 provides a summary of the results obtained.
  • Cucumber seeds are soaked approximately 5-72 hours in nucleotides, either ssDNA and/or dsRNA oligos directed to the promoter and/or the coding region of a target of interest.
  • seeds can be soaked in water for a few hours prior to soaking in oligonucleotide solution.
  • Soaking solution consists of 20 nm of each ssDNA nucleotide or 0.03-1 nm dsRNA, 0.1% silwet L77, 50 mM NaPO4 in a final volume 200 uL in water.
  • the radicals of the cucumber seeds emerge within 72 hours, after which the seeds are placed on germination paper until root length is approximately 2 inches.
  • Seedlings are transplanted to sand vials for RKN inoculation 24 hours later.
  • Ten mL dry sand is added to each vial and seedlings are planted by tilting the vial and laying the seedling in the correct orientation so that the cotyledons are just above the sand and then tilting back to cover the radicals with sand.
  • 3.3 ml water is added to each vial and the vials placed in racks under fluorescent light banks.
  • 500 vermiform eggs or 300 J2 RKN are inoculated in each tube in 50 uL of deionized or spring water.
  • Harvest of the cucumber plants is performed 10 to 12 days after inoculation by washing sand off the roots.
  • soybeans using soy cyst nematodes are similar to RKN assays except for the following changes. After 5-72 hours of soaking soybean seeds are planted in 100% sand in two inch square plastic pots. Optionally, seeds are soaked in water for a few hours prior to soaking in oligonucleotide solution. Seven days after planting the soybean seed, the nematode soybean cyst nematode (SCN) inoculum (1000 vermiform eggs or 1000 J2s) are applied to the pot. Watering of the test plants is then restricted to only water as needed to prevent wilt for a period of 24 hours. After the 24 hour restricted watering, normal sub-irrigation watering is done for the duration of the test. Twenty eight days after inoculation the test is harvested and cysts counted.
  • SCN nematode soybean cyst nematode
  • RKN and SCN J2s are prepared from hatchbowls using the following solutions: RKN solution: 1 L aerated tap water, 1 ml of 50 mg/ml kanamycin, 0.5 ml of 20 mg/ml imazalil sulfate; SCN solution: 1 L aerated tap water, 1 ml of 50 mg/ml kanamycin, 0.5 ml of 20 mg/ml imazalil sulfate, 1430 mg zinc sulfate.
  • Hatchbowls are autoclaved 6 oz bowls, lined with screen mesh and paper filter. Approximately 20 ml of appropriate hatch solution is poured into each bowl. Eggs are then place in the bowls and covered with foil. The bowls are then placed in a 25° C. incubator overnight. The next day the hatched J2's are extracted, additional solution added as needed and replaced in the incubator. Each bowl is used for 2 weeks and then disposed.
  • Soybean cotyledons of the variety W82 were treated with the treatments indicated in Table 5 by topical application of the oligonucleotide solution in 5 mM NaPO 4 , 1% Ammonium Sulfate, and 0.20% SilwetTM (wt percent). Approximately 50 ⁇ l of solution containing the ssDNA oligonucleotides of Table 6, in pools of 4 ssDNAs/pool, was applied to each cotyledon of the plants and 4 plants were subjected to each treatment. One day following treatment, the plants were infected with approximately 1000 vermiform eggs of Soy Cyst Nematode applied directly to the pot. Twenty eight days after inoculation the root weights and cyst counts were recorded. ANOVA analysis for cyst count is provided in Table 8 and root weight is in Table 10. FIG. 1 shows the bar chart for cyst count and root weight.
  • Cucumber seed were soaked for 72 hr in dsRNA polynucleotide solution directed to the coding sequence of soybean Bi-1 gene. Soaking solution consisted of 0.01-1 nm dsRNA, 0.2% Silwet L77, 20 mM NaPO4 in a final volume 200 uL in water as outlined in Table 11. The radicals of the cucumber seeds emerged within 72 hours, after which the seeds were placed on germination paper until root length was approximately 2 inches. Seedlings were transplanted to sand vials for RKN inoculation 24 hours later.

Abstract

Provided are methods and compositions to improve fungal disease resistance in various crop plants. Also provided are combinations of compositions and methods to improve fungal disease resistance in various crop plants.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This U.S. Non-provisional patent application claims the benefit of U.S. Provisional Patent Application No. 61/757,291, which was filed Jan. 28, 2013 and is incorporated herein by reference in its entirety.
    • INCORPORATION OF SEQUENCE LISTING
  • A text file of the Sequence Listing contained in the file named “MON58632C_SEQ_LISTING.TXT” which is 94,742 bytes (measured in MS-Windows®) size and which was created on Jan. 27, 2014, is electronically filed herewith and is incorporated herein by reference in its entirety. This Sequence Listing consists of SEQ ID NO:1-147.
    • BACKGROUND
  • Powdery mildews are fungal diseases that affect a wide range of plants including cereals, grasses, vegetables, ornamentals, weeds, shrubs, fruit trees, broad-leaved shade and forest trees, that is caused by different species of fungi in the order Erysiphales. The disease is characterized by spots or patches of white to grayish, talcum-powder-like growth that produce tiny, pinhead-sized, spherical fruiting structures (the cleistothecia or overwintering bodies of the fungus), that are first white, later yellow-brown and finally black. The fungi that cause powdery mildews are host specific and cannot survive without the proper host plant. They produce mycelium (fungal threads) that grow only on the surface of the plant and feed by sending haustoria, or root-like structures, into the epidermal cells of the plant. The fungi overwinter on plant debris as cleistothecia or mycelia. In the spring, the cleistothecia produce spores that are moved to susceptible hosts by rain, wind or insects.
  • Powdery mildew disease is particularly prevalent in temperate and humid climates, where they frequently cause significant yield losses and quality reductions in various agricultural settings including greenhouse and field farming. This affects key cereals (e.g. barley and wheat), horticultural crops (e.g. grapevine, pea and tomato) and economically important ornamentals (e.g. roses). Limited access to natural sources of resistance to powdery mildews, rapid changes in pathogen virulence and the time consuming introgression of suitable resistance genes into elite varieties has led to the widespread use of fungicides to control the disease. This has not surprisingly led to the evolution and spread of fungicide resistance, which is especially dramatic amongst the most economically important powdery mildews.
  • Downy mildew diseases are caused by oomycete microbes from the family Peronosporaceae that are parasites of plants. Peronosporaceae are obligate biotrophic plant pathogens and parasitize their host plants as an intercellular mycelium using haustoria to penetrate the host cells. The downy mildews reproduce asexually by forming sporangia on distinctive white sporangiophores usually formed on the lower surface of infected leaves. These constitute the “downy mildew” and the initial symptoms appear on leaves as light green to yellow spots. The sporangia are wind-dispersed to the surface of other leaves. Depending on the genus, the sporangia may germinate by forming zoospores or by germ-tube. In the latter case, the sporangia behave like fungal conidia and are often referred to as such. Sexual reproduction is via oospores.
  • Most Peronosporaceae are pathogens of herbaceous dicots. Some downy mildew genera have relatively restricted host ranges, e.g. Basidiophora, Paraperonospora, Protobremia and Bremia on Asteraceae; Perofascia and Hyaloperonospora almost exclusively on Brassicaceae; Viennotia, Graminivora, Poakatesthia, Sclerospora and Peronosclerospora on Poaceae, Plasmoverna on Ranunculaceae. However, the largest genera, Peronospora and Plasmopara, have very wide host ranges.
  • Rusts (Pucciniales, formerly Uredinales) are obligate biotrophic parasites of vascular plants. Rusts affect a variety of plants; leaves, stems, fruits and seeds and is most commonly seen as coloured powder, composed of tiny aeciospores which land on vegetation producing pustules, or uredia, that form on the lower surfaces. During late spring or early summer, yellow orange or brown, hairlike or ligulate structures called telia grow on the leaves or emerge from bark of woody hosts. These telia produce teliospores which will germinate into aerial basidiospores, spreading and causing further infection.
    • SUMMARY
  • The present embodiments provide for compositions comprising polynucleotide molecules and methods for treating a plant to alter or regulate gene or gene transcript expression in the plant, for example, by providing RNA or DNA for inhibition of expression. Various aspects provide compositions comprising polynucleotide molecules and related methods for topically applying such compositions to plants to regulate endogenous BAX inhibitor 1 (BI-1) genes in a plant cell. The polynucleotides, compositions, and methods disclosed herein are useful in decreasing levels of BI-1 transcript and improving fungal disease resistance of a plant. Provided herein are compositions and methods that increase plant resistance to powdery mildew, downy mildew, rust infection or other fungal pathogens by suppression of plant BAX inhibitor 1 (BI-1) genes.
  • In one aspect, polynucleotide molecules are provided in compositions that can permeate or be absorbed into living plant tissue to initiate localized, partially systemic, or systemic gene inhibition or regulation. In certain embodiments, the polynucleotide molecules ultimately provide to a plant, or allow the in planta production of, RNA that is capable of hybridizing under physiological conditions in a plant cell to RNA transcribed from a target endogenous gene or target transgene in the plant cell, thereby effecting regulation of the endogenous BI-1 target gene. In certain embodiments, regulation of the BI-1 target genes, such as by silencing or suppression of the target gene, leads to the upregulation of another gene that is itself affected or regulated by decreasing the BI-1 target gene's expression.
  • In certain aspects or embodiments, the topical application of a composition comprising an exogenous polynucleotide and a transfer agent to a plant or plant part according to the methods described herein does not necessarily result in nor require the exogenous polynucleotide's integration into a chromosome of the plant. In certain aspects or embodiments, the topical application of a composition comprising an exogenous polynucleotide and a transfer agent to a plant or plant part according to the methods described herein does not necessarily result in nor require transcription of the exogenous polynucleotide from DNA integrated into a chromosome of the plant. In certain embodiments, topical application of a composition comprising an exogenous polynucleotide and a transfer agent to a plant according to the methods described herein also does not necessarily require that the exogenous polynucleotide be physically bound to a particle, such as in biolistic mediated introduction of polynucleotides associated with a gold or tungsten particles into internal portions of a plant, plant part, or plant cell. An exogenous polynucleotide used in certain methods and compositions provided herein can optionally be associated with an operably linked promoter sequence in certain embodiments of the methods provided herein. However, in other embodiments, an exogenous polynucleotide used in certain methods and compositions provided herein is not associated with an operably linked promoter sequence. Also, in certain embodiments, an exogenous polynucleotide used in certain methods and compositions provided herein is not operably linked to a viral vector.
  • In certain embodiments, methods for improving fungal disease resistance in a plant comprising topically applying compositions comprising a polynucleotide and a transfer agent that suppress the target BI-1 gene are provided. In certain embodiments, methods for selectively suppressing the target BI-1 gene by topically applying the polynucleotide composition to a plant surface at one or more selected seed, vegetative, or reproductive stage(s) of plant growth are provided. Such methods can provide for gene suppression in a plant or plant part on an as needed or as desired basis. In certain embodiments, methods for selectively suppressing the target BI-1 gene by topically applying the polynucleotide composition to a plant surface at one or more pre-determined seed, vegetative, or reproductive stage(s) of plant growth are provided. Such methods can provide for BI-1 gene suppression in a plant or plant part that obviates any undesired or unnecessary effects of suppressing the genes expression at certain seed, vegetative, or reproductive stage(s) of plant development.
  • In certain embodiments, methods for selectively improving fungal disease resistance in a plant by topically applying the polynucleotide composition to the plant surface at one or more selected seed, vegetative, or reproductive stage(s) are provided. Such methods can provide for improved fungal disease resistance in a plant or plant part on an as needed or as desired basis. In certain embodiments, methods for selectively improving fungal disease resistance in a plant by topically applying the polynucleotide composition to the plant surface at one or more predetermined seed, vegetative, or reproductive stage(s) are provided. Such methods can provide for improving fungal disease resistance in a plant or plant part that obviates any undesired or unnecessary effects of suppressing BI-1 gene expression at certain seed, vegetative, or reproductive stage(s) of plant development.
  • Methods and compositions that provide for the topical application of certain polynucleotides in the presence of transfer agents can be used to suppress BAX inhibitor 1 (BI-1) gene expression in an optimal manner. Topically induced BI-1 gene suppression methods and compositions provided herein can control the timing and degree of BI-1 knockdown to achieve fungal control while minimizing deleterious pleotropic effects in the host plant. In certain embodiments, the compositions provided herein can be applied on an “as needed” basis upon scouting for the occurrence of fungal disease. In certain embodiments, the compositions can be applied in a manner that obviates any deleterious effects on yield or other characteristics that can be associated with suppression of BI-1 gene expression in a crop plant. The applied polynucleotides are complementary to the BI-1 target host gene in plants and their topical application leads to suppression of the BI-1 gene.
  • Provided herein are compositions and methods for controlling plant fungal diseases. Plant fungal diseases that can be controlled with the methods and compositions provided herein include, but are not limited to, obligate biotrophic powdery mildew, downy mildew, and rust fungal infestations in plants. Plant fungal diseases that can be controlled with the methods and compositions provided herein also include, but are not limited to, fungal pathogens such as those causing anthracnose stalk rot, Diplodia Stalk or Ear Rot, Gibberella Stalk or Ear Rot, and Fusarium Stalk Rot in corn, or causing Take-all in wheat, Fusarium head blight in barley and wheat, or causing rice blast. In certain embodiments, methods and compositions for reducing expression of one or more host plant BI-1 polynucleotide and/or protein molecules in one or more cells or tissues of the plant such that the plant is rendered less susceptible to fungal infections from the order Erysiphales, the family Peronosporaceae or the order Pucciniales, are provided. In certain embodiments, nucleotide and amino acid sequences of plant BAX inhibitor 1 (BI-1) genes which can be downregulated by methods and compositions provided herein to increase plant resistance to powdery mildew, downy mildew, rust infection, or fungal pathogens such as those causing anthracnose stalk rot, Diplodia Stalk or Ear Rot, Gibberella Stalk or Ear Rot, and Fusarium Stalk Rot in corn, or causing Take-all in wheat, Fusarium head blight in barley and wheat, or causing rice blast are disclosed. Examples of powdery mildew fungi of the order Erysiphales which are controlled by the compositions and methods provided herein include, but are not limited to, Blumeria graminis f. sp. hordei, Blumeria graminis forma specialis (f. sp.) tritici, Golovinomyces orontii, Golovinomyces cichoracearum, Oidium neolycopersici, Oidium lycopersici, Erysiphe pisi, Erisyphe necator and Sphaerotheca fuliginea among others. Examples of downy mildew of the family Peronosporaceae include Pseudoperonospora humuli, Pseudoperonospora cubensis, Plasmopara viticola, Peronospora tabacina, Bremia lactucae, and Plasmopara halstedii. Examples of rusts of the order Pucciniales which are controlled by the compositions and methods provided herein include, but are not limited to, Phakopsora meibomiae, Phakopsora pachyrhizi, Puccinia graminis, Puccinia recondita, Uromyces phaseoli and Uromyces appendeculatus. Other examples of fungal pathogens which are controlled by the compositions and methods provided herein include, but are not limited to, Colletotrichum graminicola, Stenocarpella (or Diplodia) maydis, Gibberella zeae, Fusarium moniliforme, Gaeumannomyces graminis, Fusarium graminearum, Magnaporthe grisea (also known as Pyricularia grisea or Pyricularia oryzae), Septoria nodorum, and Septoria tritici.
  • Examples of plants protected by the compositions and methods provided herein include, but are not limited to, barley, rye, wheat, rice, oats, corn, sorghum, switchgrass, and sugar cane.
  • Also provided are methods and compositions where topically induced reductions in BI-1 transcript or protein levels are used to achieve fungal disease control while minimizing deleterious pleotropic effects in the host plant. Such methods and compositions provide for optimized levels of BI-1 gene inhibition and/or optimized timing of BI-1 gene inhibition.
  • Polynucleotides that can be used to suppress a BI-1 include, but are not limited to, any of: i) polynucleotides comprising at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BI-1 gene or to a transcript of the gene of SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32 or Example 5; or ii) polynucleotides comprising at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a polynucleotide of SEQ ID NO:33-106, 109-140, or 142-146 as provided herein.
  • Certain embodiments are directed to a method for producing a plant exhibiting an improvement in fungal disease resistance comprising topically applying to a plant surface a composition that comprises:
  • a. at least one polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or to a transcript of the gene; and
    b. a transfer agent, wherein the plant exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene. In certain embodiments of the methods, the polynucleotide molecule comprises sense ssDNA, sense ssRNA, dsRNA, dsDNA, a double stranded DNA/RNA hybrid, anti-sense ssDNA, or anti-sense ssRNA. In certain embodiments of the methods, the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. In certain embodiments of the methods: (a) the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24; (b) the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26; (c) the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20; (d) the plant is a soybean plant, the gene or the transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22; (e) the plant is a corn plant, the gene or the transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16; (f) the plant is a sorghum plant, the gene or the transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14; (g) the plant is a pepper plant, the gene or the transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10; (h) the plant is a grape plant, the gene or the transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8; (i) the plant is a tomato plant, the gene or the transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6; (j) the plant is a lettuce plant, the gene or the transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4; (k) the plant is a cucumber plant, the gene or the transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or (l) the plant is a cotton plant, the gene or the transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32. In certain embodiments of the methods, the composition comprises any combination of two or more polynucleotide molecules. In certain embodiments of the methods, the polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length. In certain embodiments of the methods, the composition further comprises a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, a polynucleotide that suppresses an herbicide target gene, an insecticide, a fungicide, a nematocide, or a combination thereof. In certain embodiments of the methods, the composition further comprises a non-polynucleotide herbicidal molecule and the plant is resistant to the herbicidal molecule. In certain embodiments of the methods, the transfer agent comprises an organosilicone preparation. In certain embodiments of the methods, the polynucleotide is not operably linked to a viral vector. In certain embodiments of the methods, the polynucleotide is not integrated into the plant chromosome.
  • Further embodiments are directed to: a plant made according to the above-described methods; progeny of the plant that exhibit fungal disease resistance; seed of the plant, wherein seed from the plant exhibits fungal disease resistance; and a processed product of the plant, the progeny plant, or the seed, wherein the processed product exhibits fungal disease resistance. In certain embodiments, the processed product exhibits an improved attribute relative to a processed product of an untreated control plant and the improved attribute results from the improved fungal disease resistance. An improved attribute of a processed product can include, but is not limited to, decreased mycotoxin content, improved nutritional content, improved storage characteristics, improved flavor, improved consistency, and the like when compared to a processed product obtained from an untreated plant or plant part.
  • Additional embodiments are directed to compositions comprising a polynucleotide molecule that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of the gene, wherein the polynucleotide is not operably linked to a promoter; and, b) a transfer agent. In certain embodiments of the composition, the polynucleotide is selected from the group consisting of wherein the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. In certain embodiments of the composition: (a) the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24; (b) the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26; (c) the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20; (d) the gene or the transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22; (e) the gene or the transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16; (f) the gene or the transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14; (g) the gene or the transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10; (h) the gene or the transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8; (i) the gene or the transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6; (j) the gene or the transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4; (k) the gene or the transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or (l) the gene or the transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32. In certain embodiments of the composition, the polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length. In certain embodiments of the composition, the composition further comprises a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, a polynucleotide that suppresses an herbicide target gene, an insecticide, a fungicide, a nematocide, or a combination thereof. In certain embodiments of the composition, the transfer agent is an organosilicone preparation. In certain embodiments of the composition, the polynucleotide is not physically bound to a biolistic particle.
  • Other embodiments are directed to a method of making a composition comprising the step of combining at least: a) a polynucleotide molecule comprising at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of a plant, wherein the polynucleotide is not operably linked to a promoter or a viral vector; and, b) a transfer agent. In certain embodiments of the methods, the polynucleotide is obtained by in vivo biosynthesis, in vitro enzymatic synthesis, or chemical synthesis. In certain embodiments, the methods further comprises combining with the polynucleotide and the transfer agent at least one of a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, an insecticide, a fungicide, and/or a nematocide. In certain embodiments of the methods, the transfer agent is an organosilicone preparation.
  • Yet another embodiment is directed to a method of identifying a polynucleotide for improving fungal disease resistance in a plant comprising; a) selecting a population of polynucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of a plant; b) topically applying to a surface of at least one of the plants a composition comprising at least one polynucleotide from the population and an transfer agent to obtain a treated plant; and, c) identifying a treated plant that exhibits suppression of the BAX inhibitor 1 (BI-1) gene or exhibits an improvement in fungal disease resistance, thereby identifying a polynucleotide that improves fungal disease resistance in the plant. In certain embodiments of the methods, the polynucleotide is selected from the group consisting of wherein the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. In certain embodiments of the methods: a) the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24; (b) the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26; (c) the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20; (d) the plant is a soybean plant, the gene or the transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22; (e) the plant is a corn plant, the gene or the transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16; (f) the plant is a sorghum plant, the gene or the transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14; (g) the plant is a pepper plant, the gene or the transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10; (h) the plant is a grape plant, the gene or the transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8; (i) the plant is a tomato plant, the gene or the transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6; (j) the plant is a lettuce plant, the gene or the transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4; (k) the plant is a cucumber plant, the gene or the transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or (l) the plant is a cotton plant, the gene or the transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32.
  • A further embodiment is directed to a plant comprising an exogenous polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of the gene, wherein the exogenous polynucleotide is not operably linked to a promoter or to a viral vector, is not integrated into the chromosomal DNA of the plant, and is not found in a non-transgenic plant; and, wherein the plant exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene. In certain embodiments, the plant further comprises an organosilicone compound or a component thereof. In certain embodiments, the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. In certain embodiments: a) the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24; (b) the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26; (c) the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20; (d) the plant is a soybean plant, the gene or the transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22; (e) the plant is a corn plant, the gene or the transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16; (f) the plant is a sorghum plant, the gene or the transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14; (g) the plant is a pepper plant, the gene or the transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10; (h) the plant is a grape plant, the gene or the transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8; (i) the plant is a tomato plant, the gene or the transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6; (j) the plant is a lettuce plant, the gene or the transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4; (k) the plant is a cucumber plant, the gene or the transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or (l) the plant is a cotton plant, the gene or the transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32.
  • An additional embodiment is directed to a plant part comprising an exogenous polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of the gene, wherein the exogenous polynucleotide is not operably linked to a promoter or to a viral vector and is not found in a non-transgenic plant; and, wherein the plant part exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene. In certain embodiments, the plant part further comprises an organosilicone compound or a component thereof. In certain embodiments, the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. In certain embodiments: a) the plant part is a barley plant part, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24; (b) the plant part is a rice plant part, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26; (c) the plant part is a wheat plant part, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20; (d) the plant part is a soybean plant part, the gene or the transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22; (e) the plant part is a corn plant part, the gene or the transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16; (f) the plant part is a sorghum plant part, the gene or the transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14; (g) the plant part is a pepper plant part, the gene or the transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10; (h) the plant part is a grape plant part, the gene or the transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8; (i) the plant part is a tomato plant part, the gene or the transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6; (j) the plant part is a lettuce plant part, the gene or the transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4; (k) the plant part is a cucumber plant part, the gene or the transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or (l) the plant part is a cotton plant part, the gene or the transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32. In certain embodiments, the plant part is a flower, meristem, ovule, stem, tuber, fruit, anther, pollen, leaf, root, or seed. In certain embodiments, the plant part is a seed. Also provided are processed plant products obtained from the plant parts that exhibit an improved attribute relative to a processed plant product of an untreated control plant and wherein the improved attribute results from the improved disease tolerance. In certain embodiments, the processed product is a meal, a pulp, a feed, or a food product.
  • Another embodiment is directed to a plant that exhibits an improvement in fungal disease resistance, wherein the plant was topically treated with a composition that comprises: a. at least one polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or to a transcript of the gene; and, b. a transfer agent; and, wherein the plant exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene. In certain embodiments, the transfer agent is an organosilicone preparation.
  • Certain embodiments are directed to a method for providing a seed that produces a plant exhibiting an improvement in fungal disease resistance comprising: a) soaking the seed in a liquid composition that comprises at least one polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or to a transcript of the gene, wherein the seed produces a plant exhibiting an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene. In some embodiments, the liquid composition further comprises a transfer agent. In certain embodiments, the polynucleotide comprises sense ssDNA, sense ssRNA, dsRNA, dsDNA, a double stranded DNA/RNA hybrid, anti-sense ssDNA, or anti-sense ssRNA. In certain embodiments, the polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. In certain embodiments of the methods: (a) the seed is a barley seed, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24; (b) the seed is a rice seed, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26; (c) the seed is a wheat seed, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20; (d) the seed is a soybean seed, the gene or the transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22; (e) the seed is a corn seed, the gene or the transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16; (f) the seed is a sorghum seed, the gene or the transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14; (g) the seed is a pepper seed, the gene or the transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10; (h) the seed is a grape seed, the gene or the transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8; (i) the seed is a tomato seed, the gene or the transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6; (j) the seed is a lettuce seed, the gene or the transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4; (k) the seed is a cucumber seed, the gene or the transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or (l) the seed is a cotton seed, the gene or the transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32. In certain embodiments, the liquid composition comprises any combination of two or more polynucleotide molecules. In certain embodiments, the polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length. In certain embodiments of the methods, the composition further comprises an insecticide, a fungicide, a nematocide, or a combination thereof. In certain embodiments, the transfer agent comprises an organosilicone preparation. In certain embodiments, the polynucleotide is not operably linked to a viral vector. In certain embodiments, the polynucleotide is not integrated into the plant chromosome.
  • Further embodiments are directed to: a plant grown from a seed treated according to the above-described methods; progeny of the plant that exhibit fungal disease resistance; seed of the plant, wherein seed from the plant exhibits fungal disease resistance; and a processed product of the plant, the progeny plant, or the seed, wherein the processed product exhibits fungal disease resistance. In certain embodiments, the processed product exhibits an improved attribute relative to a processed product of an untreated control plant and the improved attribute results from the improved fungal disease resistance. An improved attribute of a processed product can include, but is not limited to, decreased mycotoxin content, improved nutritional content, improved storage characteristics, improved flavor, improved consistency, and the like when compared to a processed product obtained from an untreated plant or plant part.
  • Also provided herein are transgenic plants, plant parts, plant cells, and processed plant products containing a transgene comprising a heterologous promoter that is operably linked to a polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BI-1 gene or transcript of the BI-1 gene. Such transgenes can be integrated into the genome of the transgenic plant or provided in recombinant viral genomes that can be propagated in the plant. In certain embodiments, the transgene confers an improvement in fungal disease resistance and/or nematode resistance to the transgenic plants or plant parts that contain the transgene. In certain embodiments, the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a polynucleotide selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146 or comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BI-1 gene or to a transcript of the gene of SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. In certain embodiments: (a) the plant is a barley plant, the gene or the transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24; (b) the plant is a rice plant, the gene or the transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26; (c) the plant is a wheat plant, the gene or the transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20; (d) the plant is a soybean plant, the gene or the transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22; (e) the plant is a corn plant, the gene or the transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16; (f) the plant is a sorghum plant, the gene or the transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14; (g) the plant is a pepper plant, the gene or the transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10; (h) the plant is a grape plant, the gene or the transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8; (i) the plant is a tomato plant, the gene or the transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6; (j) the plant is a lettuce plant, the gene or the transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4; (k) the plant is a cucumber plant, the gene or the transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or (l) the plant is a cotton plant, the gene or the transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and the polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32. In certain embodiments, the transgenic plant part is a flower, meristem, ovule, stem, tuber, fruit, anther, pollen, leaf, root, or seed. Processed plant products containing the transgene include, but are not limited to, a meal a pulp, a feed, or a food product obtainable from the transgenic plant parts. In certain embodiments, the processed plant products exhibit an improved attribute relative to a processed plant product of an untreated control plant and wherein the improved attribute results from the improved fungal disease resistance and/or nematode resistance conferred by the transgene. In certain embodiments, the processed product is a meal, a pulp, a feed, or a food product. Also provided herein are methods for obtaining transgenic plants exhibiting an improvement in fungal disease resistance and/or nematode resistance comprising the steps of introducing any of the aforementioned transgenes into the genome of a plant and selecting for a transgenic plant wherein expression of an endogenous BAX inhibitor 1 (BI-1) gene is suppressed, thereby obtaining a plant exhibiting an improvement in fungal disease resistance and/or nematode resistance. Also provided herein are methods for improving fungal disease resistance and/or nematode resistance in plants that comprise growing transgenic plants comprising any of the aforementioned transgenes wherein expression of an endogenous BI-1 gene is suppressed in the presence of fungi and/or nematodes, wherein fungal disease resistance and/or nematode resistance of the transgenic plants is improved in comparison to a control plant that lack a transgene that suppresses an endogenous BI-1 gene in the control plant.
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A, B. Panel A. shows a graph of cyst counts for Soy Cyst Nematode (SCN) disease measurement at twenty eight days after treatment and inoculation with SCN. Panel B. shows a graph of gall weights.
  • FIG. 2. presents the gall rating results for Root Knot Nematode (RKN) disease measured as % root mass galled for dsRNA treatments (or controls) followed by inoculation with vermiform eggs.
    •  DETAILED DESCRIPTION I. Definitions
  • The following definitions and methods are provided to better define the present embodiments and to guide those of ordinary skill in the art in the practice of the present embodiments. Unless otherwise noted, terms are to be understood according to conventional usage by those of ordinary skill in the relevant art.
  • Where a term is provided in the singular, the inventors also contemplate aspects described by the plural of that term.
  • As used herein, the terms “DNA,” “DNA molecule,” and “DNA polynucleotide molecule” refer to a single-stranded DNA or double-stranded DNA molecule of genomic or synthetic origin, such as, a polymer of deoxyribonucleotide bases or a DNA polynucleotide molecule.
  • As used herein, the terms “DNA sequence,” “DNA nucleotide sequence,” and “DNA polynucleotide sequence” refer to the nucleotide sequence of a DNA molecule.
  • As used herein, the term “gene” refers to any portion of a nucleic acid that provides for expression of a transcript or encodes a transcript. A “gene” thus includes, but is not limited to, a promoter region, 5′ untranslated regions, transcript encoding regions that can include intronic regions, and 3′ untranslated regions.
  • As used herein, the terms “RNA,” “RNA molecule,” and “RNA polynucleotide molecule” refer to a single-stranded RNA or double-stranded RNA molecule of genomic or synthetic origin, such as, a polymer of ribonucleotide bases that comprise single or double stranded regions.
  • Unless otherwise stated, nucleotide sequences in the text of this specification are given, when read from left to right, in the 5′ to 3′ direction. The nomenclature used herein is that required by Title 37 of the United States Code of Federal Regulations § 1.822 and set forth in the tables in WIPO Standard ST.25 (1998), Appendix 2, Tables 1 and 3.
  • As used herein, a “plant surface” refers to any exterior portion of a plant. Plant surfaces thus include, but are not limited to, the surfaces of flowers, stems, tubers, fruit, anthers, pollen, leaves, roots, or seeds. A plant surface can be on a portion of a plant that is attached to other portions of a plant or on a portion of a plant that is detached from the plant.
  • As used herein, the phrase “polynucleotide is not operably linked to a promoter” refers to a polynucleotide that is not covalently linked to a polynucleotide promoter sequence that is specifically recognized by either a DNA dependent RNA polymerase II protein or by a viral RNA dependent RNA polymerase in such a manner that the polynucleotide will be transcribed by the DNA dependent RNA polymerase II protein or viral RNA dependent RNA polymerase. A polynucleotide that is not operably linked to a promoter can be transcribed by a plant RNA dependent RNA polymerase.
  • As used herein, SEQ ID NO:, though displayed in the Sequence Listing in the form of ssDNA or ssRNA, encompass dsDNA equivalents, dsRNA equivalents, ssRNA as shown or equivalents, ssRNA complements, ssDNA as shown or equivalents, and ssDNA complements.
  • As used herein, a first nucleic-acid sequence is “operably” connected or “linked” with a second nucleic acid sequence when the first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence. For instance, a promoter is operably linked to an RNA and/or protein-coding sequence if the promoter provides for transcription or expression of the RNA or coding sequence. Generally, operably linked DNA sequences are contiguous and, where necessary to join two protein-coding regions, are in the same reading frame.
  • As used herein, the phrase “organosilicone preparation” refers to a liquid comprising one or more organosilicone compounds, wherein the liquid or components contained therein, when combined with a polynucleotide in a composition that is topically applied to a target plant surface, enable the polynucleotide to enter a plant cell. Examples of organosilicone preparations include, but are not limited to, preparations marketed under the trade names “Silwet®” or “BREAK-THRU®” and preparations provided in Table 1. In certain embodiments, an organosilicone preparation can enable a polynucleotide to enter a plant cell in a manner permitting a polynucleotide suppression of target gene expression in the plant cell.
  • As used herein, the phrase “provides for an improvement in fungal disease resistance” refers to any measurable increase in a plants resistance to fungal damage. In certain embodiments, an improvement in fungal disease resistance in a plant or plant part can be determined in a comparison to a control plant or plant part that has not been treated with a composition comprising a polynucleotide and a transfer agent. When used in this context, a control plant is a plant that has not undergone treatment with polynucleotide and a transfer agent. Such control plants would include, but are not limited to, untreated plants or mock treated plants.
  • As used herein, the phrase “provides for a reduction”, when used in the context of a transcript or a protein in a plant or plant part, refers to any measurable decrease in the level of transcript or protein in a plant or plant part. In certain embodiments, a reduction of the level of a transcript in a plant or plant part can be determined in a comparison to a control plant or plant part that has not been treated with a composition comprising a polynucleotide and a transfer agent. When used in this context, a control plant or plant part is a plant or plant part that has not undergone treatment with polynucleotide and a transfer agent. Such control plants or plant parts would include, but are not limited to, untreated or mock treated plants and plant parts.
  • As used herein, the phrase “wherein said plant does not comprise a transgene” refers to a plant that lacks either a DNA molecule comprising a promoter that is operably linked to a polynucleotide or a recombinant viral vector.
  • As used herein, the phrase “suppressing expression” or “suppression”, when used in the context of a gene, refers any measurable decrease in the amount and/or activity of a product encoded by the gene. Thus, expression of a gene can be suppressed when there is a reduction in levels of a transcript from the gene, a reduction in levels of a protein encoded by the gene, a reduction in the activity of the transcript from the gene, a reduction in the activity of a protein encoded by the gene, any one of the preceding conditions, or any combination of the preceding conditions. In this context, the activity of a transcript includes, but is not limited to, its ability to be translated into a protein and/or to exert any RNA-mediated biologic or biochemical effect. In this context, the activity of a protein includes, but is not limited to, its ability to exert any protein-mediated biologic or biochemical effect. In certain embodiments, a suppression of gene expression in a plant or plant part can be determined in a comparison of gene product levels or activities in a treated plant to a control plant or plant part that has not been treated with a composition comprising a polynucleotide and a transfer agent. When used in this context, a control plant or plant part is a plant or plant part that has not undergone treatment with polynucleotide and a transfer agent. Such control plants or plant parts would include, but are not limited to, untreated or mock treated plants and plant parts.
  • As used herein, the term “transcript” corresponds to any RNA that is produced from a gene by the process of transcription. A transcript of a gene can thus comprise a primary transcription product which can contain introns or can comprise a mature RNA that lacks introns.
  • As used herein, the term “liquid” refers to both homogeneous mixtures such as solutions and non-homogeneous mixtures such as suspensions, colloids, micelles, and emulsions.
    • II. Overview
  • The hypersensitive reaction (HR) in plants is a form of programmed cell death involved in many developmental processes and stress responses including disease resistance to pathogens.
  • The protein BAX inhibitor 1 (BI-1), localized at the endoplasmic reticulum and the nuclear envelope in both plants and animals, is a negative regulator of programmed cell death. The silencing of BAX inhibitor 1 increases the resistance of barley to powdery mildew infection.
  • Provided herein are certain methods and polynucleotide compositions that can be applied to living plant cells/tissues to suppress expression of target genes and that provide improved fungal disease resistance to a crop plant. Also provided herein are plants and plant parts exhibiting fungal disease resistance as well as processed products of such plants or plant parts. The compositions may be topically applied to the surface of a plant, such as to the surface of a leaf, and include a transfer agent. Aspects of the method can be applied to various crops, for example, including but not limited to: i) row crop plants including, but are not limited to, corn, barley, sorghum, soybean, cotton, canola, sugar beet, alfalfa, sugarcane, rice, and wheat; ii) vegetable plants including, but not limited to, tomato, potato, sweet pepper, hot pepper, melon, watermelon, cucumber, eggplant, cauliflower, broccoli, lettuce, spinach, onion, peas, carrots, sweet corn, Chinese cabbage, leek, fennel, pumpkin, squash or gourd, radish, Brussels sprouts, tomatillo, garden beans, dry beans, or okra; iii) culinary plants including, but not limited to, basil, parsley, coffee, or tea; iv) fruit plants including but not limited to apple, pear, cherry, peach, plum, apricot, banana, plantain, table grape, wine grape, citrus, avocado, mango, or berry; v) a tree grown for ornamental or commercial use, including, but not limited to, a fruit or nut tree; or, vi) an ornamental plant (e. g., an ornamental flowering plant or shrub or turf grass). The methods and compositions provided herein can also be applied to plants produced by a cutting, cloning, or grafting process (i. e., a plant not grown from a seed) that include fruit trees and plants. Fruit trees produced by such processes include, but are not limited to, citrus and apple trees. Plants produced by such processes include, but are not limited to, avocados, tomatoes, eggplant, cucumber, melons, watermelons, and grapes as well as various ornamental plants.
  • Without being bound by theory, the compositions and methods of the present embodiments are believed to operate through one or more of the several natural cellular pathways involved in RNA-mediated gene suppression as generally described in Brodersen and Voinnet (2006), Trends Genetics, 22:268-280; Tomari and Zamore (2005) Genes & Dev., 19:517-529; Vaucheret (2006) Genes Dev., 20:759-771; Meins et al. (2005) Annu. Rev. Cell Dev. Biol., 21:297-318; and Jones-Rhoades et al. (2006) Annu. Rev. Plant Biol., 57:19-53. RNA-mediated gene suppression generally involves a double-stranded RNA (dsRNA) intermediate that is formed intra-molecularly within a single RNA molecule or inter-molecularly between two RNA molecules. This longer dsRNA intermediate is processed by a ribonuclease of the RNAase III family (Dicer or Dicer-like ribonuclease) to one or more shorter double-stranded RNAs, one strand of which is incorporated into the RNA-induced silencing complex (“RISC”). For example, the siRNA pathway involves the cleavage of a longer double-stranded RNA intermediate to small interfering RNAs (“siRNAs”). The size of siRNAs is believed to range from about 19 to about 25 base pairs, but the most common classes of siRNAs in plants include those containing 21 to 24 base pairs (See, Hamilton et al. (2002) EMBO J., 21:4671-4679).
    • Polynucleotides
  • As used herein, “polynucleotide” refers to a DNA or RNA molecule containing multiple nucleotides and generally refers both to “oligonucleotides” (a polynucleotide molecule of 18-25 nucleotides in length) and longer polynucleotides of 26 or more nucleotides. Embodiments include compositions including oligonucleotides having a length of 18-25 nucleotides (18-mers, 19-mers, 20-mers, 21-mers, 22-mers, 23-mers, 24-mers, or 25-mers), or medium-length polynucleotides having a length of 26 or more nucleotides (polynucleotides of 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, about 65, about 70, about 75, about 80, about 85, about 90, about 95, about 100, about 110, about 120, about 130, about 140, about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, about 250, about 260, about 270, about 280, about 290, or about 300 nucleotides), or long polynucleotides having a length greater than about 300 nucleotides (e. g., polynucleotides of between about 300 to about 400 nucleotides, between about 400 to about 500 nucleotides, between about 500 to about 600 nucleotides, between about 600 to about 700 nucleotides, between about 700 to about 800 nucleotides, between about 800 to about 900 nucleotides, between about 900 to about 1000 nucleotides, between about 300 to about 500 nucleotides, between about 300 to about 600 nucleotides, between about 300 to about 700 nucleotides, between about 300 to about 800 nucleotides, between about 300 to about 900 nucleotides, or about 1000 nucleotides in length, or even greater than about 1000 nucleotides in length, for example up to the entire length of a target gene including coding or non-coding or both coding and non-coding portions of the target gene). Where a polynucleotide is double-stranded, its length can be similarly described in terms of base pairs.
  • Polynucleotide compositions used in the various embodiments include compositions including oligonucleotides, polynucleotides, or a mixture of both, including: RNA or DNA or RNA/DNA hybrids or chemically modified oligonucleotides or polynucleotides or a mixture thereof. In certain embodiments, the polynucleotide may be a combination of ribonucleotides and deoxyribonucleotides, for example, synthetic polynucleotides consisting mainly of ribonucleotides but with one or more terminal deoxyribonucleotides or synthetic polynucleotides consisting mainly of deoxyribonucleotides but with one or more terminal dideoxyribonucleotides. In certain embodiments, the polynucleotide includes non-canonical nucleotides such as inosine, thiouridine, or pseudouridine. In certain embodiments, the polynucleotide includes chemically modified nucleotides. Examples of chemically modified oligonucleotides or polynucleotides are well known in the art; see, for example, U.S. Patent Publication 2011/0171287, U.S. Patent Publication 2011/0171176, U.S. Patent Publication 2011/0152353, U.S. Patent Publication 2011/0152346, and U.S. Patent Publication 2011/0160082, which are herein incorporated by reference. Illustrative examples include, but are not limited to, the naturally occurring phosphodiester backbone of an oligonucleotide or polynucleotide which can be partially or completely modified with phosphorothioate, phosphorodithioate, or methylphosphonate internucleotide linkage modifications, modified nucleoside bases or modified sugars can be used in oligonucleotide or polynucleotide synthesis, and oligonucleotides or polynucleotides can be labeled with a fluorescent moiety (e. g., fluorescein or rhodamine) or other label (e. g., biotin).
  • Polynucleotides can be single- or double-stranded RNA, single- or double-stranded DNA, double-stranded DNA/RNA hybrids, and modified analogues thereof. In certain embodiments, the polynucleotides that provide single-stranded RNA in the plant cell may be: (a) a single-stranded RNA molecule (ssRNA), (b) a single-stranded RNA molecule that self-hybridizes to form a double-stranded RNA molecule, (c) a double-stranded RNA molecule (dsRNA), (d) a single-stranded DNA molecule (ssDNA), (e) a single-stranded DNA molecule that self-hybridizes to form a double-stranded DNA molecule, (f) a single-stranded DNA molecule including a modified Pol III gene that is transcribed to an RNA molecule, (g) a double-stranded DNA molecule (dsDNA), (h) a double-stranded DNA molecule including a modified Pol III gene that is transcribed to an RNA molecule, and (i) a double-stranded, hybridized RNA/DNA molecule, or combinations thereof. In certain embodiments, these polynucleotides can comprise both ribonucleic acid residues and deoxyribonucleic acid residues. In certain embodiments, these polynucleotides include chemically modified nucleotides or non-canonical nucleotides. In certain embodiments of the methods, the polynucleotides include double-stranded DNA formed by intramolecular hybridization, double-stranded DNA formed by intermolecular hybridization, double-stranded RNA formed by intramolecular hybridization, or double-stranded RNA formed by intermolecular hybridization. In certain embodiments where the polynucleotide is a dsRNA, the anti-sense strand will comprise at least 18 nucleotides that are essentially complementary to the target gene. In certain embodiments the polynucleotides include single-stranded DNA or single-stranded RNA that self-hybridizes to form a hairpin structure having an at least partially double-stranded structure including at least one segment that will hybridize to RNA transcribed from the gene targeted for suppression. Not intending to be bound by any mechanism, it is believed that such polynucleotides are or will produce single-stranded RNA with at least one segment that will hybridize to RNA transcribed from the gene targeted for suppression. In certain embodiments, the polynucleotides can be operably linked to a promoter—generally a promoter functional in a plant, for example, a pol II promoter, a pol III promoter, a pol IV promoter, or a pol V promoter.
  • The polynucleotide molecules of the present embodiments are designed to modulate expression by inducing regulation or suppression of an endogenous gene in a plant and are designed to have a nucleotide sequence essentially identical or essentially complementary to the nucleotide sequence of an endogenous gene of a plant or to the sequence of RNA transcribed from an endogenous gene of a plant, which can be coding sequence or non-coding sequence. These effective polynucleotide molecules that modulate expression are referred to herein as “a trigger, or triggers”. By “essentially identical” or “essentially complementary” it is meant that the trigger polynucleotides (or at least one strand of a double-stranded polynucleotide) have sufficient identity or complementarity to the endogenous gene or to the RNA transcribed from the endogenous gene (e.g. the transcript) to suppress expression of the endogenous gene (e.g. to effect a reduction in levels or activity of the gene transcript and/or encoded protein). Polynucleotides of the methods and compositions provided herein need not have 100 percent identity to a complementarity to the endogenous gene or to the RNA transcribed from the endogenous gene (i.e. the transcript) to suppress expression of the endogenous gene (i.e. to effect a reduction in levels or activity of the gene transcript or encoded protein). Thus, in certain embodiments, the polynucleotide or a portion thereof is designed to be essentially identical to, or essentially complementary to, a sequence of at least 18 or 19 contiguous nucleotides in either the target gene or messenger RNA transcribed from the target gene (e.g. the transcript). In certain embodiments, an “essentially identical” polynucleotide has 100 percent sequence identity or at least about 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99 percent sequence identity when compared to the sequence of 18 or more contiguous nucleotides in either the endogenous target gene or to an RNA transcribed from the target gene (e.g. the transcript). In certain embodiments, an “essentially complementary” polynucleotide has 100 percent sequence complementarity or at least about 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99 percent sequence complementarity when compared to the sequence of 18 or more contiguous nucleotides in either the target gene or RNA transcribed from the target gene.
  • In certain embodiments, polynucleotides used in the methods and compositions provided herein can be essentially identical or essentially complementary to any of: i) conserved regions of BAX inhibitor 1 (BI-1) genes of both monocot and dicot plants; ii) conserved regions of BAX inhibitor 1 (BI-1) genes of monocot plants; or iii) conserved regions of BAX inhibitor 1 (BI-1) genes of dicot plants. Such polynucleotides that are essentially identical or essentially complementary to such conserved regions can be used to improve fungal disease resistance by suppressing expression of BAX inhibitor 1 (BI-1) genes in any of: i) both dicot and monocot plants, including, but not limited to, corn, barley, wheat, sorghum, rice, cucumber, pea, Medicago sp., soybean, pepper, tomato, and grape; ii) monocot plants, including, but not limited to, corn, barley, wheat, sorghum, switchgrass, and rice, and; or iii) dicot plants, including, but not limited to, cucumber, pea, Medicago sp., soybean, pepper, tomato, and grape. Conserved regions of dicot and monocot plant BAX inhibitor 1 (BI-1) genes of SEQ ID NO: 2, 4, 6, 7, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, and 32 can be targeted by essentially identical or essentially complementary polynucleotides.
  • Polynucleotides containing mismatches to the target gene or transcript can thus be used in certain embodiments of the compositions and methods provided herein. In certain embodiments, a polynucleotide can comprise at least 19 contiguous nucleotides that are essentially identical or essentially complementary to said gene or said transcript or comprises at least 19 contiguous nucleotides that are essentially identical or essentially complementary to the target gene or target gene transcript. In certain embodiments, a polynucleotide of 19 continuous nucleotides that is essentially identical or essentially complementary to the endogenous target gene or to an RNA transcribed from the target gene (e.g. the transcript) can have 1 or 2 mismatches to the target gene or transcript. In certain embodiments, a polynucleotide of 20 or more nucleotides that contains a contiguous 19 nucleotide span of identity or complementarity to the endogenous target gene or to an RNA transcribed from the target gene can have 1 or 2 mismatches to the target gene or transcript. In certain embodiments, a polynucleotide of 21 continuous nucleotides that is essentially identical or essentially complementary to the endogenous target gene or to an RNA transcribed from the target gene (e.g. the transcript) can have 1, 2, or 3 mismatches to the target gene or transcript. In certain embodiments, a polynucleotide of 22 or more nucleotides that contains a contiguous 21 nucleotide span of identity or complementarity to the endogenous target gene or to an RNA transcribed from the target gene can have 1, 2, or 3 mismatches to the target gene or transcript. In designing polynucleotides with mismatches to an endogenous target gene or to an RNA transcribed from the target gene, mismatches of certain types and at certain positions that are more likely to be tolerated can be used. In certain embodiments, mismatches formed between adenine and cytosine or guanosine and uracil residues are used as described by Du et al. Nucleic Acids Research, 2005, Vol. 33, No. 5 1671-1677. In certain embodiments, mismatches in 19 base pair overlap regions can be at the low tolerance positions 5, 7, 8 or 11 (from the 5′ end of a 19 nucleotide target) with well tolerated nucleotide mismatch residues, at medium tolerance positions 3, 4, and 12-17, and/or at the high tolerance nucleotide positions at either end of the region of complementarity (i.e. positions 1, 2, 18, and 19) as described by Du et al. Nucleic Acids Research, 2005, Vol. 33, No. 5 1671-1677. It is further anticipated that tolerated mismatches can be empirically determined in assays where the polynucleotide is applied to the plants via the methods provided herein and the treated plants assayed for suppression of BAX inhibitor 1 (BI-1) expression or appearance of fungal disease resistance.
  • In certain embodiments, polynucleotide molecules are designed to have 100 percent sequence identity with or complementarity to one allele or one family member of a given target gene coding or non-coding sequence of a BI-1 target gene. In other embodiments, the polynucleotide molecules are designed to have 100 percent sequence identity with or complementarity to multiple alleles or family members of a given BAX inhibitor 1 (BI-1) target gene. In certain embodiments, the polynucleotide can thus comprise at least 18 contiguous nucleotides that are identical or complementary to SEQ ID NO: 33-106, 108-140, or 142-146. In certain embodiments, the polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
  • In certain embodiments, polynucleotide compositions and methods provided herein typically effect regulation or modulation (e. g., suppression) of gene expression during a period during the life of the treated plant of at least 1 week or longer and typically in systemic fashion. For instance, within days of treating a plant leaf with a polynucleotide composition as described herein, primary and transitive siRNAs can be detected in other leaves lateral to and above the treated leaf and in apical tissue. In certain embodiments, methods of systemically suppressing expression of a gene in a plant, the methods comprising treating said plant with a composition comprising at least one polynucleotide and a transfer agent, wherein said polynucleotide comprises at least 18 or at least 19 contiguous nucleotides that are essentially identical or essentially complementary to a gene or a transcript encoding a BAX inhibitor 1 (BI-1) gene of the plant are provided, whereby expression of the gene in said plant or progeny thereof is systemically suppressed in comparison to a control plant that has not been treated with the composition.
  • Compositions used to suppress a target gene can comprise one or more polynucleotides that are essentially identical or essentially complementary to multiple genes, or to multiple segments of one or more genes. In certain embodiments, compositions used to suppress a target gene can comprise one or more polynucleotides that are essentially identical or essentially complementary to multiple consecutive segments of a target gene, multiple non-consecutive segments of a target gene, multiple alleles of a target gene, or multiple target genes from one or more species.
  • In certain embodiments, the polynucleotide includes two or more copies of a nucleotide sequence (of 18 or more nucleotides) where the copies are arranged in tandem fashion. In another embodiment, the polynucleotide includes two or more copies of a nucleotide sequence (of 18 or more nucleotides) where the copies are arranged in inverted repeat fashion (forming an at least partially self-complementary strand). The polynucleotide can include both tandem and inverted-repeat copies. Whether arranged in tandem or inverted repeat fashion, each copy can be directly contiguous to the next, or pairs of copies can be separated by an optional spacer of one or more nucleotides. The optional spacer can be unrelated sequence (i. e., not essentially identical to or essentially complementary to the copies, nor essentially identical to, or essentially complementary to, a sequence of 18 or more contiguous nucleotides of the endogenous target gene or RNA transcribed from the endogenous target gene). Alternatively the optional spacer can include sequence that is complementary to a segment of the endogenous target gene adjacent to the segment that is targeted by the copies. In certain embodiments, the polynucleotide includes two copies of a nucleotide sequence of between about 20 to about 30 nucleotides, where the two copies are separated by a spacer no longer than the length of the nucleotide sequence.
    • Tiling
  • Polynucleotide trigger molecules can be identified by “tiling” gene targets in random length fragments, e.g. 200-300 polynucleotides in length, with partially overlapping regions, e.g. 25 or so nucleotide overlapping regions along the length of the target gene. Multiple gene target sequences can be aligned and polynucleotide sequence regions with homology in common are identified as potential trigger molecules for multiple targets. Multiple target sequences can be aligned and sequence regions with poor homology are identified as potential trigger molecules for selectively distinguishing targets. To selectively suppress a single gene, trigger sequences may be chosen from regions that are unique to the target gene either from the transcribed region or the non-coding regions, e.g., promoter regions, 3′ untranslated regions, introns and the like.
  • Polynucleotides fragments are designed along the length of the full length coding and untranslated regions of a BI-1 gene or family member as contiguous overlapping fragments of 200-300 polynucleotides in length or fragment lengths representing a percentage of the target gene. These fragments are applied topically (as sense or anti-sense ssDNA or ssRNA, dsRNA, or dsDNA) to determine the relative effectiveness in providing the fungal disease resistance phenotype. Fragments providing the desired activity may be further subdivided into 50-60 polynucleotide fragments which are evaluated for providing the fungal disease resistance phenotype. The 50-60 base fragments with the desired activity may then be further subdivided into 19-30 base fragments which are evaluated for providing the fungal disease resistance phenotype. Once relative effectiveness is determined, the fragments are utilized singly, or in combination in one or more pools to determine effective trigger composition or mixture of trigger polynucleotides for providing the fungal disease resistance phenotype.
  • Coding and/or non-coding sequences of gene families in the crop of interest are aligned and 200-300 polynucleotide fragments from the least homologous regions amongst the aligned sequences are evaluated using topically applied polynucleotides (as sense or anti-sense ssDNA or ssRNA, dsRNA, or dsDNA) to determine their relative effectiveness in providing the fungal disease resistance phenotype. The effective segments are further subdivided into 50-60 polynucleotide fragments, prioritized by least homology, and reevaluated using topically applied polynucleotides. The effective 50-60 polynucleotide fragments are subdivided into 19-30 polynucleotide fragments, prioritized by least homology, and again evaluated for induction of the fungal disease resistance phenotype. Once relative effectiveness is determined, the fragments are utilized singly, or again evaluated in combination with one or more other fragments to determine the trigger composition or mixture of trigger polynucleotides for providing the fungal disease resistance phenotype.
  • Coding and/or non-coding sequences of gene families in the crop of interest are aligned and 200-300 polynucleotide fragments from the most homologous regions amongst the aligned sequences are evaluated using topically applied polynucleotides (as sense or anti-sense ssDNA or ssRNA, dsRNA, or dsDNA) to determine their relative effectiveness in inducing the fungal disease resistance phenotype. The effective segments are subdivided into 50-60 polynucleotide fragments, prioritized by most homology, and reevaluated using topically applied polynucleotides. The effective 50-60 polynucleotide fragments are subdivided into 19-30 polynucleotide fragments, prioritized by most homology, and again evaluated for induction of the yield/quality phenotype. Once relative effectiveness is determined, the fragments may be utilized singly, or in combination with one or more other fragments to determine the trigger composition or mixture of trigger polynucleotides for providing the fungal disease resistance phenotype.
  • Also, provided herein are methods for identifying a preferred polynucleotide for improving fungal disease in a plant. Populations of candidate polynucleotides that are essentially identical or essentially complementary to a BI-1 gene or transcript of the gene can be generated by a variety of approaches, including but not limited to, any of the tiling, least homology, or most homology approaches provided herein. Such populations of polynucleotides can also be generated or obtained from any of the polynucleotides or genes provided herewith in SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 33-106, 108-140, or 142-146. Such populations of polynucleotides can also be generated or obtained from any genes that are orthologous to the genes or proteins provided herewith as SEQ ID NO: 1-32. Such polynucleotides can be topically applied to a surface of plants in a composition comprising at least one polynucleotide from said population and a transfer agent to obtain treated plants. Treated plants that exhibit suppression of the BI-1 gene and/or exhibit an improvement in fungal disease resistance are identified, thus identifying a preferred polynucleotide that improves fungal disease in a plant. Suppression of the gene can be determined by any assay for the levels and/or activity of a gene product (i.e. transcript or protein). Suitable assays for transcripts include, but are not limited to, semi-quantitative or quantitative reverse transcriptase PCR® (qRT-PCR) assays. Suitable assays for proteins include, but are not limited to, semi-quantitative or quantitative immunoassays, biochemical activity assays, or biological activity assays. In certain embodiments, the polynucleotides can be applied alone. In other embodiments, the polynucleotides can be applied in pools of multiple polynucleotides. When a pool of polynucleotides provides for suppression of the BI-1 gene and/or an improvement in fungal disease resistance are identified, the pool can be de-replicated and retested as necessary or desired to identify one or more preferred polynucleotide(s) that improves fungal disease resistance in a plant.
  • Methods of making polynucleotides are well known in the art. Such methods of making polynucleotides can include in vivo biosynthesis, in vitro enzymatic synthesis, or chemical synthesis. In certain embodiments, RNA molecules can be made by either in vivo or in vitro synthesis from DNA templates where a suitable promoter is operably linked to the polynucleotide and a suitable DNA-dependent RNA polymerase is provided. DNA-dependent RNA polymerases include, but are not limited to, E. coli or other bacterial RNA polymerases as well as the bacteriophage RNA polymerases such as the T7, T3, and SP6 RNA polymerases. Commercial preparation of oligonucleotides often provides two deoxyribonucleotides on the 3′ end of the sense strand. Long polynucleotide molecules can be synthesized from commercially available kits, for example, kits from Applied Biosystems/Ambion (Austin, Tex.) have DNA ligated on the 5′ end that encodes a bacteriophage T7 polymerase promoter that makes RNA strands that can be assembled into a dsRNA. Alternatively, dsRNA molecules can be produced from expression cassettes in bacterial cells that have regulated or deficient RNase III enzyme activity. Long polynucleotide molecules can also be assembled from multiple RNA or DNA fragments. In some embodiments design parameters such as Reynolds score (Reynolds et al. Nature Biotechnology 22, 326-330 (2004) and Tuschl rules (Pei and Tuschl, Nature Methods 3(9): 670-676, 2006) are known in the art and are used in selecting polynucleotide sequences effective in gene silencing. In some embodiments random design or empirical selection of polynucleotide sequences is used in selecting polynucleotide sequences effective in gene silencing. In some embodiments the sequence of a polynucleotide is screened against the genomic DNA of the intended plant to minimize unintentional silencing of other genes.
  • While there is no upper limit on the concentrations and dosages of polynucleotide molecules that can be useful in the methods and compositions provided herein, lower effective concentrations and dosages will generally be sought for efficiency. The concentrations can be adjusted in consideration of the volume of spray or treatment applied to plant leaves or other plant part surfaces, such as flower petals, stems, tubers, fruit, anthers, pollen, leaves, roots, or seeds. In one embodiment, a useful treatment for herbaceous plants using 25-mer polynucleotide molecules is about 1 nanomole (nmol) of polynucleotide molecules per plant, for example, from about 0.05 to 1 nmol polynucleotides per plant. Other embodiments for herbaceous plants include useful ranges of about 0.05 to about 100 nmol, or about 0.1 to about 20 nmol, or about 1 nmol to about 10 nmol of polynucleotides per plant. In certain embodiments, about 40 to about 50 nmol of a ssDNA polynucleotide are applied. In certain embodiments, about 0.5 nmol to about 2 nmol of a dsRNA is applied. In certain embodiments, a composition containing about 0.5 to about 2.0 mg/mL, or about 0.14 mg/mL of dsRNA or ssDNA (21-mer) is applied. In certain embodiments, a composition of about 0.5 to about 1.5 mg/mL of a long dsRNA polynucleotide (i.e. about 50 to about 200 or more nucleotides) is applied. In certain embodiments, about 1 nmol to about 5 nmol of a dsRNA is applied to a plant. In certain embodiments, the polynucleotide composition as topically applied to the plant contains the at least one polynucleotide at a concentration of about 0.01 to about 10 milligrams per milliliter, or about 0.05 to about 2 milligrams per milliliter, or about 0.1 to about 2 milligrams per milliliter. Very large plants, trees, or vines may require correspondingly larger amounts of polynucleotides. When using long dsRNA molecules that can be processed into multiple oligonucleotides, lower concentrations can be used. To illustrate certain embodiments, the factor 1×, when applied to oligonucleotide molecules is arbitrarily used to denote a treatment of 0.8 nmol of polynucleotide molecule per plant; 10×, 8 nmol of polynucleotide molecule per plant; and 100×, 80 nmol of polynucleotide molecule per plant.
  • The polynucleotide compositions of certain embodiments are useful in compositions, such as liquids that comprise polynucleotide molecules, alone or in combination with other components either in the same liquid or in separately applied liquids that provide a transfer agent. As used herein, a transfer agent is an agent that, when combined with a polynucleotide in a composition that is topically applied to a target plant surface, enables the polynucleotide to enter a plant cell. In certain embodiments, a transfer agent is an agent that conditions the surface of plant tissue, e. g., seeds, leaves, stems, roots, flowers, or fruits, to permeation by the polynucleotide molecules into plant cells. The transfer of polynucleotides into plant cells can be facilitated by the prior or contemporaneous application of a polynucleotide-transferring agent to the plant tissue. In some embodiments the transferring agent is applied subsequent to the application of the polynucleotide composition. The polynucleotide transfer agent enables a pathway for polynucleotides through cuticle wax barriers, stomata and/or cell wall or membrane barriers into plant cells. Suitable transfer agents to facilitate transfer of the polynucleotide into a plant cell include agents that increase permeability of the exterior of the plant or that increase permeability of plant cells to oligonucleotides or polynucleotides. Such agents to facilitate transfer of the composition into a plant cell include a chemical agent, or a physical agent, or combinations thereof. Chemical agents for conditioning or transfer include (a) surfactants, (b) an organic solvent or an aqueous solution or aqueous mixtures of organic solvents, (c) oxidizing agents, (d) acids, (e) bases, (f) oils, (g) enzymes, or combinations thereof. Embodiments of the method can optionally include an incubation step, a neutralization step (e.g., to neutralize an acid, base, or oxidizing agent, or to inactivate an enzyme), a rinsing step, or combinations thereof. Embodiments of agents or treatments for conditioning of a plant to permeation by polynucleotides include emulsions, reverse emulsions, liposomes, and other micellar-like compositions. Embodiments of agents or treatments for conditioning of a plant to permeation by polynucleotides include counter-ions or other molecules that are known to associate with nucleic acid molecules, e. g., inorganic ammonium ions, alkyl ammonium ions, lithium ions, polyamines such as spermine, spermidine, or putrescine, and other cations. Organic solvents useful in conditioning a plant to permeation by polynucleotides include DMSO, DMF, pyridine, N-pyrrolidine, hexamethylphosphoramide, acetonitrile, dioxane, polypropylene glycol, other solvents miscible with water or that will dissolve phosphonucleotides in non-aqueous systems (such as is used in synthetic reactions). Naturally derived or synthetic oils with or without surfactants or emulsifiers can be used, e. g., plant-sourced oils, crop oils (such as those listed in the 9th Compendium of Herbicide Adjuvants, publicly available on the worldwide web (internet) at herbicide.adjuvants.com can be used, e. g., paraffinic oils, polyol fatty acid esters, or oils with short-chain molecules modified with amides or polyamines such as polyethyleneimine or N-pyrrolidine. Transfer agents include, but are not limited to, organosilicone preparations.
  • In certain embodiments, an organosilicone preparation that is commercially available as Silwet® L-77 surfactant having CAS Number 27306-78-1 and EPA Number: CAL.REG.NO. 5905-50073-AA, and currently available from Momentive Performance Materials, Albany, N.Y. can be used to prepare a polynucleotide composition. In certain embodiments where a Silwet L-77 organosilicone preparation is used as a pre-spray treatment of plant leaves or other plant surfaces, freshly made concentrations in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent) are efficacious in preparing a leaf or other plant surface for transfer of polynucleotide molecules into plant cells from a topical application on the surface. In certain embodiments of the methods and compositions provided herein, a composition that comprises a polynucleotide molecule and an organosilicone preparation comprising Silwet L-77 in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent) is used or provided. In certain embodiments of the methods and compositions provided herein, a composition that comprises a polynucleotide molecule and an organosilicone preparation comprising Silwet L-77 in the range of about 0.3 to about 1 percent by weight (wt percent) or about 0.5 to about 1% by weight (wt percent) is used or provided.
  • In certain embodiments, any of the commercially available organosilicone preparations provided in the following Table 1 can be used as transfer agents in a polynucleotide composition. In certain embodiments where an organosilicone preparation of Table 1 is used as a pre-spray treatment of plant leaves or other surfaces, freshly made concentrations in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent) are efficacious in preparing a leaf or other plant surface for transfer of polynucleotide molecules into plant cells from a topical application on the surface. In certain embodiments of the methods and compositions provided herein, a composition that comprises a polynucleotide molecule and an organosilicone preparation of the following Table 1 in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent) is used or provided.
  • TABLE 1
    Name CAS number Manufacturer 1,2
    BREAK-THRU ® S 321 na Evonik Industries AG
    BREAK-THRU ® S 200 67674-67-3 Evonik Industries AG
    BREAK-THRU ® OE 68937-55-3 Evonik Industries AG
    441
    BREAK-THRU ® S 278 27306-78-1 Evonik Goldschmidt
    BREAK-THRU ® S 243 na Evonik Industries AG
    Silwet ® L-77 27306-78-1 Momentive Performance
    Materials
    Silwet ® HS 429 na Momentive Performance
    Materials
    Silwet ® HS 312 na Momentive Performance
    Materials
    BREAK-THRU ® S 233 134180-76-0 Evonik Industries AG
    Silwet ® HS 508 Momentive Performance
    Materials
    Silwet ® HS 604 Momentive Performance
    Materials
    1 Evonik Industries AG, Essen, Germany
    2 Momentive Performance Materials, Albany, New York
  • Organosilicone preparations used in the methods and compositions provided herein can comprise one or more effective organosilicone compounds. As used herein, the phrase “effective organosilicone compound” is used to describe any organosilicone compound that is found in an organosilicone preparation that enables a polynucleotide to enter a plant cell. In certain embodiments, an effective organosilicone compound can enable a polynucleotide to enter a plant cell in a manner permitting a polynucleotide mediated suppression of a target gene expression in the plant cell. In general, effective organosilicone compounds include, but are not limited to, compounds that can comprise: i) a trisiloxane head group that is covalently linked to, ii) an alkyl linker including, but not limited to, an n-propyl linker, that is covalently linked to, iii) a poly glycol chain, that is covalently linked to, iv) a terminal group. Trisiloxane head groups of such effective organosilicone compounds include, but are not limited to, heptamethyltrisiloxane. Alkyl linkers can include, but are not limited to, an n-propyl linker. Poly glycol chains include, but are not limited to, polyethylene glycol or polypropylene glycol. Poly glycol chains can comprise a mixture that provides an average chain length “n” of about “7.5”. In certain embodiments, the average chain length “n” can vary from about 5 to about 14. Terminal groups can include, but are not limited to, alkyl groups such as a methyl group. Effective organosilicone compounds are believed to include, but are not limited to, trisiloxane ethoxylate surfactants or polyalkylene oxide modified heptamethyl trisiloxane.
  • Figure US20180346923A1-20181206-C00001
  • One organosilicone compound believed to be ineffective comprises the formula:
  • Figure US20180346923A1-20181206-C00002
  • In certain embodiments, an organosilicone preparation that comprises an organosilicone compound comprising a trisiloxane head group is used in the methods and compositions provided herein. In certain embodiments, an organosilicone preparation that comprises an organosilicone compound comprising a heptamethyltrisiloxane head group is used in the methods and compositions provided herein. In certain embodiments, an organosilicone composition that comprises Compound I is used in the methods and compositions provided herein. In certain embodiments, an organosilicone composition that comprises Compound I is used in the methods and compositions provided herein. In certain embodiments of the methods and compositions provided herein, a composition that comprises a polynucleotide molecule and one or more effective organosilicone compound in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent) is used or provided.
  • In certain embodiments, the polynucleotide compositions that comprise an organosilicone preparation can comprise a salt such as ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate. Ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate can be provided in the polynucleotide composition at a concentration of about 0.5% to about 5% (w/v). An ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate concentration of about 1% to about 3%, or about 2% (w/v) can also be used in the polynucleotide compositions that comprise an organosilicone preparation. In certain embodiments, the polynucleotide compositions can comprise an ammonium salt at a concentration greater or equal to 300 millimolar. In certain embodiments, the polynucleotide compositions that comprise an organosilicone preparation can comprise ammonium sulfate at concentrations from about 80 to about 1200 mM or about 150 mM to about 600 mM.
  • In certain embodiments, the polynucleotide compositions can also comprise a phosphate salt. Phosphate salts used in the compositions include, but are not limited to, calcium, magnesium, potassium, or sodium phosphate salts. In certain embodiments, the polynucleotide compositions can comprise a phosphate salt at a concentration of at least about 5 millimolar, at least about 10 millimolar, or at least about 20 millimolar. In certain embodiments, the polynucleotide compositions will comprise a phosphate salt in a range of about 1 mM to about 25 mM or in a range of about 5 mM to about 25 mM. In certain embodiments, the polynucleotide compositions can comprise sodium phosphate at a concentration of at least about 5 millimolar, at least about 10 millimolar, or at least about 20 millimolar. In certain embodiments, the polynucleotide compositions can comprise sodium phosphate at a concentration of about 5 millimolar, about 10 millimolar, or about 20 millimolar. In certain embodiments, the polynucleotide compositions will comprise a sodium phosphate salt in a range of about 1 mM to about 25 mM or in a range of about 5 mM to about 25 mM. In certain embodiments, the polynucleotide compositions can comprise a sodium phosphate buffer at a pH of about 6.8.
  • In certain embodiments, other useful transfer agents or adjuvants to transfer agents that can be used in polynucleotide compositions provided herein include surfactants and/or effective molecules contained therein. Surfactants and/or effective molecules contained therein include, but are not limited to, sodium or lithium salts of fatty acids (such as tallow or tallowamines or phospholipids) and organosilicone surfactants. In certain embodiments, the polynucleotide compositions that comprise a transfer agent are formulated with counter-ions or other molecules that are known to associate with nucleic acid molecules. Illustrative examples include, tetraalkyl ammonium ions, trialkyl ammonium ions, sulfonium ions, lithium ions, and polyamines such as spermine, spermidine, or putrescine. In certain embodiments, the polynucleotide compositions are formulated with a non-polynucleotide herbicide. Non-polynucleotide herbicidal molecules include, but are not limited to, glyphosate, auxin-like benzoic acid herbicides including dicamba, chloramben and TBA, glufosinate, auxin-like herbicides including phenoxy carboxylic acid herbicide, pyridine carboxylic acid herbicide, quinoline carboxylic acid herbicide, pyrimidine carboxylic acid herbicide, and benazolin-ethyl herbicide, sulfonylureas, imidazolinones, bromoxynil, delapon, cyclohezanedione, protoporphyrionogen oxidase inhibitors, and 4-hydroxyphenyl-pyruvate-dioxygenase inhibiting herbicides.
  • In certain embodiments, the polynucleotides used in the compositions that are essentially identical or essentially complementary to the BI-1 target gene or transcript will comprise the predominant nucleic acid in the composition. Thus in certain embodiments, the polynucleotides that are essentially identical or essentially complementary to the target gene or transcript will comprise at least about 50%, 75%, 95%, 98%, or 100% of the nucleic acids provided in the composition by either mass or molar concentration. However, in certain embodiments, the polynucleotides that are essentially identical or essentially complementary to the target gene or transcript can comprise at least about 1% to about 50%, about 10% to about 50%, about 20% to about 50%, or about 30% to about 50% of the nucleic acids provided in the composition by either mass or molar concentration. Also provided are compositions where the polynucleotides that are essentially identical or essentially complementary to the target gene or transcript can comprise at least about 1% to 100%, about 10% to 100%, about 20% to about 100%, about 30% to about 50%, or about 50% to a 100% of the nucleic acids provided in the composition by either mass or molar concentration.
  • Polynucleotides comprising ssDNA, dsDNA, ssRNA, dsRNA, or RNA/DNA hybrids that are essentially identical or complementary to certain plant target genes or transcripts and that can be used in compositions containing transfer agents that include, but are not limited to, organosilicone preparations, to suppress those target genes when topically applied to plants are disclosed in co-assigned U.S. patent application Ser. No. 13/042,856. Various polynucleotide herbicidal molecules, compositions comprising those polynucleotide herbicidal molecules and transfer agents that include, but are not limited to, organosilicone preparations, and methods whereby herbicidal effects are obtained by the topical application of such compositions to plants are also disclosed in co-assigned U.S. patent application Ser. No. 13/042,856 (U.S. Patent Application Publication No. 20110296556), and those polynucleotide herbicidal molecules, compositions, and methods are incorporated herein by reference in their entireties. Genes encoding proteins that can provide tolerance to an herbicide and/or that are targets of a herbicide are collectively referred to herein as “herbicide target genes”. Herbicide target genes include, but are not limited to, a 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), a glyphosate oxidoreductase (GOX), a glyphosate decarboxylase, a glyphosate-N-acetyl transferase (GAT), a dicamba monooxygenase, a phosphinothricin acetyltransferase, a 2,2-dichloropropionic acid dehalogenase, an acetohydroxyacid synthase, an acetolactate synthase, a haloarylnitrilase, an acetyl-coenzyme A carboxylase (ACCase), a dihydropteroate synthase, a phytoene desaturase (PDS), a protoporphyrin IX oxygenase (PPO), a hydroxyphenylpyruvate dioxygenase (HPPD), a para-aminobenzoate synthase, a glutamine synthase, a cellulose synthase, a beta tubulin, and a serine hydroxymethyltransferase gene. The effects of applying certain compositions comprising polynucleotides that are essentially identical or complementary to certain herbicide target genes and transfer agents on plants containing the herbicide target genes was shown to be potentiated or enhanced by subsequent application of an herbicide that targets the same gene as the polynucleotide in co-assigned U.S. patent application Ser. No. 13/042,856. For example, compositions comprising polynucleotides targeting the EPSPS herbicide target gene were potentiated by glyphosate in experiments disclosed in co-assigned U.S. patent application Ser. No. 13/042,856.
  • In certain embodiments of the compositions and methods disclosed herein, the composition comprising a polynucleotide and a transfer agent can thus further comprise a second polynucleotide comprising at least 19 contiguous nucleotides that are essentially identical or essentially complementary to a transcript to a protein that confers resistance to a herbicide. In certain embodiments, the second polynucleotide does not comprise a polynucleotide that is essentially identical or essentially complementary to a transcript encoding a protein of a target plant that confers resistance to said herbicidal molecule. Thus, in a non-limiting embodiment, the second polynucleotide could be essentially identical or essentially complementary to a transcript encoding a protein that confers resistance to a herbicide in a weed (such as an EPSPS encoding transcript) but would not be essentially identical or essentially complementary to a transcript encoding a protein that confers resistance to that same herbicide in a crop plant.
  • In certain embodiments, the polynucleotide compositions that comprise a transfer agent can comprise glycerin. Glycerin can be provided in the composition at a concentration of about 0.1% to about 1% (w/v or v/v). A glycerin concentration of about 0.4% to about 0.6%, or about 0.5% (w/v or v/v) can also be used in the polynucleotide compositions that comprise a transfer agent.
  • In certain embodiments, the polynucleotide compositions that comprise a transfer agent can further comprise organic solvents. Such organic solvents include, but are not limited to, DMSO, DMF, pyridine, N-pyrrolidine, hexamethylphosphoramide, acetonitrile, dioxane, polypropylene glycol, other solvents miscible with water or that will dissolve phosphonucleotides in non-aqueous systems (such as is used in synthetic reactions).
  • In certain embodiments, the polynucleotide compositions that comprise a transfer agent can further comprise naturally derived or synthetic oils with or without surfactants or emulsifiers. Such oils include, but are not limited to, plant-sourced oils, crop oils (such as those listed in the 9th Compendium of Herbicide Adjuvants, publicly available on line at www.herbicide.adjuvants.com), paraffinic oils, polyol fatty acid esters, or oils with short-chain molecules modified with amides or polyamines such as polyethyleneimine or N-pyrrolidine.
  • In some embodiments, methods include one or more applications of the composition comprising a polynucleotide and a transfer agent or one or more effective components contained therein. In certain embodiments of the methods, one or more applications of a transfer agent or one or more effective components contained therein can precede one or more applications of the composition comprising a polynucleotide and a transfer agent. In embodiments where a transfer agent and/or one or more effective molecules contained therein is used either by itself as a pre-treatment or as part of a composition that includes a polynucleotide, embodiments of the polynucleotide molecules are double-stranded RNA oligonucleotides, single-stranded RNA oligonucleotides, double-stranded RNA polynucleotides, single-stranded RNA polynucleotides, double-stranded DNA oligonucleotides, single-stranded DNA oligonucleotides, double-stranded DNA polynucleotides, single-stranded DNA polynucleotides, chemically modified RNA or DNA oligonucleotides or polynucleotides or mixtures thereof.
  • Compositions and methods described herein are useful for modulating or suppressing the expression of an endogenous BAX inhibitor 1 (BI-1) target gene or transgenic BAX inhibitor 1 (BI-1) target gene in a plant cell or plant. In certain embodiments of the methods and compositions provided herein, expression of BI-1 target genes can be suppressed completely, partially and/or transiently to result in an improvement in fungal disease resistance. In various embodiments, a BAX inhibitor 1 (BI-1) target gene includes coding (protein-coding or translatable) sequence, non-coding (non-translatable) sequence, or both coding and non-coding sequence. Compositions can include polynucleotides and oligonucleotides designed to target multiple BAX inhibitor 1 (BI-1) genes, or multiple segments of one or more BAX inhibitor 1 (BI-1) genes. The target gene can include multiple consecutive segments of a target BAX inhibitor 1 (BI-1) gene, multiple non-consecutive segments of a BAX inhibitor 1 (BI-1) target gene, multiple alleles of a target gene, or multiple BAX inhibitor 1 (BI-1) target genes from one or more species. BAX inhibitor 1 (BI-1) target genes include, but are not limited to, the endogenous BAX inhibitor 1 (BI-1) plant genes of SEQ ID NO: or. BAX inhibitor 1 (BI-1) target genes include, but are not limited to, BAX inhibitor 1 (BI-1) plant genes that encode proteins that are orthologous to the proteins encoded by SEQ ID NO:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, or 31. BAX inhibitor 1 (BI-1) target genes include, but are not limited to, BAX inhibitor 1 (BI-1) plant genes that encode the proteins of SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, or 31.
  • Target genes and plants containing those target genes can be obtained from: i) row crop plants including, but are not limited to, corn, soybean, cotton, canola, sugar beet, alfalfa, sugarcane, rice, and wheat; ii) vegetable plants including, but not limited to, tomato, potato, sweet pepper, hot pepper, melon, watermelon, cucumber, eggplant, cauliflower, broccoli, lettuce, spinach, onion, peas, carrots, sweet corn, Chinese cabbage, leek, fennel, pumpkin, squash or gourd, radish, Brussels sprouts, tomatillo, garden beans, dry beans, or okra; iii) culinary plants including, but not limited to, basil, parsley, coffee, or tea; iv) fruit plants including but not limited to apple, pear, cherry, peach, plum, apricot, banana, plantain, table grape, wine grape, citrus, avocado, mango, or berry; v) a tree grown for ornamental or commercial use, including, but not limited to, a fruit or nut tree; or, vi) an ornamental plant (e. g., an ornamental flowering plant or shrub or turf grass). The methods and compositions provided herein can also be applied to plants produced by a cutting, cloning, or grafting process (i. e., a plant not grown from a seed) include fruit trees and plants that include, but are not limited to, citrus, apples, avocados, tomatoes, eggplant, cucumber, melons, watermelons, and grapes as well as various ornamental plants. Such row crop, vegetable, culinary, fruit, tree, or ornamental plants improvements in fungal disease resistance that result from suppressing BAX inhibitor 1 (BI-1) gene expression are provided herein. Such row crop, vegetable, culinary, fruit, tree, or ornamental plant parts or processed plant products exhibiting improvements in fungal disease resistance that result from suppressing BAX inhibitor 1 (BI-1) gene expression are also provided herein. Such plant parts can include, but are not limited to, flowers, stems, tubers, fruit, anthers, meristems, ovules, pollen, leaves, or seeds. Such processed plant products obtained from the plant parts can include, but are not limited to, a meal, a pulp, a feed, or a food product.
  • In some embodiments, a method for modulating or suppressing expression of an BAX inhibitor 1 (BI-1) gene in a plant including (a) conditioning of a plant to permeation by polynucleotides and (b) treatment of the plant with the polynucleotide molecules, wherein the polynucleotide molecules include at least one segment of 18 or more contiguous nucleotides cloned from or otherwise identified from the BAX inhibitor 1 (BI-1) target gene in either anti-sense or sense orientation, whereby the polynucleotide molecules permeate the interior of the plant and induce modulation of the target gene is provided. The conditioning and polynucleotide application can be performed separately or in a single step. When the conditioning and polynucleotide application are performed in separate steps, the conditioning can precede or can follow the polynucleotide application within minutes, hours, or days. In some embodiments more than one conditioning step or more than one polynucleotide molecule application can be performed on the same plant. In embodiments of the method, the segment can be cloned or identified from (a) coding (protein-encoding), (b) non-coding (promoter and other gene related molecules), or (c) both coding and non-coding parts of the BAX inhibitor 1 (BI-1) target gene. Non-coding parts include DNA, such as promoter regions or the RNA transcribed by the DNA that provide RNA regulatory molecules, including but not limited to: introns, 5′ or 3′ untranslated regions, and microRNAs (miRNA), trans-acting siRNAs, natural anti-sense siRNAs, and other small RNAs with regulatory function or RNAs having structural or enzymatic function including but not limited to: ribozymes, ribosomal RNAs, t-RNAs, aptamers, and riboswitches. In certain embodiments where the polynucleotide used in the composition comprises a promoter sequence essentially identical to, or essentially complementary to at least 18 contiguous nucleotides of the promoter of the endogenous target gene, the promoter sequence of the polynucleotide is not operably linked to another sequence that is transcribed from the promoter sequence.
  • Compositions comprising a polynucleotide and a transfer agent provided herein can be topically applied to a plant or plant part by any convenient method, e.g., spraying or coating with a powder, or with a liquid composition comprising any of an emulsion, suspension, or solution. Such topically applied sprays or coatings can be of either all or of any a portion of the surface of the plant or plant part. Similarly, compositions that comprise a transfer agent or other pre-treatment can in certain embodiments be applied to the plant or plant part by any convenient method, e. g., spraying or wiping a solution, emulsion, or suspension. Compositions comprising a polynucleotide and a transfer agent provided herein can be topically applied to plant parts that include, but are not limited to, flowers, stems, tubers, meristems, ovules, fruit, anthers, pollen, leaves, or seeds.
  • Application of compositions comprising a polynucleotide and a transfer agent to seeds is specifically provided herein. Seeds can be contacted with such compositions by spraying, misting, immersion, and the like.
  • In certain embodiments, application of compositions comprising a polynucleotide and a transfer agent to plants, plant parts, or seeds in particular can provide for an improvement in fungal disease resistance in progeny plants, plant parts, or seeds derived from those treated plants, plant parts, or seeds. In certain embodiments, progeny plants, plant parts, or seeds derived from those treated plants, plant parts, or seeds will exhibit an improvement in an improvement in fungal disease resistance that results from suppressing expression of an BI-1 gene. In certain embodiments, the methods and compositions provided herein can provide for an improvement in an improvement in fungal disease resistance in progeny plants or seeds as a result of epigenetically inherited suppression of BI-1 expression. In certain embodiments, such progeny plants exhibit an improvement in an improvement in fungal disease resistance from epigenetically inherited suppression of BI-1 gene expression that is not caused by a transgene where the polynucleotide is operably linked to a promoter, a viral vector, or a copy of the polynucleotide that is integrated into a non-native location in the chromosomal DNA of the plant. Without seeking to be limited by theory, progeny plants or seeds derived from those treated plants, plant parts, or seeds can exhibit an improvement in an improvement in fungal disease resistance through an epigenetic mechanism that provides for propagation of an epigenetic condition where suppression of BI-1 gene expression occurs in the progeny plants, plant parts, or plant seeds. In certain embodiments, progeny plants or seeds exhibiting an improvement in an improvement in fungal disease resistance as a result of epigenetically inherited suppression of BI-1 gene expression can also exhibit increased methylation, and in particular, increased methylation of cytosine residues, in the endogenous BI-1 gene of the plant. Plant parts, including seeds, of the progeny plants that exhibit an improvement in an improvement in fungal disease resistance as a result of epigenetically inherited suppression of BI-1 gene expression, can also in certain embodiments exhibit increased methylation, and in particular, increased methylation of cytosine residues, in the endogenous BI-1 gene. In certain embodiments, DNA methylation levels in DNA encoding the endogenous BI-1 gene can be compared in plants that exhibit the an improvement in fungal disease resistance and control plants that do not exhibit an improvement in fungal disease resistance to correlate the presence of the an improvement in fungal disease resistance to epigenetically inherited suppression of BI-1 gene expression and to identify plants that comprise the epigenetically inherited improvement in fungal disease resistance.
  • Various methods of spraying compositions on plants or plant parts can be used to topically apply to a plant surface a composition comprising a polynucleotide that comprises a transfer agent. In the field, a composition can be applied with a boom that extends over the crops and delivers the composition to the surface of the plants or with a boomless sprayer that distributes a composition across a wide area. Agricultural sprayers adapted for directional, broadcast, or banded spraying can also be used in certain embodiments. Sprayers adapted for spraying particular parts of plants including, but not limited to, leaves, the undersides of leaves, flowers, stems, male reproductive organs such as tassels, meristems, pollen, ovules, and the like can also be used. Compositions can also be delivered aerially, such as by a crop dusting airplane. In certain embodiments, the spray can be delivered with a pressurized backpack sprayer calibrated to deliver the appropriate rate of the composition. In certain embodiments, such a backpack sprayer is a carbon dioxide pressurized sprayer with a 11015 flat fan or equivalent spray nozzle with a customized single nozzle assembly (to minimize waste) at a spray pressure of about 0.25 MPa and/or any single nozzle sprayer providing an effective spray swath of 60 cm above the canopy of 3 to 12 inch tall growing plants can be used. Plants in a greenhouse or growth chamber can be treated using a track sprayer or laboratory sprayer with a 11001XR or equivalent spray nozzle to deliver the sample solution at a determined rate. In some embodiments, a non-limiting rate is about 140 L/ha at about 0.25 MPa pressure.
  • In certain embodiments, it is also contemplated that a plant part can be sprayed with the composition comprising a polynucleotide that comprises a transfer agent. Such plant parts can be sprayed either pre- or post-harvest to provide for an improvement in fungal disease resistance in the plant part that results from suppression of BI-1 gene expression. Compositions can be topically applied to plant parts attached to a plant by a spray as previously described. Compositions can be topically applied to plant parts that are detached from a plant by a spray as previously described or by an alternative method. Alternative methods for applying compositions to detached parts include, but are not limited to, passing the plant parts through a spray by a conveyor belt or trough, or immersing the plant parts in the composition.
  • Compositions comprising polynucleotides and transfer agents can be applied to plants or plant parts at one or more developmental stages as desired and/or as needed. Application of compositions to pre-germination seeds and/or to post-germination seedlings is provided in certain embodiments. Seeds can be treated with polynucleotide compositions provided herein by methods including, but not limited to, spraying, immersion, or any process that provides for coating, imbibition, and/or uptake of the polynucleotide composition by the seed. Seeds can be treated with polynucleotide compositions using seed batch treatment systems or continuous flow treatment systems. Seed coating systems are at least described in U.S. Pat. Nos. 6,582,516, 5,891,246, 4,079,696, and 4,023,525. Seed treatment can also be effected in laboratory or commercial scale treatment equipment such as a tumbler, a mixer, or a pan granulator. A polynucleotide composition used to treat seeds can contain one or more other desirable components including, but not limited to liquid diluents, binders to serve as a matrix for the polynucleotide, fillers for protecting the seeds during stress conditions, and plasticizers to improve flexibility, adhesion and/or spreadability of the coating. In addition, for oily polynucleotide compositions containing little or no filler, drying agents such as calcium carbonate, kaolin or bentonite clay, perlite, diatomaceous earth or any other adsorbent material can be added. Use of such components in seed treatments is described in U.S. Pat. No. 5,876,739. Additional ingredients can be incorporated into the polynucleotide compositions used in seed treatments. Such ingredients include but are not limited to: conventional sticking agents, dispersing agents such as methylcellulose (Methocel A15LV or Methocel A15C, for example, serve as combined dispersant/sticking agents for use in seed treatments), polyvinyl alcohol (e.g., Elvanol 51-05), lecithin (e.g., Yelkinol P), polymeric dispersants (e.g., polyvinylpyrrolidone/vinyl acetate PVPNA S-630), thickeners (e.g., clay thickeners such as Van Gel B to improve viscosity and reduce settling of particle suspensions), emulsion stabilizers, surfactants, antifreeze compounds (e.g., urea), dyes, colorants, and the like that can be combined with compositions comprising a polynucleotide and a transfer agent. Further ingredients used in compositions that can be applied to seeds can be found in McCutcheon's, vol. 1, “Emulsifiers and Detergents,” MC Publishing Company, Glen Rock, N.J., U.S.A., 1996 and in McCutcheon's, vol. 2, “Functional Materials,” MC Publishing Company, Glen Rock, N.J., U.S.A., 1996. Methods of applying compositions to seeds and pesticidal compositions that can be used to treat seeds are described in US patent application publication 20080092256, which is incorporated herein by reference in its entirety.
  • Application of the compositions in early, mid-, and late vegetative stages of plant development is provided in certain embodiments. Application of the compositions in early, mid-, and late reproductive stages is also provided in certain embodiments. Application of the compositions to plant parts at different stages of maturation is also provided.
  • The following examples are included to demonstrate certain embodiments. Those of skill in the art should, in light of the present disclosure, appreciate that many changes can be made in the specific embodiments that are disclosed and still obtain a like or similar result without departing from the spirit and scope of the invention.
    • EXAMPLES Example 1. BI-1 Target Gene Sequences
  • Target BI-1 genes at least occur in the genome of plants provided in Table 2. The BI-1 genes and provided in Table 2 or their corresponding transcripts, can be used as targets of polynucleotide compositions comprising a polynucleotide that of at least 18 contiguous nucleotides that are essentially identical or essentially complementary to those genes or transcripts. The genes and proteins provided in Table 2, or sequences contained within those genes provided herewith in Example 5 can also be used to obtain orthologous BI-1 genes from plants not listed in Table 2. Such orthologous genes and their transcripts can then serve as targets of polynucleotides provided herein or as a source of polynucleotides that are specifically designed to target the orthologous genes or transcripts.
  • TABLE 2
    BAX inhibitor 1 (BI-1) sequences from various plants that are
    useful targets for topical suppression to control fungal pathogens.
    SEQ ID NO: 1 Arabidopsis thaliana Arabidopsis BI-1 protein
    SEQ ID NO: 2 Arabidopsis thaliana Arabidopsis BI-1 gene
    SEQ ID NO: 3 Lactuca sativa Lettuce BI-1 protein
    SEQ ID NO: 4 Lactuca sativa Lettuce BI-1 gene
    SEQ ID NO: 5 Solanum lycopersicum Tomato BI-1 protein
    SEQ ID NO: 6 Solanum lycopersicum Tomato BI-1 gene
    SEQ ID NO: 7 Vitis vinifera Grape BI-1 protein
    SEQ ID NO: 8 Vitis vinifera Grape BI-1 gene
    SEQ ID NO: 9 Capsicum annuum Pepper BI-1 protein
    SEQ ID NO: 10 Capsicum annuum Pepper BI-1 gene
    SEQ ID NO: 11 Glycine max Soybean BI-1 protein
    SEQ ID NO: 12 Glycine max Soybean BI-1 gene
    SEQ ID NO: 13 Sorghum bicolor Sorghum BI-1 protein
    SEQ ID NO: 14 Sorghum bicolor Sorghum BI-1 gene
    SEQ ID NO: 15 Zea mays Corn BI-1 protein
    SEQ ID NO: 16 Zea mays Corn BI-1 gene
    SEQ ID NO: 17 Triticum aestivum Wheat BI-1 protein
    SEQ ID NO: 18 Triticum aestivum Wheat BI-1 gene
    SEQ ID NO: 19 Triticum aestivum Wheat BI-1 protein
    SEQ ID NO: 20 Triticum aestivum Wheat BI-1 gene
    SEQ ID NO: 21 Glycine max Soybean BI-2 protein
    SEQ ID NO: 22 Glycine max Soybean BI-2 gene
    SEQ ID NO: 23 Hordeum vulgare Barley BI-1 protein
    SEQ ID NO: 24 Hordeum vulgare Barley BI-1 gene
    SEQ ID NO: 25 Oryza sativa subsp. Rice BI-1 protein
    Japonica
    SEQ ID NO: 26 Oryza sativa subsp. Rice BI-1 gene
    Japonica
    SEQ ID NO: 27 Cucumis sativus BI-1 protein
    SEQ ID NO: 28 Cucumis sativus BI-1 gene
    SEQ ID NO: 29 Cucumis sativus Cucumber BI-1 protein
    SEQ ID NO: 30 Cucumis sativus Cucumber BI-1 gene
    SEQ ID NO: 31 Gossypium hirsutum Cotton BI-1 protein
    SEQ ID NO: 32 Gossypium hirsutum Cotton BI-1 gene
  • Table 2 contains the target BI-1 DNA sequences from the indicated plant species. For each gene having a DNA sequence provided in Table 2, polynucleotides such as single stranded or double stranded DNA or RNA fragments in sense and/or antisense orientation will be mixed with an organosilicone preparation. These compositions will be topically applied to plants to effect expression of the target genes in the specified plant to obtain the plants that exhibit disease resistance. In particular, plants that are resistant to powdery mildew, downy mildew, rust and/or other fungal infections will be obtained through the application of such compositions.
    • Example 2. Identification of Orthologous BI-1 Genes
  • The sequences disclosed in SEQ ID NO: 1 through 32, along with the phylogenetic method for functional assignment described above, can be used to efficiently identify and clone BI-1 homologs useful for the control on pathogens causing powdery mildews, downy mildews or rusts, from other plant species not explicitly described here.
    • Example 3. Polynucleotides that can be Used to Reduce BI-1 Expression in Various Plants
  • Examples of polynucleotides that can be used to reduce expression of BI-1 genes in various plants is provided herewith as SEQ ID NOS: 33-106, 109-140, and 142-146. Other regions of BI-1 genes can also be targeted to modify expression including the use of antisense DNA oligonucleotides against coding regions and/or targeting promoter regions using sense/antisense dsRNA, sense or antisense ssDNA as well as sense/antisense double stranded DNA. For example, a polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32 can be used to downregulate expression of those BI-1 genes.
    • Example 4. Topical Oligonucleotide Application and Powdery Mildew Testing Methods
  • Barley seeds are planted in 2 inch pots in the greenhouse. Five days later, barley seedlings are sprayed with polynucleotides such as ssDNA and/or dsRNA oligos directed to the promoter and/or targeting the coding region of a target gene of interest. The nucleotide solution applied consists of 6-20 nm of each ssDNA oligonucleotide or 0.5-4 nm dsRNA, 0.1 to 0.3% L77 silwet, 50 mM NaPO4 in a final volume of 40 microliters of water. Two to 4 days post spraying, seedlings will be infected with dry spores of barley powdery mildew (Blumeria graminis f. sp. hordei) and 7 days post infection, disease development is scored for the percentage of leaf area covered with powdery mildew.
  • Cucumber seeds are planted in a 3-inch square pot and thinned to one plant per pot after emergence. When the first true leaf is fully expanded and the second leaf is opening, a polynucleotide solution such as ssDNA and/or dsRNA oligos directed to the promoter and/or targeting the coding region of a target gene of interest is applied to the first true leaf or the cotyledons. The nucleotide solution applied consists of 6-20 nm of each ssDNA oligonucleotide or 0.5-4 nm dsRNA, 0.1 to 0.3% L77 Silwet, 50 mM NaPO4 in a final volume of 40 microliters of water. Two days later the entire cucumber plant is inoculated with a shower of dry spores of cucumber powdery mildew (Sphaerotheca fuliginea) shaken off diseased plants. Disease severity will be evaluated on the treated leaf and succeeding leaves 10 days later and at subsequent intervals.
  • Tomato seeds are planted in a 3-inch square pot and thinned to one plant per pot after emergence. Two weeks old tomato seedlings are treated with 6-20 nm of each ssDNA oligonucleotide or 0.5-4 nm dsRNA, 0.2-0.5% L77 silwet, 50 mM NaPO4, 1% ammonium sulfate in a final volume of 30 microliters of water. Two to 4 days post spraying plants are innoculated with dry spores of tomato powdery mildew (Oidium neolycopersici) and 13 days post infection, disease development is scored for the percentage of leaf area covered with powdery mildew.
    • Example 5. Control of Powdery Mildew with Oligonucleotide Applications
  • Barley plants were treated with control and oligonucleotide containing solutions essentially as indicated in Example 4. More specifically, Barley seeds (Perry variety) are planted about ¼″ into soil in 2 inch pots in the growth chamber and grown at 25° C. with a 16 hr light cycle in 50% humidity. Before polynucleotide application the plants are randomized. Application of polynucleotides (either ssDNA oligos and/or dsRNA) is performed by pipet application where 5 μL of solution containing nucleotides is applied to both sides of the first leaf. The nucleotide solution applied consists of ˜3-15 nm of each ssDNA oligonucleotide or ˜0.5-1 nm dsRNA, 0.1-0.3% Silwet L-77, 5 mM NaPO4, and 1% AMS in Gibco ultra pure water. Two days post treatment seedlings are infected with barley powdery mildew (Blumeria graminis f. sp. hordei). The growth chamber settings for the infection are as follows: 23° C., with a 12 hr light cycle in 70% humidity. At seven days post infection disease severity is scored for the percentage of leaf area covered with powdery mildew.
  • Data is analyzed using Anova Single Factor Analysis (α=0.1). The ½ LSD is calculated and custom error bars created for the bar graphs. Percent disease reduction is compared to formulation blank and nucleic acid control
  • Experiments were conducted using pools of polynucleotides from the following Table 3.
  • TABLE 3
    Polynucleotides
    Se- Se- SEQ
    quence quence ID
    Type name Sequence Length NO:
    anti-  T5895 TCAGGGCAATGTGTAGGTAAGCACC  25  93
    sense
    DNA
    anti-  T5896 AGCATTGTCAGCATCCCGCCGATGT  25  94
    sense
    DNA
    anti-  T5897 TTCCAGGAGGGCTGCACCCATCAGC  25  95
    sense
    DNA
    anti-  T5898 CAATCAGAGGTCCAACCGAAGCCCC  25  96
    sense
    DNA
    anti-  T5899 CTTGGGTCAAAGTCTATGGCAAGCT  25  97
    sense
    DNA
    anti-  T5900 TCCGACAAACCCTGTCACGAGGATG  25  98
    sense
    DNA
    anti-  T5901 AGAAGCACCCAAAGGCGATGGCGGT  25  99
    sense
    DNA
    anti-  T5902 CGCTTGGCGATGATGGCGGCGCCAG  25 100
    sense
    DNA
    anti-  T5903 GCCACCGAGGTACAGGTACTCCCTG  25 101
    sense
    DNA
    anti-  T5904 GGATCGACAGGCCAGACGAGAGCA  25 102
    sense G
    DNA
    anti-  T5905 GACGTGACAAACTGCAGCCAGAGCA  25 103
    sense
    DNA
    anti-  T5906 GCTGCCAGAGGAGTGGCCAAAGATG  25 104
    sense
    DNA
    anti-  T5907 GGCCAAAGTAAACCTCAAACATGAA  25 105
    sense
    DNA
    anti-  T5908 ACCATGTACCCCAGGAAGATCAACA  25 106
    sense
    DNA
    anti-  T4211 GGGGTGCTGGAGAGGCCCAGGTGG  24 107
    sense
    DNA
    sense T4211_S CCACCTGGGCCTCTCCAGCACCCC  24 108
    anti- T5909 CTCGATGATCTCCTGCGTGTCGTAC  25 109
    sense
    DNA
    anti-  T4223A_ GACCCCCTCTTCCTCTTCTTCTTG  24 110
    sense AS
    DNA
    anti-  T4223B_ CGTTCTTGAGCATGATGATGAGGA  24 111
    sense AS
    DNA
    anti- T4223C_ GCAACAAAGTCGGTGAAGAGG  21 112
    sense AS
    DNA
    anti-  T4223D_ GTCAGCATCCCGCCGATGTTCAG  23 113
    sense AS
    DNA
    anti-  T4223E_ CCACGGCAGATGAGGCCAGTGCA  23 114
    sense AS
    DNA
    anti-  T4223F_ TAAACGAGCTTGAGGTGGGACTG  23 115
    sense AS
    DNA
    anti-  T4223G_ AACTGCAGCCAGAGCAGGATCG  22 116
    sense AS
    DNA
    anti-  T4223H_ AGCAGGCCACCGAGGTACAGGT  22 117
    sense AS
    DNA
    anti-  T4223I_ GGCGGCGCCAGAGAAGCACCC  21 118
    sense AS
    DNA
    dsRNA T5942 ATGGACGCCTTCTACTCGACCTCGTC 150 119
    GGCGGCGGCGAGCGGCTGGGGCCA
    CGACTCCCTCAAGAACTTCCGCCAGA
    TCTCCCCCGCCGTGCAGTCCCACCTC
    AAGCTCGTTTACCTGACTCTATGCTTT
    GCACTGGCCTCATCTGCCGTG
    dsRNA T5943 AGGGCGCACCATGGCGACATGGACT 150 120
    ACATCAAGCACGCCCTCACCCTCTTC
    ACCGACTTTGTTGCCGTCCTCGTCCG
    AGTCCTCATCATCATGCTCAAGAACG
    CAGGCGACAAGTCGGAGGACAAGA
    AGAAGAGGAAGAGGGGGTCCTGA
    dsRNA T5944 CGCTTGTGTCGGAACTATCGCCTGGA 150 121
    TGTTCTCGGTGCCAGTCTATGAGGAG
    AGGAAGAGGTTTGGGCTGCTGATGG
    GTGCAGCCCTCCTGGAAGGGGCTTC
    GGTTGGACCTCTGATTGAGCTTGCCA
    TAGACTTTGACCCAAGCATCCT
  • Table 4 provides a summary of the results obtained.
  • TABLE 4
    Powdery Mildew control results
    Anova: Single Factor
    SUMMARY
    Average
    Percent
    Oligos Disease
    Groups in pool Count Sum Area Variance
    Non Treated 10 256 25.6 480.2667
    Blank 10 321 32.1 405.2111
    MLO_T42111 SEQ ID NO: 10 6 0.6 0.266667
    107
    BI1_T5895-98 SEQ ID NO: 10 14 1.4 1.6
    93, 94,
    95, 96
    BI1_T5899-02 SEQ ID NO: 10 31 3.1 14.98889
    97, 98,
    99, 100
    BI1_T5903-06 SEQ ID NO: 10 42 4.2 56.17778
    101, 102,
    103, 104
    BI1_T5907-09 SEQ ID NO: 10 78 7.8 52.17778
    105, 106,
    109
    1A positive control oligonucleotide that suppresses the endogenous barley Mildew Resistance Locus O (MLO) gene and provides fungal disease control.
    • Example 6. Topical Oligonucleotide Application and Nematode Testing Methods Application of Oligonucleotides to Seeds for Nematode Control
  • Cucumber seeds are soaked approximately 5-72 hours in nucleotides, either ssDNA and/or dsRNA oligos directed to the promoter and/or the coding region of a target of interest. Optionally, seeds can be soaked in water for a few hours prior to soaking in oligonucleotide solution. Soaking solution consists of 20 nm of each ssDNA nucleotide or 0.03-1 nm dsRNA, 0.1% silwet L77, 50 mM NaPO4 in a final volume 200 uL in water. The radicals of the cucumber seeds emerge within 72 hours, after which the seeds are placed on germination paper until root length is approximately 2 inches. Seedlings are transplanted to sand vials for RKN inoculation 24 hours later. Ten mL dry sand is added to each vial and seedlings are planted by tilting the vial and laying the seedling in the correct orientation so that the cotyledons are just above the sand and then tilting back to cover the radicals with sand. 3.3 ml water is added to each vial and the vials placed in racks under fluorescent light banks. 500 vermiform eggs or 300 J2 RKN are inoculated in each tube in 50 uL of deionized or spring water. Harvest of the cucumber plants is performed 10 to 12 days after inoculation by washing sand off the roots. A root gall rating and visual phytotoxicity rating is assigned using the following scales: Gall rating scale (Gall: % root mass galled): 0=0-5%; 1=6-20%; 2=21-50%; and 3=51-100%. The average of the triplicate gall rating is then calculated: no galls=0.00-0.33; mild galling=0.67-1.33; moderate galling=1.67-2.33; severe galling=2.67-3.00. Visual phytotoxicity scale is also assigned (Vis. tox; visual reduction in root mass compared to the control): rs1=mild stunting; rs2=moderate stunting; rs3=severe stunting.
  • Experiments in soybeans using soy cyst nematodes (SCN) are similar to RKN assays except for the following changes. After 5-72 hours of soaking soybean seeds are planted in 100% sand in two inch square plastic pots. Optionally, seeds are soaked in water for a few hours prior to soaking in oligonucleotide solution. Seven days after planting the soybean seed, the nematode soybean cyst nematode (SCN) inoculum (1000 vermiform eggs or 1000 J2s) are applied to the pot. Watering of the test plants is then restricted to only water as needed to prevent wilt for a period of 24 hours. After the 24 hour restricted watering, normal sub-irrigation watering is done for the duration of the test. Twenty eight days after inoculation the test is harvested and cysts counted.
  • Experiments in corn using lesion nematodes are similar to above except for the following changes. After 5-72 hours of soaking, corn seeds are planted in a sand:Turface mix 2:1 in 4 inch deep pots (Turface™ MVP, Profile Products, LLC., Buffalo Grove, Ill.). Optionally, seeds are soaked in water for a few hours prior to soaking in oligonucleotide solution. Inoculum of 2 gm of roots P. scribneri infested corn roots are applied to seedings and removed from the pot after 7 days. Watering of the test plants is then restricted to only water as needed to prevent wilt for a period of 24 hours after inoculation. After the 24 hour restricted watering, normal sub-irrigation watering as needed is done for the duration of the test. 12-14 days post inoculation, plants are harvested and nematodes extracted for 6 days from the cut up roots in a mist tent.
  • RKN and SCN J2s are prepared from hatchbowls using the following solutions: RKN solution: 1 L aerated tap water, 1 ml of 50 mg/ml kanamycin, 0.5 ml of 20 mg/ml imazalil sulfate; SCN solution: 1 L aerated tap water, 1 ml of 50 mg/ml kanamycin, 0.5 ml of 20 mg/ml imazalil sulfate, 1430 mg zinc sulfate.
  • Hatchbowls are autoclaved 6 oz bowls, lined with screen mesh and paper filter. Approximately 20 ml of appropriate hatch solution is poured into each bowl. Eggs are then place in the bowls and covered with foil. The bowls are then placed in a 25° C. incubator overnight. The next day the hatched J2's are extracted, additional solution added as needed and replaced in the incubator. Each bowl is used for 2 weeks and then disposed.
    • Example 7. Protection of Soybean from Soy Cyst Nematode (SCN)
  • Soybean cotyledons of the variety W82 were treated with the treatments indicated in Table 5 by topical application of the oligonucleotide solution in 5 mM NaPO4, 1% Ammonium Sulfate, and 0.20% Silwet™ (wt percent). Approximately 50 μl of solution containing the ssDNA oligonucleotides of Table 6, in pools of 4 ssDNAs/pool, was applied to each cotyledon of the plants and 4 plants were subjected to each treatment. One day following treatment, the plants were infected with approximately 1000 vermiform eggs of Soy Cyst Nematode applied directly to the pot. Twenty eight days after inoculation the root weights and cyst counts were recorded. ANOVA analysis for cyst count is provided in Table 8 and root weight is in Table 10. FIG. 1 shows the bar chart for cyst count and root weight.
  • TABLE 5
    Treatments
    Treatment # Description Oligo Final Conc.
    1 Bi1-1 pool 1 AS coding 80 nmol/4 × 10 μL
    2 Bi1-1 pool 2 AS coding 80 nmol/4 × 10 μL
    3 Bi1-1 pool 3 AS coding 80 nmol/4 × 10 μL
    4 Bi 1-2 pool 4 AS coding 80 nmol/4 × 10 μL
    5 Bi1-2 pool 5 AS coding 80 nmol/4 × 10 μL
    6 GFP AS control 80 nmol/4 × 10 μL
    7 Mock treated no Silwet L-77
    8 Formulation
  • TABLE 6
    Oligonucleotides used
    SEQ
    ID Pool
    NO Sequence Maps to ID
    122 TTGAATCGAAGAAGGAATTGAAGGAGTCCAT Soybean 1
    Bil-1
    SEQ ID
    NO 12
    123 AGGTAAGCCCCAACAGCCGCAGCAACCA Soybean 1
    Bil-1
    SEQ ID
    NO 12
    124 CTCTTTTCCTCTCTTCAAAAGGAGGTGTC Soybean 1
    Bil-1
    SEQ ID
    NO 12
    125 TGCACTAAAGATAAGGCTTGGATCGAT Soybean 1
    Bil-1
    SEQ ID
    NO 12
    126 ATCCAGAAGAAACCAAGCCACCAAGGT Soybean 2
    Bil-1
    SEQ ID
    NO 12
    127 CCTACAAACACCAAAAGCCCAAAGTAC Soybean 2
    Bil-1
    SEQ ID
    NO 12
    128 ACTGCAACCAAATCGGTAAACAAGGTCAA Soybean 2
    Bil-1
    SEQ ID
    NO 12
    129 TCAATCTCTCCTCTTCTTTTTCTTC Soybean 2
    Bil-1
    SEQ ID
    NO 12
    130 TCAAGGGACCAACGAAGGCTAATTTCG Soybean 3
    Bil-1
    SEQ ID
    NO 12
    131 GGCTTTGAATTTCAACACCCCTAATT Soybean 3
    Bil-1
    SEQ ID
    NO 12
    132 GCTTGCAATCGGAGAAACACAAATTT Soybean 3
    Bil-1
    SEQ ID
    NO 12
    133 ATGGGGACTTGAAGAAAGTGTCCAT Soybean 4
    Bil-2
    SEQ ID
    NO 22
    134 TAAAATAAACCAGTTTGATGTGATTCTG Soybean 4
    Bil-2
    SEQ ID
    NO 22
    135 TGCTCCCAATGGAAGCCACCGTGGTGA Soybean 4
    Bil-2
    SEQ ID
    NO 22
    136 AATCAGAGGTCCAATGGAAGCACCCTGA Soybean 4
    Bil-2
    SEQ ID
    NO 22
    137 GCCTTGCAACTAAGGCTACTGCAGAAAA Soybean 5
    Bil-2
    SEQ ID
    NO 22
    138 AGAGCTATAGAGCCCCCAAAGAGAGAGG Soybean 5
    Bil-2
    SEQ ID
    NO 22
    139 TCCAGGTCACCAAAGTGAGCCCTCTCA Soybean 5
    Bil-2
    SEQ ID
    NO 22
    140 CTTCTCATTTCTCTTAGATGAATTATT Soybean 5
    Bil-2
    SEQ ID
    NO 22
    141 GTTGTAGTTGTACTCCATCTTATTG GFP
    Control
  • TABLE 7
    Cyst counts
    trt# rep1 rep2 rep3 rep4 avg
    1 143.0 109.0 90.0 111.0 113.3
    2 42.0 46.0 44.0 31.0 40.8
    3 78.0 197.0 193.0 101.0 142.3
    4 138.0 75.0 80.0 51.0 86.0
    5 141.0 136.0 92.0 107.0 119.0
    6 72.0 67.0 75.0 95.0 77.3
    7 83.0 128.0 52.0 103.0 91.5
    8 179.0 122.0 165.0 184.0 162.5
  • TABLE 8
    ANOVA Single Factor analysis of Cyst counts
    Anova: Single Factor
    SUMMARY
    Groups Count Sum Average Variance
    Row
    1 4 453 113.25 482.9167
    Row 2 4 163 40.75 44.91667
    Row 3 4 569 142.25 3800.917
    Row 4 4 344 86 1362
    Row 5 4 476 119 548.6667
    Row 6 4 309 77.25 150.9167
    Row 7 4 366 91.5 1032.333
    Row 8 4 650 162.5 793.6667
    ANOVA
    Source
    of Var-
    iation SS df MS F P-value F crit
    Be- 41568.88 7 5938.411 5.782054 0.000521 2.422629
    tween
    Groups
    Within 24649 24 1027.042
    Groups
    Total 66217.88 31
    std of 22.6 df = 1.711
    diff
    lsd 38.8
    ½ lsd 19.4
  • TABLE 9
    Root Weight
    trt# rep1 rep2 rep3 rep4 avg
    1 16.0 18.4 14.8 18.8 17.0
    2 13.5 16.7 18.6 4.0 13.2
    3 5.6 15.1 11.7 10.5 10.7
    4 14.8 14.1 12.6 12.4 13.5
    5 12.9 13.1 14.1 12.4 13.1
    6 15.8 17.0 19.8 16.9 17.4
    7 15.6 15.1 14.0 11.5 14.1
    8 14.2 16.2 17.2 14.8 15.6
  • TABLE 10
    ANOVA analysis of root weight
    Anova: Single Factor
    SUMMARY
    Treatment Count Sum Average Variance
    1 4 68 17 3.68
    2 4 52.8 13.2 42.04667
    3 4 42.9 10.725 15.46917
    4 4 53.9 13.475 1.355833
    5 4 52.5 13.125 0.509167
    6 4 69.5 17.375 2.909167
    7 4 56.2 14.05 3.336667
    8 4 62.4 15.6 1.84
    ANOVA
    Source
    of Var-
    iation SS df MS F P-value F crit
    Be- 138.1888 7 19.74125 2.219781 0.068719 2.422629
    tween
    Treatm.
    Within 213.44 24 8.893333
    Treat-
    ment
    Total 351.6288 31
    std of 2.1 df = 1.711
    diff
    lsd 3.6
    ½ lsd 1.8
    • Example 8. Protection of Cucumber from Root Knot Nematode (RKN)
  • Cucumber seed were soaked for 72 hr in dsRNA polynucleotide solution directed to the coding sequence of soybean Bi-1 gene. Soaking solution consisted of 0.01-1 nm dsRNA, 0.2% Silwet L77, 20 mM NaPO4 in a final volume 200 uL in water as outlined in Table 11. The radicals of the cucumber seeds emerged within 72 hours, after which the seeds were placed on germination paper until root length was approximately 2 inches. Seedlings were transplanted to sand vials for RKN inoculation 24 hours later. Ten mL dry sand was added to each vial and seedlings were planted by tilting the vial and laying the seedling in the correct orientation so that the cotyledons were just above the sand and then tilting back to cover the radicals with sand. 3.3 ml water was added to each vial and the vials placed in racks under fluorescent light banks. 500 vermiform eggs or 300 J2 RKN were inoculated in each tube in 50 uL of deionized or spring water. Harvest of the cucumber plants was performed 10 to 12 days after inoculation by washing sand off the roots.
  • A root gall rating and visual phytotoxicity rating was assigned using the following scales: Gall rating scale (Gall: % root mass galled): 0=0-5%; 1=6-20%; 2=21-50%; and 3=51-100%. The average of the triplicate gall rating was then calculated: no galls=0.00-0.33; mild galling=0.67-1.33; moderate galling=1.67-2.33; severe galling=2.67-3.00. Table 11 summarizes the treatments performed and Table 12 shows the gall rating results. These results are also graphically displayed in FIG. 2.
  • TABLE 11
    Treatments
    SEQ Volume
    Trigger ID Conc of each
    Treatment# type Trigger NOs (nmol/μL) dsRNA
    1 dsRNA Bi-1 142 0.0172 0.70
    0.06 nmol 143 0.022 0.55
    (0.012 nmol 144 0.0148 0.81
    each) 145 0.0195 0.62
    146 0.0216 0.56
    2 dsRNA Bi-1 142 0.0172 1.74
    0.15 nmol 143 0.022 1.36
    (0.03 nmol 144 0.0148 2.03
    each) 145 0.0195 1.54
    146 0.0216 1.39
    3 dsRNA GFP 147 0.0157 3.82
    control
    0.06 nmol
    4 dsRNA GFP 147 0.0157 9.55
    control
    0.15 nmol
    5 Mock, no
    Silwet
    6 Formulation
  • TABLE 12
    RKN Assay Results
    Treatment
    No. Treatment Score % AVG St Dev
    1 Bax1 dsRNA 15 25 10 10 15 7.071067812
    coding
    .06 nmol
    (.012 nmol
    each)
    2 Bax1 dsRNA 10 40 5 20 18.76 15.47847968
    coding
    .15 nmol
    (0.03 nmol
    each)
    3 GFP dsRNA 15 40 50 20 31.25 16.52
    control
    .06 nmol
    4 GFP dsRNA 50 65 57.50 10.61
    control
    .15 nmol
    5 Mock no 25 50 40 40 38.75 10.31
    silwet
    6 Formulation 50 30 70 30 45 19.15

Claims (26)

1. A method for producing a plant exhibiting an improvement in fungal disease resistance comprising topically applying to a plant surface a composition that comprises:
(a) at least one polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or to a transcript of said gene, wherein said polynucleotide is not operably linked to a promoter or a viral vector and wherein said polynucleotide is not integrated into the plant chromosome; and,
(b) a transfer agent, wherein said plant exhibits an improvement in fungal disease resistance that results from suppression of said BAX inhibitor 1 (BI-1) gene.
2. The method of claim 1, wherein said polynucleotide molecule comprises sense ssDNA, sense ssRNA, dsRNA, dsDNA, a double stranded DNA/RNA hybrid, anti-sense ssDNA, or anti-sense ssRNA.
3. The method of claim 1, wherein said polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
4. The method of claim 3, wherein:
(a) said plant is a barley plant, said gene or said transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
(b) said plant is a rice plant, said gene or said transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
(c) said plant is a wheat plant, said gene or said transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20;
(d) said plant is a soybean plant, said gene or said transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22;
(e) said plant is a corn plant, said gene or said transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16;
(f) said plant is a sorghum plant, said gene or said transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14;
(g) said plant is a pepper plant, said gene or said transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10;
(h) said plant is a grape plant, said gene or said transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8;
(i) said plant is a tomato plant, said gene or said transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6;
(j) said plant is a lettuce plant, said gene or said transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4;
(k) said plant is a cucumber plant, said gene or said transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or
(l) said plant is a cotton plant, said gene or said transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32.
5. The method of claim 1, wherein said composition comprises any combination of two or more polynucleotide molecules.
6. The method of claim 1, wherein said polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length.
7. The method of claim 1, wherein said composition further comprises a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, a polynucleotide that suppresses an herbicide target gene, an insecticide, a fungicide, a nematocide, or a combination thereof.
8. The method of claim 1, wherein said composition further comprises a non-polynucleotide herbicidal molecule and said plant is resistant to said herbicidal molecule.
9. The method of claim 1, wherein said transfer agent comprises an organosilicone preparation.
10-18. (canceled)
19. A composition comprising a polynucleotide molecule that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of said gene, wherein said polynucleotide is not operably linked to a promoter; and, b) a transfer agent.
20. The composition of claim 19, wherein said polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
21. The composition of claim 19, wherein:
a) said gene or said transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
(b) said gene or said transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
(c) said gene or said transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20;
(d) said gene or said transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22;
(e) said gene or said transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16;
(f) said gene or said transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14;
(g) said gene or said transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10;
(h) said gene or said transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8;
(i) said gene or said transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6;
(j) said gene or said transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4;
(k) said gene or said transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or
(l) said gene or said transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32.
22. The composition of claim 19, wherein said polynucleotide is at least 18 to about 24, about 25 to about 50, about 51 to about 100, about 101 to about 300, about 301 to about 500, or at least about 500 or more residues in length.
23. The composition of claim 19, wherein said composition further comprises a non-polynucleotide herbicidal molecule, a polynucleotide herbicidal molecule, a polynucleotide that suppresses an herbicide target gene, an insecticide, a fungicide, a nematocide, or a combination thereof.
24. The composition of claim 19, wherein said transfer agent is an organosilicone preparation
25. The composition of claim 19, wherein said polynucleotide is not physically bound to a biolistic particle.
26. A plant comprising an exogenous polynucleotide that comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a BAX inhibitor 1 (BI-1) gene or transcript of said gene, wherein said exogenous polynucleotide is not operably linked to a promoter or to a viral vector, is not integrated into the chromosomal DNA of the plant, and is not found in a non-transgenic plant; and, wherein said plant exhibits an improvement in fungal disease resistance that results from suppression of the BAX inhibitor 1 (BI-1) gene.
27. The plant of claim 26, wherein said plant further comprises an organosilicone compound or a component thereof.
28. The plant of claim 26, wherein said polynucleotide is selected from the group consisting of SEQ ID NO: 33-106, 109-140, and 142-146, or wherein said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32.
29. The plant of claim 26, wherein:
a) said plant is a barley plant, said gene or said transcript is a barley BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 73-76, 93-106, 109-120, and 121, and 121, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO:24;
(b) said plant is a rice plant, said gene or said transcript is a rice BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 77-79, and 80, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 26;
(c) said plant is a wheat plant, said gene or said transcript is a wheat BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:61-67, and 68, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to a wheat gene or transcript that encodes SEQ ID NO:18 or 20;
(d) said plant is a soybean plant, said gene or said transcript is a soybean BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 49-52, 69-72, and 122-140, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 12 or 22;
(e) said plant is a corn plant, said gene or said transcript is a corn BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:57-59, and 60, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 16;
(f) said plant is a sorghum plant, said gene or said transcript is a sorghum BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 53-55, and 56, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 14;
(g) said plant is a pepper plant, said gene or said transcript is a pepper BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO: 45-47, and 48, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 10;
(h) said plant is a grape plant, said gene or said transcript is a grape BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:41-43, and 44, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 8;
(i) said plant is a tomato plant, said gene or said transcript is a tomato BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:37-39, and 40, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 6;
(j) said plant is a lettuce plant, said gene or said transcript is a lettuce BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:33-35, and 36, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 4;
(k) said plant is a cucumber plant, said gene or said transcript is a cucumber BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:81-88, and 142-146, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 28 or 30; or
(l) said plant is a cotton plant, said gene or said transcript is a cotton BAX inhibitor 1 (BI-1) gene or transcript, and said polynucleotide molecule is selected from the group consisting of SEQ ID NO:89-91, and 92, or said polynucleotide comprises at least 18 contiguous nucleotides that are essentially identical or essentially complementary to SEQ ID NO: 32.
30. A progeny plant of said plant of claim 26, wherein said progeny plant exhibits said improvement in fungal disease resistance.
31. A seed of said plant of claim 26, wherein said seed exhibits said improvement in fungal disease resistance.
32. A processed product of said plant of claim 26, wherein said processed product exhibits an improved attribute relative to a processed product of an untreated control plant and wherein said improved attribute results from said fungal disease resistance.
33. A processed product of said progeny plant of claim 30, wherein said processed product exhibits an improved attribute relative to a processed product of an untreated control plant and wherein said improved attribute results from said fungal disease resistance.
34. A processed product of said seed of claim 31, wherein said processed product exhibits an improved attribute relative to a processed product of an untreated control plant and wherein said improved attribute results from said fungal disease resistance.
US16/011,218 2013-01-28 2018-06-18 Methods and Compositions for Plant Pest Control Abandoned US20180346923A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/011,218 US20180346923A1 (en) 2013-01-28 2018-06-18 Methods and Compositions for Plant Pest Control

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361757291P 2013-01-28 2013-01-28
US14/165,097 US10000767B2 (en) 2013-01-28 2014-01-27 Methods and compositions for plant pest control
US16/011,218 US20180346923A1 (en) 2013-01-28 2018-06-18 Methods and Compositions for Plant Pest Control

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14/165,097 Continuation US10000767B2 (en) 2013-01-28 2014-01-27 Methods and compositions for plant pest control

Publications (1)

Publication Number Publication Date
US20180346923A1 true US20180346923A1 (en) 2018-12-06

Family

ID=51224618

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/165,097 Expired - Fee Related US10000767B2 (en) 2013-01-28 2014-01-27 Methods and compositions for plant pest control
US16/011,218 Abandoned US20180346923A1 (en) 2013-01-28 2018-06-18 Methods and Compositions for Plant Pest Control

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/165,097 Expired - Fee Related US10000767B2 (en) 2013-01-28 2014-01-27 Methods and compositions for plant pest control

Country Status (1)

Country Link
US (2) US10000767B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229223A (en) * 2019-06-14 2019-09-13 中国科学院遗传与发育生物学研究所 Wheat anti-powdery mildew correlation BFR albumen and its encoding gene and application

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9840715B1 (en) 2011-09-13 2017-12-12 Monsanto Technology Llc Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
US9920326B1 (en) 2011-09-14 2018-03-20 Monsanto Technology Llc Methods and compositions for increasing invertase activity in plants
EP2908620A4 (en) 2012-10-18 2016-07-27 Monsanto Technology Llc Methods and compositions for plant pest control
US10000767B2 (en) 2013-01-28 2018-06-19 Monsanto Technology Llc Methods and compositions for plant pest control
US20140283211A1 (en) 2013-03-14 2014-09-18 Monsanto Technology Llc Methods and Compositions for Plant Pest Control
CN105979770B (en) * 2014-01-15 2019-07-05 孟山都技术公司 For using the method and composition of the Weeds distribution of EPSPS polynucleotides
NZ728986A (en) * 2014-08-06 2023-12-22 Valagro Spa Method for modulating plant processes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100088777A1 (en) * 2006-10-24 2010-04-08 Basf Plant Science Gmbh Methods For Increasing The Resistance In Plants To Biotropic Fungi

Family Cites Families (284)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
NL154598B (en) 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4079696A (en) 1975-09-22 1978-03-21 Gustafson, Inc. Apparatus for treating seeds with a liquid
US4023525A (en) 1976-08-04 1977-05-17 Gustafson, Inc. Seed treater
US5023243A (en) 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
US4476301A (en) 1982-04-29 1984-10-09 Centre National De La Recherche Scientifique Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon
US4535060A (en) 1983-01-05 1985-08-13 Calgene, Inc. Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthetase, production and use
US5094945A (en) 1983-01-05 1992-03-10 Calgene, Inc. Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase, production and use
US5304732A (en) 1984-03-06 1994-04-19 Mgi Pharma, Inc. Herbicide resistance in plants
US4761373A (en) 1984-03-06 1988-08-02 Molecular Genetics, Inc. Herbicide resistance in plants
US5331107A (en) 1984-03-06 1994-07-19 Mgi Pharma, Inc. Herbicide resistance in plants
US5550111A (en) 1984-07-11 1996-08-27 Temple University-Of The Commonwealth System Of Higher Education Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
US4581847A (en) 1984-09-04 1986-04-15 Molecular Genetics Research And Development Tryptophan overproducer mutants of cereal crops
DE3587548T2 (en) 1984-12-28 1993-12-23 Plant Genetic Systems Nv Recombinant DNA that can be introduced into plant cells.
US5185444A (en) 1985-03-15 1993-02-09 Anti-Gene Deveopment Group Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
US5166315A (en) 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5405938A (en) 1989-12-20 1995-04-11 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4940835A (en) 1985-10-29 1990-07-10 Monsanto Company Glyphosate-resistant plants
JP2615013B2 (en) 1985-08-07 1997-05-28 モンサント コンパニ− Glyphosate resistant chimeric gene
US4810648A (en) 1986-01-08 1989-03-07 Rhone Poulenc Agrochimie Haloarylnitrile degrading gene, its use, and cells containing the gene
ES2018274T5 (en) 1986-03-11 1996-12-16 Plant Genetic Systems Nv VEGETABLE CELLS RESISTANT TO GLUTAMINE SYNTHETASE INHIBITORS, PREPARED BY GENETIC ENGINEERING.
US5188958A (en) 1986-05-29 1993-02-23 Calgene, Inc. Transformation and foreign gene expression in brassica species
US5273894A (en) 1986-08-23 1993-12-28 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5605011A (en) 1986-08-26 1997-02-25 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5378824A (en) 1986-08-26 1995-01-03 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5013659A (en) 1987-07-27 1991-05-07 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5004863B2 (en) 1986-12-03 2000-10-17 Agracetus Genetic engineering of cotton plants and lines
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US4971908A (en) 1987-05-26 1990-11-20 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase
US5145783A (en) 1987-05-26 1992-09-08 Monsanto Company Glyphosate-tolerant 5-endolpyruvyl-3-phosphoshikimate synthase
US5312910A (en) 1987-05-26 1994-05-17 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase
US4924624A (en) 1987-10-22 1990-05-15 Temple University-Of The Commonwealth System Of Higher Education 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
US5188897A (en) 1987-10-22 1993-02-23 Temple University Of The Commonwealth System Of Higher Education Encapsulated 2',5'-phosphorothioate oligoadenylates
US5922602A (en) 1988-02-26 1999-07-13 Biosource Technologies, Inc. Cytoplasmic inhibition of gene expression
EP0406309A4 (en) 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
US5278302A (en) 1988-05-26 1994-01-11 University Patents, Inc. Polynucleotide phosphorodithioates
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5258300A (en) 1988-06-09 1993-11-02 Molecular Genetics Research And Development Limited Partnership Method of inducing lysine overproduction in plants
US5416011A (en) 1988-07-22 1995-05-16 Monsanto Company Method for soybean transformation and regeneration
GB8825402D0 (en) 1988-10-31 1988-11-30 Cambridge Advanced Tech Sulfonamide resistance genes
US5310667A (en) 1989-07-17 1994-05-10 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases
US5550318A (en) 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US7705215B1 (en) 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5399676A (en) 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
US5264564A (en) 1989-10-24 1993-11-23 Gilead Sciences Oligonucleotide analogs with novel linkages
US5264562A (en) 1989-10-24 1993-11-23 Gilead Sciences, Inc. Oligonucleotide analogs with novel linkages
US5177198A (en) 1989-11-30 1993-01-05 University Of N.C. At Chapel Hill Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
US5587361A (en) 1991-10-15 1996-12-24 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
HU220773B1 (en) 1990-01-22 2002-05-28 Dekalb Genetics Corporation Process for producing productive transgenic maize plants
US5321131A (en) 1990-03-08 1994-06-14 Hybridon, Inc. Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling
US5470967A (en) 1990-04-10 1995-11-28 The Dupont Merck Pharmaceutical Company Oligonucleotide analogs with sulfamate linkages
AU655197B2 (en) 1990-06-25 1994-12-08 Monsanto Technology Llc Glyphosate tolerant plants
US5623070A (en) 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5608046A (en) 1990-07-27 1997-03-04 Isis Pharmaceuticals, Inc. Conjugated 4'-desmethyl nucleoside analog compounds
US5541307A (en) 1990-07-27 1996-07-30 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs and solid phase synthesis thereof
US5677437A (en) 1990-07-27 1997-10-14 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5610289A (en) 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5618704A (en) 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
US5489677A (en) 1990-07-27 1996-02-06 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
DK0541722T3 (en) 1990-08-03 1996-04-22 Sterling Winthrop Inc Compounds and Methods for Inhibiting Gene Expression
US5177196A (en) 1990-08-16 1993-01-05 Microprobe Corporation Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
US6403865B1 (en) 1990-08-24 2002-06-11 Syngenta Investment Corp. Method of producing transgenic maize using direct transformation of commercially important genotypes
US5633435A (en) 1990-08-31 1997-05-27 Monsanto Company Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
US5214134A (en) 1990-09-12 1993-05-25 Sterling Winthrop Inc. Process of linking nucleosides with a siloxane bridge
US5561225A (en) 1990-09-19 1996-10-01 Southern Research Institute Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages
CA2092002A1 (en) 1990-09-20 1992-03-21 Mark Matteucci Modified internucleoside linkages
US5866775A (en) 1990-09-28 1999-02-02 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases
US5767366A (en) 1991-02-19 1998-06-16 Louisiana State University Board Of Supervisors, A Governing Body Of Louisiana State University Agricultural And Mechanical College Mutant acetolactate synthase gene from Ararbidopsis thaliana for conferring imidazolinone resistance to crop plants
USRE36449E (en) 1991-03-05 1999-12-14 Rhone-Poulenc Agro Chimeric gene for the transformation of plants
FR2673643B1 (en) 1991-03-05 1993-05-21 Rhone Poulenc Agrochimie TRANSIT PEPTIDE FOR THE INSERTION OF A FOREIGN GENE INTO A PLANT GENE AND PLANTS TRANSFORMED USING THIS PEPTIDE.
FR2673642B1 (en) 1991-03-05 1994-08-12 Rhone Poulenc Agrochimie CHIMERIC GENE COMPRISING A PROMOTER CAPABLE OF GIVING INCREASED TOLERANCE TO GLYPHOSATE.
ES2163400T3 (en) 1991-05-15 2002-02-01 Monsanto Technology Llc METHOD OF CREATING A TRANSFORMED RICE PLANT.
US5731180A (en) 1991-07-31 1998-03-24 American Cyanamid Company Imidazolinone resistant AHAS mutants
US5571799A (en) 1991-08-12 1996-11-05 Basco, Ltd. (2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response
US5593874A (en) 1992-03-19 1997-01-14 Monsanto Company Enhanced expression in plants
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
WO1994000977A1 (en) 1992-07-07 1994-01-20 Japan Tobacco Inc. Method of transforming monocotyledon
EP0606454A1 (en) 1992-07-30 1994-07-20 Keygene N.V. Dna constructs, cells and plants derived therefrom
US5721138A (en) 1992-12-15 1998-02-24 Sandford University Apolipoprotein(A) promoter and regulatory sequence constructs and methods of use
US5476925A (en) 1993-02-01 1995-12-19 Northwestern University Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
US6414222B1 (en) 1993-02-05 2002-07-02 Regents Of The University Of Minnesota Gene combinations for herbicide tolerance in corn
CA2159629A1 (en) 1993-03-31 1994-10-13 Sanofi Oligonucleotides with amide linkages replacing phosphodiester linkages
US6118047A (en) 1993-08-25 2000-09-12 Dekalb Genetic Corporation Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
GB9403941D0 (en) 1994-03-01 1994-04-20 Sandoz Ltd Improvements in or relating to organic compounds
US5625050A (en) 1994-03-31 1997-04-29 Amgen Inc. Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US5939602A (en) 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
JPH10506269A (en) 1994-08-19 1998-06-23 モンサント・カンパニー Delivery of exogenous chemicals to plant tissue
DE4430307A1 (en) 1994-08-26 1996-02-29 Bayer Ag Method and device for the simultaneous dispersion and atomization of at least two liquids
US5631152A (en) 1994-10-26 1997-05-20 Monsanto Company Rapid and efficient regeneration of transgenic plants
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US5853973A (en) 1995-04-20 1998-12-29 American Cyanamid Company Structure based designed herbicide resistant products
PL186091B1 (en) 1995-04-20 2003-10-31 American Cyanamid Co Products resistant to herbicides designed on the basis of structure
FR2734842B1 (en) 1995-06-02 1998-02-27 Rhone Poulenc Agrochimie DNA SEQUENCE OF A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE AND OBTAINING PLANTS CONTAINING A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE, TOLERANT TO CERTAIN HERBICIDES
US6084155A (en) 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
IL122290A0 (en) 1995-06-07 1998-04-05 Inex Pharmaceuticals Corp Lipid-nucleic acid complex its preparation and use
US5876739A (en) 1996-06-13 1999-03-02 Novartis Ag Insecticidal seed coating
EA199800212A1 (en) 1996-06-21 1998-10-29 Монсанто Компани METHODS OF OBTAINING SUSTAINABLE TRANSFORMABLE HIGH-PRODUCTIVE WHEAT BY TRANSFORMATION MEDIATED BY AGROBACTERIUM AND THE COMBINATION OBTAINED BY THEM
FR2751347B1 (en) 1996-07-16 2001-12-07 Rhone Poulenc Agrochimie CHIMERIC GENE WITH MULTIPLE HERBICIDE TOLERANCE GENES, PLANT CELL AND PLANT TOLERANT WITH MULTIPLE HERBICIDES
MY119146A (en) * 1996-08-16 2005-04-30 Monsanto Technology Llc Sequential application method for treating plants with exogenous chemicals
JPH10117776A (en) 1996-10-22 1998-05-12 Japan Tobacco Inc Transformation of indica rice
DE19652284A1 (en) 1996-12-16 1998-06-18 Hoechst Schering Agrevo Gmbh Novel genes encoding amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use
US5981840A (en) 1997-01-24 1999-11-09 Pioneer Hi-Bred International, Inc. Methods for agrobacterium-mediated transformation
GB9703146D0 (en) 1997-02-14 1997-04-02 Innes John Centre Innov Ltd Methods and means for gene silencing in transgenic plants
US6040497A (en) 1997-04-03 2000-03-21 Dekalb Genetics Corporation Glyphosate resistant maize lines
US7022896B1 (en) 1997-04-04 2006-04-04 Board Of Regents Of University Of Nebraska Methods and materials for making and using transgenic dicamba-degrading organisms
US7105724B2 (en) 1997-04-04 2006-09-12 Board Of Regents Of University Of Nebraska Methods and materials for making and using transgenic dicamba-degrading organisms
US5891246A (en) 1997-08-15 1999-04-06 Gustafson, Inc. Seed coating apparatus
US6245968B1 (en) 1997-11-07 2001-06-12 Aventis Cropscience S.A. Mutated hydroxyphenylpyruvate dioxygenase, DNA sequence and isolation of plants which contain such a gene and which are tolerant to herbicides
FR2770854B1 (en) 1997-11-07 2001-11-30 Rhone Poulenc Agrochimie DNA SEQUENCE OF A GENE OF HYDROXY-PHENYL PYRUVATE DIOXYGENASE AND PRODUCTION OF PLANTS CONTAINING SUCH A GENE, HERBICIDE TOLERANT
US6069115A (en) 1997-11-12 2000-05-30 Rhone-Poulenc Agrochimie Method of controlling weeds in transgenic crops
US20090077685A1 (en) 1998-06-16 2009-03-19 Buehler Robert E Nucleic acid molecules and other molecules associated with plants
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
US6421956B1 (en) 1997-12-29 2002-07-23 Van Dok Ijsbrand Method and apparatus for priming seed
US5914451A (en) 1998-04-06 1999-06-22 Monsanto Company Efficiency soybean transformation protocol
US6906245B1 (en) 1998-04-30 2005-06-14 Sumitomo Chemical Company, Limited Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
AR020078A1 (en) 1998-05-26 2002-04-10 Syngenta Participations Ag METHOD FOR CHANGING THE EXPRESSION OF AN OBJECTIVE GENE IN A PLANT CELL
WO1999067284A2 (en) 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
CA2332643A1 (en) 1998-06-22 1999-12-29 Regents Of The University Of Minnesota Dna encoding oat acetyl coa carboxylase
JP2000083680A (en) 1998-07-16 2000-03-28 Nippon Paper Industries Co Ltd Introduction of gene into plant utilizing adventitious bud redifferentiation gene put under control due to photoinduction type promoter as selection marker gene and vector for transduction of gene into plant used therefor
US6121513A (en) 1998-07-20 2000-09-19 Mendel Biotechnology, Inc. Sulfonamide resistance in plants
US6717034B2 (en) 2001-03-30 2004-04-06 Mendel Biotechnology, Inc. Method for modifying plant biomass
AU2037700A (en) 1998-12-03 2000-06-19 E.I. Du Pont De Nemours And Company Plant vitamin e biosynthetic enzymes
EP1141346A2 (en) 1999-01-14 2001-10-10 Monsanto Co. Soybean transformation method
IL128207A (en) 1999-01-24 2005-03-20 Bio Oz Advanced Biotechnologic Multi-barrel plant inoculation gun
WO2000044914A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US6992237B1 (en) 1999-04-16 2006-01-31 Pioneer Hi-Bred International Inc. Regulated expression of genes in plant seeds
CA2378107A1 (en) 1999-07-23 2001-02-01 Wisconsin Alumni Research Foundation <i>arabidopsis thaliana</i> cyclic nucleotide-gated ion channel/<i>dnd</i> genes; regulators of plant disease resistance and cell death
US6713077B1 (en) 1999-07-28 2004-03-30 Monsanto Technology, Llc Control of shoot/foliar feeding pests with pesticide seed treatments
AR025996A1 (en) 1999-10-07 2002-12-26 Valigen Us Inc NON-TRANSGENIC PLANTS RESISTANT TO HERBICIDES.
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
US6582516B1 (en) 1999-11-29 2003-06-24 Gustafson, Llc Continuous batch seed coating system
US20010042257A1 (en) 1999-12-07 2001-11-15 Dannette Connor-Ward Sugarbeet regeneration and transformation
IL134830A0 (en) 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US6768044B1 (en) 2000-05-10 2004-07-27 Bayer Cropscience Sa Chimeric hydroxyl-phenyl pyruvate dioxygenase, DNA sequence and method for obtaining plants containing such a gene, with herbicide tolerance
US7109393B2 (en) 2000-08-15 2006-09-19 Mendel Biotechnology, Inc. Methods of gene silencing using inverted repeat sequences
BR0003908A (en) 2000-08-18 2002-06-18 Suzano Papel & Celulose Method for genetic transformation of eucalyptus spp
US6453609B1 (en) 2000-09-06 2002-09-24 University Of Iowa Research Foundation Method for uptake of a substance into a seed
FR2815969B1 (en) 2000-10-30 2004-12-10 Aventis Cropscience Sa TOLERANT PLANTS WITH HERBICIDES BY METABOLIC BYPASS
US7462481B2 (en) 2000-10-30 2008-12-09 Verdia, Inc. Glyphosate N-acetyltransferase (GAT) genes
WO2002061101A2 (en) 2000-11-03 2002-08-08 Monsanto Technology Llc Method of imparting disease resistance to plants by reducing polyphenol oxidase activity
EP1341903B1 (en) 2000-12-07 2012-12-26 Syngenta Limited Plant derived hydroxy phenyl pyruvate dioxygneases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases
US6800748B2 (en) 2001-01-25 2004-10-05 Large Scale Biology Corporation Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
US6743905B2 (en) 2001-04-16 2004-06-01 Applera Corporation Mobility-modified nucleobase polymers and methods of using same
ES2192945B1 (en) 2001-07-06 2005-03-01 Consejo Superior De Investigaciones Cientificas A METHOD TO INTERFER WITH VIRUS INFECTION IN PLANTS.
US20030150017A1 (en) 2001-11-07 2003-08-07 Mesa Jose Ramon Botella Method for facilitating pathogen resistance
JP2005519607A (en) 2002-03-14 2005-07-07 コモンウェルス　サイエンティフィック　アンド　インダストリアル　リサーチ　オーガニゼーション Modified gene silencing RNA and uses thereof
JP4504689B2 (en) 2002-03-20 2010-07-14 ビーエーエスエフ ソシエタス・ヨーロピア Serine hydroxymethyltransferase as a herbicide target
US7166771B2 (en) 2002-06-21 2007-01-23 Monsanto Technology Llc Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
JP2005529959A (en) 2002-06-14 2005-10-06 マイラス コーポレイション Novel method for delivering polynucleotides to cells
BR0312580A (en) 2002-07-10 2006-10-10 Univ Kansas State compositions and methods for controlling parasitic nematodes
WO2004007691A2 (en) 2002-07-17 2004-01-22 Sepro Corporation Herbicide-resistant plants, and polynucleotides and methods for providing same
AU2003247962B2 (en) 2002-07-18 2008-06-12 Monsanto Technology Llc Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
AU2003274906A1 (en) 2002-07-31 2004-02-16 Nucleonics, Inc. Double stranded rna structures and constructs, and methods for generating and using the same
US20040053289A1 (en) 2002-09-09 2004-03-18 The Regents Of The University Of California Short interfering nucleic acid hybrids and methods thereof
AU2003304398A1 (en) 2002-10-16 2005-02-25 Board Of Regents, The University Of Texas System Methods and compositions for increasing the efficacy of biologically-active ingredients
ATE506438T1 (en) 2002-12-18 2011-05-15 Athenix Corp GENES CONFERRING HERBICIDE RESISTANCE
US20040133944A1 (en) 2003-01-08 2004-07-08 Delta And Pine Land Company Seed oil suppression to enhance yield of commercially important macromolecules
WO2004062351A2 (en) 2003-01-09 2004-07-29 Virginia Tech Intellectual Properties, Inc. Gene encoding resistance to acetolactate synthase-inhibiting herbicides
CN101173273B (en) 2003-02-18 2013-03-20 孟山都技术有限公司 Glyphosate resistant class I 5-enolpyruvylshikimate-3-phosphate synthase(epsps)
WO2005003362A2 (en) 2003-03-10 2005-01-13 Athenix Corporation Methods to confer herbicide resistance
DE502004010001D1 (en) * 2003-03-12 2009-10-15 Basf Plant Science Gmbh PROCESS FOR INCREASING RESISTANCE TO STRESS FACTORS IN PLANTS
WO2004089061A2 (en) 2003-04-11 2004-10-21 Bio-Oz Biotechnologies Ltd. Liquid discharge apparatus particularly useful as a portable inoculation gun for anti-virus inoculation of plants
US7682829B2 (en) 2003-05-30 2010-03-23 Monsanto Technology Llc Methods for corn transformation
US7578598B2 (en) 2006-11-13 2009-08-25 Black & Decker Inc. Battery charging work light
PT1633767T (en) 2003-06-02 2019-02-27 Univ Massachusetts Methods and compositions for controlling efficacy of rna silencing
WO2005017108A2 (en) 2003-06-30 2005-02-24 United Soybean Board Soybean selection system based on aec-resistance
KR100568457B1 (en) 2003-07-22 2006-04-07 학교법인 성균관대학 Cationic Oligopeptide-mediated RNA Delivery into Plants
US7371927B2 (en) 2003-07-28 2008-05-13 Arborgen, Llc Methods for modulating plant growth and biomass
US20050026290A1 (en) 2003-08-01 2005-02-03 Ciardi Joseph Anthony Inhibiting gene expression with dsRNA
US20120159672A1 (en) 2004-02-06 2012-06-21 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20060272049A1 (en) 2003-11-17 2006-11-30 Waterhouse Peter M Insect resistance using inhibition of gene expression
US7297541B2 (en) 2004-01-26 2007-11-20 Monsanto Technology Llc Genes encoding 4-hydroxyphenylpyruvate dioxygenase (HPPD) enzymes for plant metabolic engineering
US7622301B2 (en) 2004-02-24 2009-11-24 Basf Plant Science Gmbh Compositions and methods using RNA interference for control of nematodes
CA2762011C (en) 2004-04-09 2019-05-07 Monsanto Technology Llc Compositions and methods for control of insect infestations in plants
EP2308977B2 (en) 2004-04-30 2017-04-26 Dow AgroSciences LLC Novel herbicide resistance gene
WO2006026738A2 (en) 2004-08-31 2006-03-09 Qiagen North American Holdings, Inc. Methods and compositions for rna amplification and detection using an rna-dependent rna-polymerase
US20060135758A1 (en) 2004-08-31 2006-06-22 Kunsheng Wu Soybean polymorphisms and methods of genotyping
US20060247197A1 (en) 2004-10-04 2006-11-02 Van De Craen Marc Method for down-regulating gene expression in fungi
CA2582550C (en) 2004-10-25 2019-06-25 Devgen Nv Rna constructs
US7393812B2 (en) 2004-11-19 2008-07-01 Dow Agrosciences Llc Methylidene mevalonates and their use as herbicides
US8404927B2 (en) 2004-12-21 2013-03-26 Monsanto Technology Llc Double-stranded RNA stabilized in planta
US20060200878A1 (en) 2004-12-21 2006-09-07 Linda Lutfiyya Recombinant DNA constructs and methods for controlling gene expression
US8314290B2 (en) 2004-12-21 2012-11-20 Monsanto Technology Llc Temporal regulation of gene expression by MicroRNAs
US8030473B2 (en) 2005-01-07 2011-10-04 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Method to trigger RNA interference
US8088976B2 (en) 2005-02-24 2012-01-03 Monsanto Technology Llc Methods for genetic control of plant pest infestation and compositions thereof
US9085774B2 (en) 2005-04-19 2015-07-21 Basf Plant Science Gmbh Methods controlling gene expression
JP2006343473A (en) 2005-06-08 2006-12-21 Seiko Epson Corp Image forming apparatus
EP1907549A1 (en) 2005-06-17 2008-04-09 Pioneer-Hi-Bred International, Inc. Methods and compositions for gene silencing
EP1907551A1 (en) 2005-07-07 2008-04-09 CBD Technologies Ltd. Compositions and methods comprising stinging capsules/cells for delivering a biologically active agent into a plant cell
NZ568867A (en) 2005-08-24 2010-12-24 Pioneer Hi Bred Int Compositions providing tolerance to multiple herbicides and methods of use thereof
US7671254B2 (en) 2005-08-25 2010-03-02 The Board Of Trustees Of The University Of Illinois Herbicide resistance gene, compositions and methods
US7842856B2 (en) 2005-08-25 2010-11-30 The Board Of Trustees Of The University Of Illinois Herbicide resistance gene, compositions and methods
EP2426208B1 (en) 2005-09-16 2016-11-09 Monsanto Technology, LLC Methods for genetic control of insect infestations in plants and compositions thereof
AU2006329563B2 (en) 2005-09-16 2014-02-20 Devgen Nv dsRNA as insect control agent
CN101268194A (en) 2005-09-20 2008-09-17 巴斯福植物科学有限公司 Methods for controlling gene expression using ta-siRNA
CA2625031C (en) 2005-10-13 2016-07-19 Monsanto Technology Llc Methods for producing hybrid seed
EP1948196B1 (en) 2005-11-03 2012-12-26 Zoser B. Salama Use of tetraorganosilicon compounds
WO2007070389A2 (en) 2005-12-12 2007-06-21 Syngenta Participations Ag Control of parasitic weeds
KR20080081979A (en) 2005-12-23 2008-09-10 바스프 에스이 A method for controlling aquatic weeds
EP2347759B1 (en) 2006-01-12 2017-10-18 deVGen N.V. Methods for controlling pests using RNAi
US20090298787A1 (en) 2006-01-12 2009-12-03 Devgen N.V. Dsrna as Insect Control Agent
WO2008063203A2 (en) 2006-01-27 2008-05-29 Whitehead Institute For Biomedical Research Compositions and methods for efficient gene silencing in plants
US20080022423A1 (en) 2006-02-03 2008-01-24 Monsanto Technology Llc IN PLANTA RNAi CONTROL OF FUNGI
ES2479090T3 (en) 2006-02-10 2014-07-23 Monsanto Technology, Llc Identification and use of target genes for the control of plant parasitic nematodes
AU2007214547B2 (en) 2006-02-13 2012-09-20 Monsanto Technology Llc Selecting and stabilizing dsRNA constructs
US20070214515A1 (en) 2006-03-09 2007-09-13 E.I.Du Pont De Nemours And Company Polynucleotide encoding a maize herbicide resistance gene and methods for use
WO2007104570A2 (en) 2006-03-16 2007-09-20 Devgen N.V. Nematode control
US20070281900A1 (en) 2006-05-05 2007-12-06 Nastech Pharmaceutical Company Inc. COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY
JP2009536029A (en) 2006-05-09 2009-10-08 リライアンス ライフ サイエンシーズ プライベイト リミテッド Molecular cloning and sequencing of the acetyl-CoA carboxylase (ACCase) gene from Jatrophacurcas
US7884262B2 (en) 2006-06-06 2011-02-08 Monsanto Technology Llc Modified DMO enzyme and methods of its use
US9315818B2 (en) 2006-06-07 2016-04-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Plant expression constructs and methods of utilizing same
BRPI0711953A2 (en) 2006-06-08 2012-01-17 Athenix Corp isolated polynucleotide and polypeptide conferring resistance to glutamine synthetase and methods for producing transgenic plants and plant cells having improved nitrogen production and utilization
GB0613901D0 (en) 2006-07-13 2006-08-23 Univ Lancaster Improvements in and relating to plant protection
US7897846B2 (en) 2006-10-30 2011-03-01 Pioneer Hi-Bred Int'l, Inc. Maize event DP-098140-6 and compositions and methods for the identification and/or detection thereof
GB0709710D0 (en) 2007-05-21 2007-06-27 Syngenta Ltd Herbicidal compositions
WO2008148223A1 (en) 2007-06-07 2008-12-11 Agriculture And Agri-Food Canada Nanocarrier based plant transfection and transduction
CN101778561B (en) 2007-08-16 2013-12-25 巴斯夫欧洲公司 Seed treatment compositions and methods
ES2402341T3 (en) 2007-10-05 2013-04-30 Dow Agrosciences Llc Methods for transferring molecular substances into plant cells
CA2704549A1 (en) 2007-11-05 2009-05-14 Baltic Technology Development, Ltd. Use of oligonucleotides with modified bases as antiviral agents
MX2010004984A (en) 2007-11-05 2010-07-29 Baltic Technology Dev Ltd Use of oligonucleotides with modified bases in hybridization of nucleic acids.
WO2009085982A1 (en) 2007-12-19 2009-07-09 Monsanto Technology Llc Method to enhance yield and purity of hybrid crops
NZ586678A (en) 2008-02-20 2012-08-31 Syngenta Participations Ag Aqueous herbicide formulation comprising an HPPD inhibitor, an encapsulated chloroacetamide/isoxazoline, glyphosate/glufosinate and a pH adjuster
WO2009116151A1 (en) 2008-03-19 2009-09-24 アグロカネショウ株式会社 1-phenyl-5-difluoromethylpyrazole-4-carboxamide derivatives and herbicides containing the derivatives as the active ingredient
WO2009125401A2 (en) 2008-04-10 2009-10-15 Rosetta Genomics Ltd. Compositions and methods for enhancing oil content in plants
US8271857B2 (en) 2008-05-13 2012-09-18 International Business Machines Corporation Correcting errors in longitudinal position (LPOS) words
CA2729713C (en) 2008-07-01 2020-07-28 Monsanto Technology Llc Recombinant dna constructs and methods for modulating expression of a target gene
TWI455944B (en) 2008-07-01 2014-10-11 Daiichi Sankyo Co Ltd Double-stranded polynucleotides
WO2010018003A2 (en) 2008-08-15 2010-02-18 Salama Zoser B Carrier system for biological agents containing organosilicon compounds and uses thereof
WO2010036702A1 (en) 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
AR075089A1 (en) 2008-09-30 2011-03-09 Basf Se COMPOSITION TO IMPROVE THE EFFECTIVENESS OF HERBICIDES
EP2204366A1 (en) 2008-12-19 2010-07-07 Bayer CropScience AG Herbicidal and insecticidal phenyl-substituted pyridazinones
US9012723B2 (en) 2009-01-16 2015-04-21 Monsanto Technology Llc Isolated novel acid and protein molecules from soy and methods of using those molecules to generate transgene plants with enhanced agronomic traits
JP2010235603A (en) 2009-03-13 2010-10-21 Sumitomo Chemical Co Ltd Pyridazinone compound and use thereof
EP2229813A1 (en) 2009-03-21 2010-09-22 Bayer CropScience AG Pyrimidine-4-ylpropandinitrile derivatives, method for their manufacture and their use as herbicides and plant growth regulators
GB0905441D0 (en) 2009-03-30 2009-05-13 Syngenta Ltd Herbicidal compounds
AU2010233534B2 (en) 2009-04-06 2015-03-12 Syngenta Limited Herbicidal quinoline and 1,8 -naphthyridine compounds
JP5741429B2 (en) 2009-04-14 2015-07-01 日産化学工業株式会社 Haloalkylsulfonanilide derivatives
CN102459612A (en) 2009-04-21 2012-05-16 巴斯夫植物科学有限公司 Rna-mediated induction of gene expression in plants
GB0908293D0 (en) 2009-05-14 2009-06-24 Syngenta Ltd Herbicidal compounds
JP2012531924A (en) 2009-06-30 2012-12-13 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド Introduction of DNA into plant cells
WO2011003776A2 (en) 2009-07-09 2011-01-13 Basf Se Substituted cyanobutyrates having a herbicidal effect
US9145562B2 (en) 2009-11-20 2015-09-29 Alberta Innovates—Technology Futures Variegation in plants
BR112012012404B1 (en) 2009-11-23 2019-03-06 Monsanto Technology Llc "AMPLICON RECONBINANT DNA Molecule, DNA Probe, DNA Molecule Pair METHOD FOR DETECTING THE PRESENCE OF A DNA MOLECULE AND DNA DETECTION KIT".
US9562235B2 (en) 2009-12-06 2017-02-07 A.B. Seeds Ltd. MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
WO2011076882A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
AR081095A1 (en) 2009-12-28 2012-06-13 Evogene Ltd POLINUCLEOTIDES AND ISOLATED POLYPEPTIDES AND METHODS TO USE THEM TO INCREASE THE PERFORMANCE OF THE PLANT, BIOMASS, GROWTH RATE, VIGOR, OIL CONTENT, TOLERANCE TO THE ABIOTIC STRESS AND EFFECTIVENESS IN THE USE OF NITROG NITROG
WO2011094199A1 (en) 2010-01-26 2011-08-04 Pioneer Hi-Bred International, Inc. Polynucleotide and polypeptide sequences associated with herbicide tolerance
HUE033056T2 (en) 2010-03-08 2017-11-28 Monsanto Technology Llc Polynucleotide molecules for gene regulation in plants
EP2385129A1 (en) 2010-05-03 2011-11-09 BASF Plant Science Company GmbH Enhanced methods for gene regulation in plants
WO2012001626A1 (en) 2010-06-30 2012-01-05 Basf Plant Science Company Gmbh Novel microrna precursor and use thereof in regulation of target gene expression
EP2418283A1 (en) 2010-08-07 2012-02-15 Nomad Bioscience GmbH Process of transfecting plants
CN101914540A (en) * 2010-08-09 2010-12-15 大连大学 Method for introducing RNA interference into plants
EP2633056A1 (en) 2010-10-25 2013-09-04 A.B. Seeds Ltd. ISOLATED POLYNUCLEOTIDES EXPRESSING OR MODULATING MICRORNAs OR TARGETS OF SAME, TRANSGENIC PLANTS COMPRISING SAME AND USES THEREOF IN IMPROVING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, BIOMASS, VIGOR OR YIELD OF A PLANT
BR122021012776B1 (en) 2010-12-17 2022-08-16 Monsanto Technology Llc METHOD TO IMPROVE THE COMPETENCE OF A PLANT CELL FOR BACTERIAL-MEDIATED TRANSFORMATION
BRPI1107329A2 (en) 2010-12-30 2019-11-19 Dow Agrosciences Llc nucleic acid molecules that target the vacuolar atpase h-subunit that confer resistance to Coleoptera pests, plant transformation vector, transformed cell, as well as methods for controlling a Coleoptera pest population, controlling an infestation by said pest, improving the yield of a crop and to produce a transgenic cell
EP2530159A1 (en) 2011-06-03 2012-12-05 Sandoz Ag Transcription terminator sequences
EP3369822A1 (en) 2011-07-18 2018-09-05 Devgen NV Downregulation of gene expression in plant pathogens
WO2013025670A1 (en) 2011-08-16 2013-02-21 Syngenta Participations Ag Methods and compositions for introduction of exogenous dsrna into plant cells
CA2848371A1 (en) 2011-09-13 2013-03-21 Monsanto Technology, Llc Method and composition for weed control comprising topical application_of als polynucleotide
EP2756086B1 (en) 2011-09-13 2018-02-21 Monsanto Technology LLC Methods and compositions for weed control
BR112014005795A2 (en) 2011-09-13 2020-12-08 Monsanto Technology Llc methods of controlling plants, reducing the expression of a plant's hppd gene, preparing a nucleotide, and identifying polynucleotides useful in modulating the expression of the hppd gene in the external treatment of a plant, compositions and cassette of microbial expression
MX361938B (en) 2011-09-13 2018-12-19 Monsanto Technology Llc Methods and compositions for weed control.
BR112014005975A8 (en) 2011-09-13 2017-09-12 Monsanto Technology Llc PLANT CONTROL METHOD, METHOD OF REDUCING EXPRESSION OF A PDS GENE IN A PLANT, MICROBIAL EXPRESSION CASSETTE, METHOD OF MAKING A POLYNUCLEOTIDE, METHOD OF IDENTIFICATION OF POLYNUCLEOTIDES, AND COMPOSITIONS FOR WEED CONTROL
UY34333A (en) 2011-09-13 2013-04-30 Monsanto Technology Llc ? METHODS AND COMPOSITIONS FOR WEED CONTROL, AND METHODS TO REDUCE THE EXPRESSION OF ENZYME DHPS?
MX343071B (en) 2011-09-13 2016-10-21 Monsanto Technology Llc Methods and compositions for weed control.
BR112014005951A2 (en) 2011-09-13 2017-04-04 Monsanto Technology Llc Weed control methods and compositions
WO2013175480A1 (en) 2012-05-24 2013-11-28 A.B. Seeds Ltd. Compositions and methods for silencing gene expression
FI3622810T3 (en) 2012-09-24 2024-03-21 Seminis Vegetable Seeds Inc Methods and compositions for extending shelf life of plant products
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
EA032406B1 (en) 2013-01-01 2019-05-31 Эй.Би. СИДЗ ЛТД. METHODS OF INTRODUCING dsRNA TO PLANT SEEDS FOR MODULATING GENE EXPRESSION
US10000767B2 (en) 2013-01-28 2018-06-19 Monsanto Technology Llc Methods and compositions for plant pest control
UA123082C2 (en) 2013-03-13 2021-02-17 Монсанто Текнолоджи Ллс Methods and compositions for weed control
US10612019B2 (en) 2013-03-13 2020-04-07 Monsanto Technology Llc Methods and compositions for weed control
US20140283211A1 (en) 2013-03-14 2014-09-18 Monsanto Technology Llc Methods and Compositions for Plant Pest Control
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
JP6668236B2 (en) 2013-07-19 2020-03-18 モンサント テクノロジー エルエルシー Composition for controlling LEPTINOTARSA and method therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100088777A1 (en) * 2006-10-24 2010-04-08 Basf Plant Science Gmbh Methods For Increasing The Resistance In Plants To Biotropic Fungi

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229223A (en) * 2019-06-14 2019-09-13 中国科学院遗传与发育生物学研究所 Wheat anti-powdery mildew correlation BFR albumen and its encoding gene and application

Also Published As

Publication number Publication date
US20140215656A1 (en) 2014-07-31
US10000767B2 (en) 2018-06-19

Similar Documents

Publication Publication Date Title
US10435701B2 (en) Methods and compositions for plant pest control
US20180346923A1 (en) Methods and Compositions for Plant Pest Control
US10844398B2 (en) Methods and compositions for plant pest control
US20220081695A1 (en) Compositions and methods for controlling insect pests
US10435702B2 (en) Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
RU2662995C2 (en) Reducing gene expression in insect pests
US20190008156A1 (en) Methods and Compositions for Plant Pest Control
CN114009454A (en) Compositions and methods for controlling insect pests
MX2012010479A (en) Polynucleotide molecules for gene regulation in plants.
US20160230186A1 (en) Compositions and methods for controlling diabrotica
US20150247153A1 (en) Method for Improving Shelf Life by Regulating Expression of Polyphenol Oxidase
CN110946137A (en) Methods and compositions for controlling plant viral infections
US10428338B2 (en) Methods and compositions for increasing invertase activity in plants
US20230189818A1 (en) Rna-based control of botrytis
WO2022192241A2 (en) Rna-based control of powdery mildew
WO2021231791A2 (en) Rna-based control of lepidopteran pests

Legal Events

Date Code Title Description
AS Assignment

Owner name: MONSANTO TECHNOLOGY LLC, MISSOURI

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CRAWFORD, MICHAEL J.;LI, XIANGQIAN;KAPOOR, MAHAK;AND OTHERS;SIGNING DATES FROM 20130131 TO 20130211;REEL/FRAME:046217/0370

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION